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Abstract 
 
Amyotrophic lateral sclerosis (ALS) is a devastating and progressive disease that results in 
selective death of motor neurons in the cortex, brain stem and spinal cord. ALS is the most common adult 
onset motor neuron disease resulting in paralysis and death, commonly within 2 – 5 years of symptom 
onset, yet there remains no effective treatment for the disease. The majority of ALS cases show no 
hereditary link (referred to as sporadic ALS or sALS); however, ~10% of cases show a dominant pattern 
of inheritance (referred to as familial ALS or fALS). Over 170 different mutations in human Cu, Zn 
superoxide dismutase (SOD1) have been identified to account for ~20% of fALS. SOD1 is a ubiquitously 
expressed homodimeric antioxidant enzyme. It is widely accepted that mutations in SOD1 result in a gain 
of toxic function, rather than a loss of native function. A prominent hypothesis for the gain of function is 
the formation of protein aggregates, which have been shown to be toxic to motor neurons. Protein 
aggregation is observed in a number of neurodegenerative disorders, including Alzheimer’s, Huntington’s 
and Parkinson’s disease.  
Each β-rich monomer of SOD1 binds one catalytic Cu ion and one structural Zn ion. The 
metallation state of SOD1 significantly influences the structure, dynamics, activity, stability, and 
aggregation propensity. A similar trend has been observed in a number of metalloenzymes and as such a 
method to rapidly and accurately quantitate metal ions in proteins is of great importance. Here a review of 
previous methods using the chromogenic chelator PAR to quantitate metal ions in proteins is presented. 
Three methods are assessed for their accuracy, precision and ease of use. The methods vary in accuracy, 
which is highest only under the specific conditions it was designed for.  A robust new method is presented 
here that uses spectral decomposition software to accurately resolve the absorption bands of Cu and Zn 
with high precision. This method may be successful as a more general method for metal analysis of 
proteins allowing for the quantitation of additional metal combinations (e.g. Zn/Co, Ni/Cu, Ni/Co).  
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Thermodynamic stability has widely been implicated as playing a major role in the aggregation of 
globular proteins. Metal loss significantly decreases the global stability of SOD1 and as such metal-
depleted (apo) forms of SOD1 have largely been the focus of SOD1 investigations. Recent studies, 
however, suggest that complete global unfolding is not required for protein aggregation. Local unfolding 
has been investigated and proposed to be sufficient to induce irreversible protein aggregation in the 
absence of global destabilization. Enhanced local unfolding has been observed in a number of disease-
related proteins. Since SOD1 aggregation may occur from partially unfolded forms, NMR temperature 
dependence studies have been carried out on the most abundant form of SOD1 in vivo, the fully 
metallated (holo) dimer, to provide a residue specific picture of subglobal structural changes in SOD1 
upon heating.  
Amide proton (N
1
H) temperature coefficients report on the hydrogen bonding status of a protein. 
A curved N
1
H temperature dependence indicates that the proton populates an alternative conformation 
generally within 5 kcal/mol of the ground state. NMR temperature dependence studies of pseudoWT 
indicate that the thermal unfolding process of holo pWT begins with “fraying” of the structure at its 
periphery. In particular, increased disorder is observed in edge strands β5 and β6, as well as surrounding 
the zinc binding site. The local stability and conformational heterogeneity of ALS-associated mutants 
G93A, E100G and V148I was also assessed. All mutants display similar local unfolding patterns to 
pseudoWT, but also show distinct differences in the hydrogen bonding network surrounding the mutation 
site. Interestingly, each mutation regardless of its structural context results in altered dynamics at the β-
barrel plug, a key stabilizing element in SOD1. A significant proportion of residues (~30%) access 
alternative states in both pseudoWT and mutants, however, overall mutants appear to be able to access 
higher free energy alternative states compared to pseudoWT. The implications of these results for the 
mechanism of protein aggregation and disease are discussed.   
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Chapter 1 
General Introduction 
 
1.1 Protein folding 
 
The ability of a protein to serve its biological purpose is most often dependent upon its ability to 
form a stable, three-dimensional structure referred to as the native state (1). Protein folding is a complex 
process that can begin even before the newly synthesized polypeptide chain is released from the 
ribosome. As the polypeptide folds it forms an intricate network of weak noncovalent interactions that 
stabilize the native state. Solving the “folding problem” and identifying the pathways between the 
unstructured and native state are key to understanding and predicting sequence to structure relationships. 
The ability to predict structure would be instrumental also in the design of novel polypeptides able to 
serve a diverse range of functions from biomaterials to drug delivery systems, highlighting the importance 
of further investigations in this area.   
Many years ago, Levinthal proposed that if a protein were to sample all of the states available to 
the unfolded polypeptide it would take longer than the age of the universe for a protein to reach the native 
state (2). Protein folding has since been proposed to occur through a number of defined pathways. The 
framework model suggests that a protein may fold through a sequential process, first by rapidly forming 
secondary structure that serves as a scaffold for the subsequent formation of tertiary structure (3). Two 
mechanisms proposed for this process include nucleation and diffusion-collision. In the nucleation 
mechanism, it is believed that folding initiates from a small number of key residues around which the 
remainder of the structure can then pack. In the diffusion-collision mechanism, secondary structures are 
formed and then through diffuse movement, collide and combine to form the tertiary structure. An 
alternative model is hydrophobic collapse, which involves the collapse of the protein due to hydrophobic 
interactions and within the confined volume formation of secondary and tertiary structure (3). Computer 
simulations using lattices models and in vitro folding studies have further developed the folding model 
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(4). This new view describes protein folding via numerous parallel pathways along an energy landscape, 
often depicted using a protein folding funnel (Figure 1.1). The top of the funnel is very broad, 
representing the vast number of conformations the unfolded polypeptide can adopt. As native interactions 
are formed through dynamic movements, the number of possible conformations is reduced as indicated by 
narrowing of the funnel. The local minima represent transient, partially folded intermediate states 
populated in the folding process. The bottom of the funnel represents the lowest energy, native state of the 
protein.  
 
Figure 1.1 – Schematic depiction of the protein folding energy landscape adapted from Radford (2000)(5). An 
ensemble of different protein conformations all fold via multiple parallel pathways to reach the lowest energy native 
state. The jagged edges represent partially folded intermediates occupied along the folding pathway. Figure 
reproduced with permission from Rumfeldt, J., 2006 (6).  
 
The Gibbs Helmholtz equation (Eq. 1.1) is often used to describe the thermodynamics of protein 
folding: 
                                                                    ΔG = ΔH – TΔS Eq. 1.1 
where the differences in Gibbs free energy, enthalpy and entropy, of the folded state relative to the 
unfolded state, are given by ΔG, ΔH, and ΔS, respectively. The thermodynamics of solvent water also 
contribute to these terms. This is because as a protein unfolds many of the intramolecular hydrogen bonds 
and electrostatic interactions within the protein are replaced by intermolecular interactions with solvent 
water (7). Protein folding also involves overcoming at least one free energy barrier, with the highest point 
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of this barrier corresponding to the transition state (TS) and the rate determining step (Figure 1.2). Protein 
folding can and has been shown to exhibit both two-state and multi-state kinetics (8). Small monomeric 
proteins often fold via two-state kinetics, which involves the formation of the native protein from the 
unfolded peptide through one transition state (Figure 1.2) (9). Larger, more complex proteins tend to fold 
via multi-state kinetics with more elaborate mechanisms and parallel pathways (10). In multi-state 
kinetics there will be more than one of these barriers present and thus intermediates will be populated. 
The structure of the transition state cannot be observed directly, as it is formed transiently and does not 
build up to any significant concentration, however, it can be inferred through φ-value analysis, an 
experimental method that involves mutation of individual side chains to identify native-like interactions 
formed in the transition state (11).  
 
Figure 1.2 – Free energy diagram of two-state folding (N ↔ U). The highest energy point represents the transition 
state (TS
‡
). The difference in unfolded and folded free energy values is referred to as the free energy change of 
folding (∆G). The kinetic folding and unfolded barriers are given by ΔGf
‡ 
and ΔGu
‡
, respectively.  
 
1.2 Protein misfolding and aggregation  
 
Despite the vast number of conformations available to a polypeptide chain, remarkably, proteins 
are able to spontaneously fold into their native state. Anfinsen showed in 1961 that all of the information 
necessary for proper folding is contained in the amino acid sequence (12). The intracellular environment, 
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however, is a complex one that consists of a compartmentalized, inhomogeneous milieu of 
macromolecules (proteins, lipids, nucleic acids, etc.) at concentrations of 200-400 mg/mL (13). 
Macromolecular crowding can affect protein stability, the mechanisms of protein folding and kinetic rates 
associated with the process (14). In order to ensure proper folding in vivo, molecular chaperones often aid 
in the process (15). Some chaperones are involved early in the folding process to prevent protein 
aggregation, while others direct later stages of the process such as the binding of cofactors or the 
development of quaternary structure (1). In spite of this, and the fact that the native state of the protein is 
the most stable under physiological conditions, mistakes in protein folding occur.  
Protein misfolding arises when a polypeptide acquires lasting non-native interactions that affect 
the overall structure and/or function of the protein (1). When misfolded or unfolded proteins cannot be 
prevented from forming or recovered they are often targeted for destruction through the ubiquitin-
proteasome system (16). When all of these mechanisms to prevent the presence of misfolded or unfolded 
proteins in the cell fail, protein aggregation can occur. Aggregation involves the formation of non-native 
complexes of varied protein conformations containing many copies of the same protein. Aggregates are 
often formed through protein-protein interactions created by solvent exposed hydrophobic patches of 
misfolded or unfolded proteins (1). The type of aggregate structure formed depends on the specific 
protein as well as the environmental conditions; however, aggregates can range from small soluble 
oligomers to large, insoluble, well-ordered fibrils (17). The most well characterized type of aggregate is 
amyloid, a fibrillar aggregate with extensive beta-sheet structure suggested to be attainable by any protein 
under extreme conditions (18, 19). In some cases, protein aggregation may serve a physiological function, 
as in the case of F-actin filament formation in muscles; however, most often the result is toxic (20). 
Despite being the most fundamental process in molecular biology, there is still much to be learned about 
the mechanisms of protein folding, misfolding and aggregation.  
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1.3 Protein aggregation and disease 
Protein aggregation has been linked to numerous peripheral diseases, such as renal amyloidosis, 
Type II diabetes and atherosclerosis, as well as many neurodegenerative diseases such as Alzheimer’s 
disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS) (20). Despite differing compositions 
of protein aggregates as well as varied disease symptoms, in general neurodegenerative diseases exhibit 
adult onset, extensive neuronal loss and the presence of cerebral protein aggregates suggesting a 
commonality in disease mechanisms (21). The exact mechanisms by which protein aggregates exert toxic 
effects on cells are not known. Various hypotheses have been proposed for the pathways by which 
intracellular aggregates lead to neuronal cell death, including decreased chaperone activity, sequestration 
of cellular components, enhanced oxidative stress, mitochondrial dysfunction, and impaired capabilities 
of the proteasome (20, 22). The involvement of aggregates in cell death is supported by studies that reveal 
the presence of abnormal protein aggregates in regions of the brain most damaged by disease, as well as 
in vitro studies showing that misfolded protein aggregates induce apoptosis in cells (23, 24). Recent 
studies however have shown that small, soluble oligomers are most toxic to cells (25). In some animal 
models, for example, disease symptoms appear well before insoluble aggregate formation(21). In 
addition, clinical studies have demonstrated that the presence of insoluble inclusions does not always 
correlated with disease symptoms (21). Rather, patient data for various neurodegenerative diseases show 
that neuronal cells containing large insoluble inclusion bodies are often healthier than surrounding cells 
lacking these structures(21). Taken together, these findings suggest that it is the earlier stages of 
aggregate formation are most toxic and likely the main causes of neurodegeneration.  
1.4 Factors that affect protein aggregation 
While not completely understood, there are a number of genetic and environmental factors that 
have been implicated in protein aggregation, such as point mutations, post-translational modifications and 
ionic strength (17, 20). The thermodynamic stability of proteins has widely been implicated as playing a 
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major role in the aggregation propensity of globular proteins (26). This theory has been supported by 
calorimetric analyses on a wide range of mutant proteins associated with protein misfolding diseases, 
which often show decreased conformational stability when compared to the wild-type (WT) protein and 
through in vitro studies revealing that aggregate formation generally requires at least mildly destabilizing 
conditions (27-31). An underlying assumption of the protein stability hypothesis is that the aggregation-
prone state of a protein exists in the conformational ensemble in solution and is in equilibrium with the 
native state (32). With this model, destabilization of the native state will result in a higher population of 
the aggregation-prone species and thus an increase in observed aggregation (32). However, an increasing 
body of evidence shows that aggregation propensity cannot always be correlated well with protein global 
thermodynamic stability, challenging this theory. 
It has been proposed that kinetic stability (33), as well as other factors, such as reduced global 
cooperativity (see below) (34), decreased net charge (35), and the pH-dependence of protein solubility 
(36), may also play vital roles in the misfolding and aggregation of proteins. The protein transthyretin 
(TTR) provides an example where the study of folding energetics has been instrumental in the 
understanding of protein aggregation. TTR is a homotetramer found in the cerebral spinal fluid and blood 
plasma. TTR has been implicated in 4 amyloid diseases: (1) familial amyloidotic polyneuropathy (FAP), 
(2) familial amyloidotic cardiomyopathy (FAC), (3) senile systemic amyloidosis and (4) the rare central-
nervous-system-selective amyloidosis (37). Over 80 different point mutations have been identified to 
cause FAP and FAC (38). Different mutations have been associated with diversity in the age of onset, 
penetrance and tissues affected (39). Mutations destabilize the native state of TTR, however, decreases in 
thermodynamic stability alone (i.e. ΔG) do not correlate well with disease severity (37). For example, the 
most destabilized TTR mutants, D18G and A25T, are not the most pathogenic (40, 41). In contrast, when 
both kinetic and thermodynamic data are considered together, the effects of mutations can more reliably 
predict disease severity. TTR aggregation is believed to occur through a mechanism referred to as 
downhill polymerization (42). In this case, tetramer dissociation is the rate-limiting step and thus 
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mutations that decrease the kinetic barrier associated with dissociation may increase aggregation without 
destabilizing the native state. However, tetramer-monomer-unfolded monomer equilibria are strongly 
influenced by thermodynamic stability, as shown by urea denaturation studies (43), and thus 
destabilization of the tetramer or folded monomer can  enhance aggregation propensity (37). The 
combined results of these studies indicate that there is a strong interplay between kinetic and 
thermodynamic stability in relation to aggregation and associated disease properties.  
Recently, based on studies on dimeric T7 endonuclease I, the Eisenberg group proposed a 
different model for understanding the pathways of protein aggregation, called the prepared model (32). 
The new model suggests that the protein ensemble in solution is governed by both protein sequence and 
solution conditions and only under certain conditions, when the protein is said to be “prepared”, does the 
protein ensemble in solution contain the aggregation-prone species. The authors propose that this model 
complements the protein stability hypothesis as it can account for cases where disease-causing mutations 
do not result in a decrease in protein stability. In this case the mutations prepare the protein by making the 
aggregation-prone state accessible without actually destabilizing the native state. This model also 
complements the conformational change hypothesis, suggesting that the preparation of a protein requires 
specific local conformational changes rather than complete unfolding  (32). 
1.4.1 The role of local unfolding in protein aggregation 
Local unfolding, or localized increases in protein dynamics, have been investigated and proposed 
to be sufficient to induce irreversible protein aggregation in the absence of global destabilization (34, 44). 
In the native state, the globular fold of many proteins buries much of the main chain of the polypeptide 
within the structure preventing it from forming non-native interactions. Fluctuations, or breathing 
motions, of the protein can expose very local regions to solvent but such conformations are transient and 
unlikely to form strong intermolecular interactions (45). Rather, it may be more likely that conditions 
promoting the formation of a partially unfolded state exposing larger sections of the polypeptide 
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backbone to solvent induce aggregation (46). The generic building block model of protein aggregation 
postulates that the residual structured regions of a partially unfolded protein form non-native interactions, 
serving as building blocks for the formation of aggregates and as such these structured regions represent 
the core-forming segments (47-49). This theory suggests that variations in local unfolding patterns, due to 
genetic or environmental influences, can explain the different aggregate morphologies observed for 
proteins (50). 
Enhanced local unfolding has been characterized in a number of disease-related proteins, such as 
human Cu,Zn superoxide dismutase (SOD1) (47, 51, 52), lysozyme (45), β2-microglobulin (30), and γ-
crystallin (53). Hydrogen-deuterium exchange studies on the WT and an amyloidogenic variant of human 
lysozyme (D67H) revealed that upon mutation two regions of the protein, the β-domain and the adjacent 
C-terminal region, showed marked decreases in stability (45). The transient unfolding of these two 
regions appeared to be cooperative, resulting in a partially structured intermediate with both of these 
regions simultaneously unfolded. When compared to WT, the population of this partially unfolded 
intermediate and the degree of cooperativity of partial unfolding were much greater for the mutant; both 
factors likely contribute to the increased aggregation propensity of D67H (45). Another study on β2-
microglobulin, the protein implicated in hemodialysis-related disorders, used nuclear magnetic resonance 
(NMR) spectroscopy to monitor that stability of the protein on an atomic level as a function of pH and 
urea (30). Again, the state proposed to be the amyloid precursor is a partially folded intermediate that has 
lost structure in 2 of the seven β-strands that make up the native fold (30). Molecular dynamics 
simulations also support the role of partially unfolded species in disease. Computational studies of γ-
crystallin, linked to inherited cataract disease, suggest that a partially unfolded intermediate, with a 
structured C-terminus but a largely unstructured N-terminus, is the aggregation prone species (53). 
Together these studies demonstrate that complete unfolding of a protein is likely not necessary for 
pathogenesis and understanding of local unfolding patterns may be vital to elucidating protein 
aggregation mechanisms.  
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1.5 Amyotrophic lateral sclerosis 
 ALS is the most common adult onset motor neuron disease, with approximately 1 in 2000 people 
being affected. Patients with ALS exhibit selective death of motor neurons in the cortex, brain stem and 
spinal cord. This leads to total paralysis and death, often due to respiratory failure, usually within 2-5 
years of disease onset (54). A universal characteristic of ALS is the appearance of protein deposits called 
inclusion bodies in degenerating neurons (55). Patients who have no genetic link are classified as having 
sporadic ALS (sALS), while those with family inheritance are classified as familial ALS (fALS). The 
majority of ALS cases show no hereditary link, however, ~10% show a dominant pattern of inheritance. 
In 1993, it was found that mutations in the gene SOD1 account for ~20% of the fALS (56). Knowledge of 
the mechanisms underlying SOD1 dysfunction is crucial to an understanding of the familial form of the 
disease, and since the phenotypes and molecular mechanisms of the sporadic and familial forms are 
similar, this suggests common therapies may be possible. Currently, there is no cure for ALS and very 
little available in terms of medical therapy, which is mainly limited to amelioration of disease symptoms 
(57).  
1.6 Cu, Zn Superoxide dismutase  
1.6.1 SOD1 structure 
SOD1 is a 32 kDa homodimeric metalloenzyme with 153 amino acids per monomer. Each 
monomer consists of a Greek key beta barrel motif with eight antiparallel β-strands connected by a series 
of loops (Figure 3) (54). SOD1 undergoes a variety of post-translational modifications, including metal 
binding, the formation of a disulphide bond between Cys57 and Cys146 (Figure 3), and dimerization to 
form the mature protein (58). The dimer interface is formed by ~14 side chains from each subunit, with 8 
of these being hydrophobic residues (59). Three residues, Gly51, Gly114 and Ile151, form the four 
hydrogen bonds that span the dimer interface (58). Dimerization buries approximately 8% of the total 
monomer surface area which is relatively small compared to other homodimeric proteins (58, 60).  
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Figure 1.3 – Structure and topology of human SOD1. (A) Ribbon diagram of pWT SOD1. Copper and zinc atoms 
are shown by turquoise and black spheres, respectively. Cys57 and Cys 146 are shown in yellow space-filling 
representation. β-sheet 1 (strands β1, β2, β3 and β6)  is coloured blue. β-sheet 2 (strands β4, β5, β7 and β8)  is 
coloured orange.  Loops IV and VII are coloured green and purple, respectively. Prepared using MOLMOL (61) and 
PDB coordinates 1SOS (62) (B) Topology diagram of SOD1 monomer illustrating the Greek-key barrel. β-strands 
are numbered and loops are labelled in roman numerals. The amino acid sequence is labelled numerically at the end 
of each β-strand. Figure adapted from Rumfeldt, J., 2006 (6).  
 
Each monomer binds one copper and one zinc ion (Figure 1.4). The copper ion is coordinated by 
four histidine residues (His46, His48, His63, and His120) and one water molecule. The imidazole group 
of His63 bridges the copper and zinc ions. The zinc ion is coordinated by two other histidine residues 
(His71 and His80) and the aspartyl group of Asp83 forming a tetrahedral geometry (62, 63). The copper 
ion is essential for the enzyme’s catalytic activity while the both copper and zinc contribute to the 
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stability of the enzyme (54). Excess free copper within cells can be damaging and thus the concentration 
within the cytoplasm is highly regulated. Transfer into the cell and between compartments often involves 
metallochaperones, which bind to the ion to reduce its toxic effects (31). In vivo, SOD1 has been shown 
to obtain copper through an interaction with the metallochaperone, Cu chaperone for SOD1 (CCS), which 
catalyzes both copper insertion and disulphide formation. In yeast, it has been shown that zinc must be 
bound to SOD1 in order for it to interact with CCS (64). SOD1 has been shown to obtain copper through 
alternative mechanisms in the absence of CCS, such as through a glutathione dependent pathway (see 
section 2.1.2) (65). The mechanisms through which SOD1 acquires zinc remain unknown. 
 
Figure 1.4 – Structure of human SOD1 metal binding site. Copper and zinc atoms are shown by green and black 
spheres, respectively. Side chains of meal binding ligands are shown in stick representation, coloured orange.  
 
1.6.2 SOD1 activity 
SOD1 is expressed in all tissue types but is found in higher concentrations within the central 
nervous system (66). The physiological concentration of SOD1 is approximately 40 μM in motor neurons 
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(67). Within the cell, SOD1 is found in the nucleus, peroxisomes, mitochondrial intermembrane space and 
most abundantly in the cytosol (54). SOD1 serves to reduce oxidative damage from reactive oxygen 
species (ROS) through the conversion of superoxide to hydrogen peroxide and oxygen: 
2O2
-
 + 2H
+
 → O2 + H2O2 Eq. 1.2 
The active site of SOD1 is located at the bottom of a long channel formed by the metal binding loop (loop 
electrostatic field that guides the negatively charged superoxide radical into the active site (58).  The 
mechanism of SOD1 activity involves the successive oxidation and reduction of Cu
2+ 
(68). In the first step 
copper is reduced converting the superoxide radical to molecular oxygen. In the second step the copper is 
reoxidized and a second superoxide radical is reduced and protonated to form hydrogen peroxide (69).  
1.6.3 SOD1 stability 
The fully metallated (holo) form of SOD1 is extremely stable with a melting temperature (Tm) of 
approximately 90°C (70, 71). This fully mature form of the protein is also highly resistant to chemical 
denaturation and proteolytic degradation (70). Partially and unmetallated (apo) SOD1 are considerably 
less stable (72) and have been reported to have an increased aggregation propensity (72-74). In the apo 
form of SOD1, reduction of the disulfide bond, which connects a portion of loop IV to the β-barrel 
(Figure 1.3 A), increases the rate of dimer dissociation, increasing the population of the apo monomer, a 
species that has been implicated in disease (75). Interestingly, reduction of the disulfide bond in the holo 
form has been reported to have no measurable effect on the monomer-dimer equilibrium (76). It has been 
proposed that in addition to the stability conferred by metal binding, the tight packing of the two halves of 
the β-barrel core and of the hydrophobic dimer interface in the holo state also confer greater stability (77).  
1.6.4 SOD1 mutations 
To date, 177 different mutations in SOD1 have been linked to ALS (http://alsod.iop.kcl.ac.uk/). 
Initially, it was proposed that mutations promote disease through a loss of protective function leading to 
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increased oxidative damage within the cell (78). This theory was later disproved using mice models. Mice 
lacking the SOD1 gene did not develop the disease but mice expressing both their endogenous SOD1 
gene and a mutant form of the human SOD1 gene did develop disease symptoms (66). This finding and 
the autosomal dominant pattern of inheritance in patients indicate that mutant SOD1 promote disease 
through a toxic gain of function, which has yet to be elucidated. Current hypotheses for the mechanisms 
by  which mutant SOD1 may cause disease include endoplasmic reticulum stress, excitotoxicity from 
failure to remove synaptic glutamate, mitochondrial damage and aberrant enzymatic activity (22). The 
most widely supported hypothesis for the gain of function is the formation of toxic intracellular protein 
aggregates (21). Patient data for both the sporadic and familial forms of ALS, as well as mice models, 
show that inclusions found in neuronal cells contain SOD1, as well as ubiquitin and neurofilament 
proteins (79). The non-native protein aggregates may form unfavourable interactions interfering with 
various cellular components, such as chaperones, protein trafficking and degradation machinery, and 
membranes (22).  
The fALS SOD1 mutation sites span the entire polypeptide chain. It is noteworthy that despite the 
varying sites of mutation and differences in stability, hydrophobicity, metal binding status and 
susceptibility to post-translational modifications caused by mutation, each leads to the same fatal outcome 
(80). Most mutations do result in a decrease in conformation stability in both the holo and apo state; 
however this is not always true (81). The disease-associated mutant V148I has increased stability 
compared to WT, a low aggregation propensity compared to other mutants, and yet, surprisingly, a short 
average disease duration of ~1.7 years (Figure 1.5) (80). There does not appear to be a correlation 
between mutant destabilization and disease duration. DSC studies reveal that mutations can have 
differential effects on the stability of the holo and apo states while ITC studies show the same is true for 
the extent to which the dimer interface is destabilized (81). Thus, different mutations can increase the 
population of folded and/or unfolded monomers to varying extents depending on the combination of the 
varying effects on folding energetics. SOD1 aggregation is likely a multifactorial process that is 
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dependent on the concomitant alteration of a number of different factors in addition to mutation (20). 
Elucidation of these factors may help to understand the role, if any, of WT SOD1 in sALS. 
 
Figure 1.5 – Disease duration and global stability of mutant SOD1s. The global stability is given as a grey bar and is 
the difference in the temperature where half of the protein is unfolded (Tm; measured by DSC) from that for pWT 
(ΔTm = Tm(pwT) – Tm(mutant)). Disease durations are given as a black line and were obtained from Wang et al., 2008 
(80).  
 
1.6.5 SOD1 folding energetics 
The observed folding mechanism of SOD1 depends on the conditions for denaturation. Thermal 
denaturation of holo SOD1 at relatively high protein concentration fits as a 2-state transition between 
folded dimers and unfolded monomers (81, 82). On the other hand, in chemical denaturation experiments 
at lower protein concentrations the observed transition is 3-state, as a monomeric intermediate also 
becomes populated (70). Similar behaviour is observed for apo SOD1 which again is well fit as a 2-state 
and 3-transition for thermal and chemical denaturation, respectively. However, at decreased 
concentrations it appears that the thermal denaturation of apo SOD1 becomes less cooperative as a 
monomeric intermediate is populated. Mutations also influence the observed unfolding of SOD1 as it has 
been shown that some mutants exhibit more 3-state behaviour (81, 82) (and unpublished). In the most 
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immature form (apo, disulfide reduced), SOD1 is monomeric and shows a 2-state transition between 
folded and unfolded monomers (83). The low heat capacity (ΔCp) for unfolding suggests that the apo, 
disulfide reduced monomer is expanded compared to that in the holo, oxidized dimeric state (81, 83).  
 
1.6.6 SOD1 gain of toxic function 
 
 
It has been proposed that dimer dissociation and metal loss are required for SOD1 aggregation 
(84-86). However, the role of metal and/or disulfide deficient or misfolded forms of SOD1 in disease still 
remain unclear (81, 87, 88). Various factors have been suggested to promote SOD1 aggregation, 
including increased flexibility of loops IV and VII upon metal loss (89), the formation of intermolecular 
disulfide bonds between cysteine residues of SOD1 (90), a reduction in net charge upon mutation (35), 
and oxidation induced misfolding (91). There is evidence that some mutations weaken metal binding 
affinity resulting in an increased propensity to loose metals (92). Loss of metals will not only result in 
increased dynamics in the metal binding loop (loop IV) but can favour monomerization as the metal 
binding loop also forms a portion of the dimer interface, which is weakened in apo SOD1 compared to 
holo SOD1 (92, 93). Further, even in the holo state mutations have been shown to increase the global 
dynamics of SOD1 (75, 94, 95). Increased dynamics could provide non-native substrates access to the 
active site allowing for aberrant chemistry and oxidative damage to the protein (95) or increase the 
population of locally unfolded states. 
Recent work on holo SOD1 shows that even from this most mature state aggregation can and 
does occur. Under physiologically relevant conditions, over time holo SOD1 can undergo changes in 
metallation and/or dimerization resulting in the formation of aggregates (92). This process is increased by 
but does not require mutation. Holo SOD1 is a remarkably stable protein and while mutations are 
destabilizing, in this form the extent to which mutations increase the population of unfolded protein under 
physiologically relevant conditions is very small (81). It is for this reason that the role of holo SOD1 in 
disease is often overlooked, with the focus often instead on the most immature, monomeric form of the 
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protein (75, 84, 96-100). However, even in the most immature reduced apo monomeric form, some 
disease associated variants, such as H48Q, H46R, D101N, and V148I, do not enhance global unfolding at 
physiological temperature (83, 101). This suggests that local unfolding, in both the holo and apo state, 
may play important roles in SOD1 aggregation.   
Computational analyses on the conformational dynamics and aggregation propensity of WT and 
two fALS mutants (G37R and I149T) suggest that the apo monomer undergoes common modes of local 
unfolding (49). It was found that the two long loops (loop IV and VII), as well as strands 4, 5 and 7, 
which make up most of the C-terminal β-sheet 2, show a high degree of unfolding. Furthermore, 
mutations were shown to alter the local unfolding dynamics of SOD1 resulting in aggregates with 
different core-forming segments and structural polymorphism (49). Interestingly, recent experimental and 
computational studies have shown that the morphologies of protein aggregates affect the resulting disease 
phenotype which may help to explain the diversity in the age of onset and disease duration seen in ALS 
patients, for example (49, 102, 103). The β-barrel was identified early on as a key stabilizing element is 
SOD1 (58, 78). Leu38 is often referred to as the “plug” as it fills a cavity created by a number of residues 
(Val14, Ile35, Leu144 and His43) in the structure. With the exception of Ile35, all of these residues have 
been reported as disease-causing mutations (http://alsod.iop.kcl.ac.uk/). Molecular dynamics (MD) 
simulations on the apo dimer of WT and fALS mutants A4V, H46R and G37R, show that regardless of 
the mutation site and effect on stability, mutations commonly alter the dynamics in the β-barrel plug, 
suggesting that local destabilization may be sufficient to induce aggregation and could provide a general 
mechanism for SOD1 aggregation (104). 
Experimental work further supports the presence of local unfolding in the apo monomer of 
SOD1. Edge-to-edge aggregation is commonly seen in de novo designed β-sheet proteins since edge 
strands are aligned perfectly to interact with any other β-strand they encounter (105). In nature, it appears 
proteins have evolved a number of ways to protect against this phenomenon, such as the β-barrel structure 
which has continuous H-bonding around the barrel cylinder or the placement of charged residues in edge 
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strands to avoid association (105). SOD1 employs both a β-barrel structure and as well as charged edge 
strands to avoid edge-to-edge aggregation (52). Charged strands β6 and β8 serve to protect the 
hydrophobic strands β1-3 from solvent exposure in the apo monomer. However, φ-value analysis reveals 
that these strands are largely unfolded in the transitions state, suggesting that these edge strands are more 
likely to unfold locally upon environmental perturbations (52).  
Taken together, the data show that aggregation can occur from every form of SOD1 and the 
extent of unfolding required for aggregation in disease remains unknown. Mutations likely affect a 
number of factors that influence aggregation (i.e. stability, metal loss, monomerization, dynamics, etc.), 
which when combined may help explain the role of SOD1 in disease. Understanding of the early stages 
by which holo SOD1 may give rise to aggregation is of particular interest as holo SOD1 is the major form 
of SOD1 in cells (54).  
 
1.6.7 Pseudo wild-type SOD1 
 
 
There are 4 cysteine residues in the human SOD1 polypeptide. Two of these cysteines participate 
in the intramolecular disulphide bond (Cys57 and Cys146) (Figure 1.3 A); the remaining two free 
cysteine residues (Cys6 and Cys111) have the ability to form aberrant intermolecular disulphide bonds. 
For the purposes of thermodynamic analysis, protein denaturation must be reversible. It is for that reason 
that all experiments in this thesis have been carried out on pseudo wild-type SOD1 (pWT). In pWT, Cys6 
is mutated to alanine and Cys111 to serine. Use of this variant also allows for comparison with DSC and 
ITC data previously obtained on pWT SOD1 in the Meiering lab. This construct has been characterized 
extensively, including in studies of SOD1 folding and is suitable for these experiments as it exhibits a 
much higher degree of reversibility of unfolding as well as essentially the same stability, enzymatic 
activity and structure as WT SOD1 (6, 81, 88, 106). Further, while it has been proposed that aberrant 
intermolecular reactions between Cys6 and Cys111 may play a role in protein aggregation and disease, 
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studies show that intermolecular bond formation is found only in later stages of disease in mice models 
and thus is likely a secondary effect (107).   
 
1.7 Research objectives and outline 
 
  
The main hypothesis for the toxic gain of function associated with SOD1 in ALS is protein 
aggregation (54). The Meiering lab focuses on gaining a deeper understanding of the physical and 
chemical properties of SOD1, of how mutations alter these properties, and how these alterations affect 
protein aggregation. Metal binding, for example, has a substantial influence on a number of physical and 
chemical properties (e.g. structure, activity, stability, aggregation propensity) (54, 81, 88), yet much 
remains to be learned about the effects of mutations on metal binding affinity and selectivity, and how 
these changes affect both local and global stability. It has been shown that changes in global stability do 
not always provide an accurate description of the local changes occurring within a protein (108), which 
may be important in understanding aggregation pathways. Recent studies on a number of disease related 
proteins suggest that the aggregation precursor is a partially folded form of the protein (30, 45, 53). 
In Chapter 2, a review of previous methods using the chromogenic chelator PAR for quantitation 
of metal ions in proteins is presented. Three methods are assessed for their accuracy, precision and ease of 
use. A new, more general method using PAR is presented that uses spectral decomposition software to 
separate the absorption bands of Cu and Zn. Insights into the metallation state of pWT and mutant SOD1, 
as well as the successes and failures associated with the use of a chromogenic chelator for metal analysis 
are discussed. NMR temperature dependence experiments of pWT and three fALS mutants (G93A, 
E100G and V148I) are described in Chapter 3. The local stability and conformational heterogeneity of 
each variant is investigated, with each mutant showing both common and distinct changes relative to 
pWT. Implications for the role of observed local unfolding patterns in protein aggregation are discussed. 
Residues accessing alternative states close in free energy to the native state of SOD1 are identified and 
provide insight into the thermal unfolding pathway of SOD1.  
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Chapter 2  
Spectrophotometric Metal Determination Assay 
 
2.1 Introduction 
2.1.1 Metalloproteins 
 Metal cofactors are naturally found in many proteins. In fact, approximately one third of all 
proteins are metalloproteins and ~40% of enzymes require metals for catalytic function (109). The 
incorporation of metals in proteins takes advantage of metals’ small size, simple structure and positive 
charge, serving to create or enhance functionality as well as diversify proteins (110). The importance of 
metals is supported by their requirement for life. Bulk metals form 1-2% of the human body weight and 
include sodium, potassium, magnesium and calcium (111). Trace metals represent less that 0.01% of the 
human body weight and include vanadium, chromium, molybdenum, manganese, iron, cobalt, nickel, 
copper and zinc (111). Zn is the second most abundant trace metal, following iron, and is found in more 
than 300 enzymes (112). Zn is an interesting cofactor since it has a filled d orbital shell and thus only has 
a single redox state making it a stable ion (112, 113).  
 The concentration of metals in cells is strictly limited as excess free metals can be damaging 
(109). For example, free Cu is almost non-existent in the cytoplasm due to its redox potential as it can 
participate in or catalyze aberrant redox reactions which can result in oxidative damage of proteins, lipids 
and nucleic acids (109). Since the concentration of many metals is restricted in cells, chaperone proteins 
often aid in protein metallation. Some metals bind to the unfolded polypeptide providing local structure 
that aids in protein folding. Other metals do not bind until the structured active site is formed (109). 
Commonly metals stabilize the native state of the protein. Metals with only one redox state (e.g. Zn) are 
often used to counteract negative charges in protein. Metals with multiple redox states are often involved 
in enzymatic activity (114). A metal can participate in reactions in different ways depending on the local 
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environment. The iron in heme, for example, can act as a reversible electron carrier (cytochrome), a 
dioxygen carrier (hemoglobin) or an activator (cytochrome P450) (115). Further, it has been shown that 
undermetallation or the binding of non-native metals can promote protein aggregation (110). 
 The vast number of metalloproteins and the requirement of metals for native structure and 
function highlight the importance of knowledge of metal binding affinity and selectivity in proteins. This 
knowledge would be useful for investigating catalytic reactions, protein folding and aggregation, and 
signal transduction (110). Further, it is important to understand how flexibility in the metal-binding site 
may affect metal affinity and in contrast how metal binding affects protein flexibility, for example in Cu, 
Zn SOD1 (see also Chapter 3).  
2.1.2 Metals and SOD1 
 The most immature form of SOD1 observed in cells is the reduced apo form. As described in 
Chapter 1 (section 1.6.1), SOD1 undergoes a number of post-translational modifications to reach the 
mature, fully active state (58). These maturation steps include the binding of one Cu and one Zn ion per 
monomer.  Cu is believed to be transported into cells by the Ctr1 transmembrane protein through a Cu 
specific pore. Once inside the cell, Cu chaperones mediate transfer of the metal to its various targets, 
aiding in the efficiency of Cu metallation in vivo (31). SOD1 is understood to bind Cu through an 
interaction with the Cu chaperone, CCS. This metallochaperone consists of 3 domains: (1) a highly 
conserved N-terminal Cu binding domain located in a surface exposed loop, (2) a β-barrel domain that 
structurally resembles monomeric SOD1 and (3) a second highly conserved C-terminal Cu binding 
domain (31, 116). The second domain cannot bind Cu and thus it has been proposed that the main 
function of this domain is target recognition (117) (118).  
One model for CCS activity proposes that Cu binding in domain 1 results in a conformational 
change within the protein that causes domain 3 to rotate and form a Cu binding complex with domain 1 
(118). This reorientation allows domains 1 and 3 to interact with the active site residues of SOD1 and 
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facilitates Cu release. CCS has also been implicated in disulfide bond formation between Cys57 and 
Cys146. The interaction between CCS and SOD1 results in a disulfide bond between Cys57 and a 
cysteine residue in the third domain of CCS (118). Once Cu is transferred to SOD1, the intermolecular 
disulfide bond is replaced by an intramolecular bond with Cys146. This transfer is expected to help 
facilitate dissociation of the heterodimer. In vitro studies reveal that in both mammalian and yeast cells 
null of CCS, a glutathione-dependent pathway exists for copper insertion into SOD1. The role of this 
pathway in cells with CCS present remains unclear however it has been proposed that interaction with 
glutathione may damage or alter SOD1 and thus this pathway may play some role in toxicity of SOD1 
(65). The mechanisms by which SOD1 obtains Zn remain unknown however it should be noted that the 
natural concentration of SOD1 in cells is on the order of 10-100 μM, which is much greater than the 
amount of free Zn present in the cytosol (119).  
MD simulations reveal that metal binding has a greater influence on the thermostability of SOD1 
than formation of the disulfide bond (47). The metal ions have been proposed to stabilize SOD1 
monomers by holding together strands 4 and 7, which are disordered in apo SOD1 (47). Zn ions have 
been proposed to confer stability to proteins by counteracting negative charges within proteins (114). This 
occurs in SOD1 as the Zn ion binds at the C-terminal end of a helix located in loop VII with a negative 
dipole (120). Further, the conformation of loop VII has been shown to be strictly dependent upon the 
conformation of loop IV; the conformation of the latter is dependent upon Zn binding as loop IV contains 
key residues that coordinate the bound zinc (120). Interestingly, the binding of a Zn ion to one subunit of 
SOD1 will stabilize the second subunit in the dimer highlighting a propagating network of interactions 
between monomers (121).  
The dissociation constants (Kd) for Cu and Zn binding to wild-type SOD1 have previously been 
measured using a competition assay (122). The results show that Cu binds more strongly to SOD1 than 
Zn with Kd values of 6.0 x 10
-18
 M
-1
 and 4.2 x 10
-14
 M
-1
, respectively. The Kd values were also determined 
for 4 mutants (A4TV, A4T, I113T and L38V) and reveal that the affinity for Zn is reduced up to 30-fold 
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in mutants (122). In addition to the decreased affinity, in vitro studies show that mutants also have 
reduced metal binding selectivity and are more likely to be mismetallated (123). This lack of specificity 
has been attributed to irregularities in the Zn binding site (123, 124). Denaturation studies monitoring the 
metal status of SOD1 reveal that the major unfolding pathway involves rapid dimer dissociation and Zn 
loss, followed by a slow conformational rearrangement that results in Cu release before global unfolding 
(125). Unfolding kinetic experiments reveal that mutants favour increased formation of a Zn-free 
monomer intermediate; a state implicated in non-native protein association (126).  
Zn deficiency has been proposed to play a role in disease for both WT and mutant SOD1 (127). 
Zn-deficient SOD1 has been shown to initiate apoptosis in motor neurons (128, 129). Loss of Zn alters 
the structure of SOD1 more than fALS mutations and results in the formation of a 4Å wide channel 
allowing non-native small molecules to the active site (127). Further, loss of Zn alters the coordination of 
Cu as they share a bridging histidine ligand (His63) decreasing Cu binding affinity (130). This connection 
between the metal binding affinities has also been observed in computational studies (131, 132). Previous 
studies reveal that in the absence of Zn, the catalytic activity of SOD1 can actually be reversed producing 
ROS which can damage the protein (130). It is clear that Zn binding significantly modulates the structure 
and activity of SOD1. 
A study analyzing the metal content of WT and 14 different fALS mutants as-isolated from Sf21 
insect cells revealed that Cu deficiency was much more common than Zn deficiency (133). Previous 
studies monitoring Cu and Zn release from SOD1 during unfolding found that while the major unfolding 
pathway involves Zn loss prior to Cu, mutant SOD1s showed a greater propensity to unfold using the 
minor pathway that involves Cu loss first (134). The role of Cu deficiency in disease is supported by the 
finding that Cu levels in the spinal cords of rats are increased which was proposed to likely be a 
consequence of reduced incorporation of Cu into SOD1 (135). On the other hand, studies of ALS-
transgenic mice reveal that aggregated SOD1 found in spinal cords is not enriched in Cu or Zn (136). A 
few investigations have reported how the presence of bound metal affects aggregation. One study showed 
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that reduced apo SOD1 could recruit Zn-bound but not Cu-bond protein into aggregates (121). A 
contradicting study revealed that the presence of one equivalent of Zn per dimer was sufficient to 
eliminate the oligomerization of reduced and oxidized apo SOD mutants (98). The exact role of metal 
ions in disease still remains unclear. 
The above-mentioned studies and others (81, 88, 109) provide strong evidence that metallation 
strongly influences the structure, stability, activity, dynamics and propensity of SOD1. It is therefore 
important to be able to accurately characterize the metal status of not just SOD1 but also other 
metalloproteins.  
2.1.3 Common methods for metal quantitation of metalloproteins 
 Measurement of the metal content of proteins is complicated by a number of factors including the 
complex structure of proteins and the generally low metal content. For these reasons especially sensitive 
and selective methods are required. The most common methods for metal determination in proteins are 
often referred to as hybrid methods as they combine a chromatographic method for protein separation 
with a high sensitivity method for metal detection in solution (137). Well-known detection methods 
include atomic absorption spectroscopy (AAS), inductively coupled plasma atomic emission spectroscopy 
(ICP-AES) and inductively coupled plasma mass spectrometry (ICP-MS). ICP-MS is the most widely 
used technique due to its versatility, low detection limits and multi-element capabilities; however, for 
good separation of proteins buffers of high ionic strength are often required but high salt can also result in 
signal reduction (137). In general, hybrid methods are extremely accurate and reliable but most often they 
are also expensive, time-consuming, require fairly concentrated samples and are not always available. 
Alternatively, chromogenic chelators have been widely used for metal determination in solution, 
however, only more recently for the quantification of metals in proteins. Chromogenic chelators are rapid, 
inexpensive and sensitive but are not very selective (138). An example of a commonly used chromogenic 
chelator is 4-(2-pyridylazo)resorcinol (PAR; see below). 
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2.1.4 Metal quantitation using PAR 
 PAR is an azo dye that has been shown previously to from complexes with a variety of metal ions 
in solution (122, 125, 139-141). These complexes have high molar absorptivities making PAR a very 
sensitive indicator of metal ion concentrations. The free PAR absorption spectrum exhibits a symmetric 
peak with a maximum absorption at approximately 416 nm (λmax). Upon metal binding the absorbance at 
416 nm decreases and a shoulder appears at approximately 500 nm. The λmax and shape of the shoulder is 
dependent upon the metal bound. Due to the low selectivity of PAR, its use in metal determination was 
initially restricted to solutions containing just one metal (141). The use of PAR for metal determination in 
proteins was first described in 1984 when it was used to quantify Zn by measuring changes in the 
absorption spectrum of PAR following denaturation of the protein (141). Denaturation of the protein was 
required to render the metal ions available for chelation by PAR. The non-selectivity of PAR can be either 
an advantage or a disadvantage. This property makes the quantification of a specific metal difficult if 
more than one is present in solution, however, if this limitation can be overcome it may allow for the 
simultaneous quantification of multiple metals in solution.  
 
Figure 2.1 - Structure of free and metal-bound PAR. Transition metals are bound through the pyridyl nitrogen atom, 
the nitrogen of the azo moiety and the 2-phenolate oxygen of the resorcinol moiety. 
 
 The simultaneous quantification of two metals using PAR was described by Crow et al. in 1997 
to measure the concentration of Cu and Zn in SOD1 (122). The binding stoichiometry is 1:1 for Cu and 
2:1 for Zn (as long as PAR is in 2.5-fold molar excess over Zn) (122). In this study, the dissociation 
constants of the PAR and Cu complex (PAR:Cu) and PAR and Zn complex (PAR2:Zn) were determined 
using a competition assay. The results reveal that PAR binds Cu more tightly than Zn with Kd values of 
7.7 x 10
-11
 M
-1
 and 2.6 x 10
-15
 M
-1
, respectively (122). For metal determination, SOD1 is denatured in 
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guanidine hydrochloride (GdnHCl) and the increase in absorbance at 500 nm upon metal release is 
monitored. When the absorbance no longer increases (~1-4 minutes), nitrilotriacetic acid (NTA) is added 
to selectively chelate Zn. It was believed that NTA binding is not strong enough to remove Cu from the 
tighter PAR:Cu complex. The decrease in absorption upon the addition of NTA is converted to a Zn 
concentration using the molar extinction coefficient for PAR2:Zn and Beer-Lambert’s law (given below). 
       Eq. 2.1 
Ethylenediaminetetraacetic acid (EDTA), a stronger chelator, is then added to strip Cu from the PAR:Cu 
complex. The decrease in absorbance at 500 nm upon addition of EDTA is converted into a Cu 
concentration using of the PAR:Cu extinction coefficient. The aim of this method is to allow for the 
simultaneous quantitation of Cu and Zn in solution by using a chelator to mask one of the metals (122). 
Initial experiments in the Meiering lab suggested there were inaccuracies with this method (Bonner, 
Primmer, and Meiering). These are investigated further in this thesis.  
An alternative PAR-based method later developed (Sabel et al. 2009) did not require of the 
second metal (139). In this case, the authors describe the simultaneous quantitation of Zn and cobalt (Co) 
in solution. The population of the three species contributing to absorbance (free PAR, PAR:Co and 
PAR2:Zn) is analyzed using the equation: 
     (  
   [   ]    
      [       ]    
      [      ]) Eq. 2.2 
where d is the pathlength (cm),   
      
       and   
       are the molar extinction coefficients for the 
free and metal-bound states of PAR, and [PAR], [PAR2:Zn] and [PAR:Co] are the concentrations for free 
and bound complexes of PAR (139). The sum of the concentrations of all PAR species in solution is equal 
to the initial amount of chelator present and as such: 
     [   ] (   
       
           
      )   with                           Eq. 2.3 
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where [PAR]0 is the total concentration of PAR, x is the molar fraction of free PAR, and y and z are the 
molar fractions of PAR complexing  Zn and Co, respectively. The concentrations of Zn and cobalt can be 
obtained by fitting the experimental absorption spectrum to Eq. 2.3 with x, y and z as fitted parameters. To 
use this method the molar extinction coefficient of all three states must be known. These values can be 
obtained from the absorbance spectra of each species at a known concentration; however, a spectrum of 
metal-bound PAR with no interfering free PAR was not attainable. Therefore the spectral contribution of 
free PAR is manually removed from the PAR2:Zn and PAR:Co spectra to create a ‘clean’ spectrum. After 
this, the ‘clean’ spectra are scaled to the same concentration the free PAR spectrum (50 μM). It is from 
these manipulated spectra that the extinction coefficients are determined. The experimental spectrum is fit 
by the least squares method as a linear combination of the component spectra using the Solver add-in in 
MS Excel (139).   
 A third method using PAR (Mulligan et al., 2008) to simultaneously quantitate two metals in 
solution relies on the different shapes of PAR:Cu and PAR2:Zn absorption peaks (125). More specifically, 
by monitoring the changes in absorbance at two wavelengths, 490 nm and 520 nm, the Cu and Zn signals 
can be resolved. Both metals have linear increases in absorbance with concentration at these two 
wavelengths however Cu has an almost identical increase at both wavelengths whereas Zn absorbance 
increases much more at 490 nm than 520 nm (125). Two linear equations can be applied: 
            [      ]         [       ]                                 Eq. 2.4  
            [      ]         [       ]                                 Eq. 2.5 
where mCu,490 and mCu,520 represent the increase in absorbance upon the formation of 1 μM PAR:Cu at 490 
nm and 520 nm, respectively and mZn,490 and mZn,520 represent the increase in absorbance upon the 
formation of 1 μM PAR2:Zn at 490 nm and 520 nm, respectively (125). These values are obtained from 
plots of absorbance at 490 nm and 520 nm versus metal concentration. The linear equations can then be 
rearranged to solve for the concentration of Cu and Zn (125). 
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[      ]  
                       
                             
                                            Eq. 2.6 
[       ]  
                       
                             
                                           Eq. 2.7 
The methods described above each use a different approach to differentiate between the two 
metals in solution. The first relies on a chelator to render one of the metals spectroscopically silent, the 
second uses a designed fitting routine to separate absorbance bands of all three PAR species present in 
solution and the third relies on the differential shapes of the metal-bound PAR absorbance peaks.  
2.1.5. Chapter overview 
 In this chapter the three methods outlined above will be for assessed for their accuracy, 
robustness and ease of use. A new method using PAR will be presented which does not require the 
determination of molar extinction coefficients or standard curves as a function of metal concentration. 
The focus will be on the quantification of Cu and Zn in SOD1 however the implications for more general 
use will be discussed. Insights into the metallation state of pWT and mutant SOD1, as well as 
complications will be addressed.  
2.2 Methods 
2.2.1 Solutions 
 All solutions were prepared using MilliQ ultrapure water (resistivity of 18.2 MΩ·cm; Millipore 
Ltd., Bedford, MA). All glassware was washed with nitric acid (50% (v/v)) then MilliQ water to remove 
any contaminating metals prior to use. Tips, eppendorf tubes and cuvettes were washed in a similar 
manor. All pH adjustments were made using either 1 M sodium hydroxide or 1 M hydrochloric acid.  
Metal stock solutions (100 mM) of Cu
2+
 and Zn
2+
 were made by dissolving Cu sulfate (2.50 g; > 98.5% 
purity) and Zn sulfate (2.88 g; > 99% purity) in 100 mL of water, respectively. All stock solutions were 
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prepared in a volumetric flask. Working stock solutions (0.25 mM) were prepared by diluting 100 μL of 
the stock solution to 40 mL with MilliQ water.  
A stock solution of GdnHCl (8 M) was prepared by dissolving the denaturant (229.2 g) in water to a final 
volume of 300 mL using a graduated cylinder.  
A stock solution of PAR (10 mM) was prepared by dissolving 0.0215 g of the chelator in 10 mL of water 
in a volumetric flask. A working 4x PAR-HEPES solution was prepared by mixing 0.89 mL or 1.78 mL 
of the PAR stock solution (final concentration of 222.22 μM or 444.44 μM, respectively) with 2.12 g of 
HEPES (final concentration of 222.22 mM) and water to a final volume of 40 mL. The pH was adjusted 
to 8.0. A 1x PAR-HEPES-GdnHCl solution was prepared by mixing the 4x PAR-HEPES solution (112.5 
μL) with 8M GdnHCl (337.5 μL) (total volume of 450 μL). The final assay volume is 500 μL (after 
addition of 50 uL of metals or protein sample) with a pH of 8.2 as measured by a standard electrode. The 
4x PAR concentrations of 222.22 μM or 444.44 μM result in a final PAR concentration of 50 μM and 100 
μM, respectively. The final concentrations of HEPES and GdnHCl in the assay solution are 50 mM and 
5.4 M, respectively.  All PAR solutions were stored in the dark at 4°C as PAR has been shown to have 
decreased stability with light exposure (142). 
EDTA (292.24 g/mol) and NTA (191.14 g/mol) stock solutions were prepared by dissolving the 
appropriate amount of chelator in 15 mL of water using a graduated cylinder. The NTA solution also 
contained 16 mM sodium hydroxide (39.997 g/mol).   
2.2.2 Sample preparation and measurement  
 Holo and apo pWT SOD1 were prepared using methods established in the Meiering lab (6, 82). 
EDTA bound to the apo protein was removed by unfolding the protein in 2M GdnHCl for 40 min 
followed by 5 exchanges against 2 M GdnHCl and then 5 exchanges against MilliQ water using a 
centricon (Ultracel 3K, MILLIPORE IRELAND, Ltd.). Protein concentration was determined by 
absorbance using the extinction coefficient at 280 nm (Ɛ280 = 5, 400 M
-1
, cm
-1
) (124).  
 29 
 
 Sample preparation and measurement for experiments using the Crow method were completed as 
outlined in Crow et al., 1997 (122) with the exceptions that HEPES buffer (50 mM) was used instead of 
sodium borate (100 mM) and the final sample pH was 8.2 instead of 7.8. Briefly, 450 μL of 1x PAR-
HEPES-GdnHCl was mixed 50 μL of sample metal solution to the desired metal concentration. After the 
initial absorbance scan, NTA was added (to a final concentration of 0.8 mM). The sample was incubated 
for at least 5 minutes in the dark before another absorbance scan was obtained. EDTA addition was 
completed in the same manner. Absorbance scans were measured from 200 to 800 nm. Trace metals 
present in solution are accounted for by measuring the decrease in absorbance at 500 nm upon the 
addition of NTA and EDTA in the absence of added metals. Observed decreases in absorbance at 500nm 
in the absence of added metal are subtracted from those observed in the presence of metal before 
calculating metal content. Dilution upon the addition of EDTA and NTA was not accounted for as the 
effect on calculated metal content was minimal (≤ 1.5%; data not shown).   
 For all other methods, 450 μL of 1x solution of PAR-HEPES-GdnHCl (final concentration of 
PAR is 100 μM unless otherwise specified) was mixed with 50uL of the desired concentration of metal-
containing sample solution. For protein metal determination, the protein (50 μL) was first added to 
GdnHCl (337.5 μL) and incubated for 40 minutes to allow sufficient time for the protein to unfold. After 
incubation, 4x PAR-HEPES was added (112.5 μL) and the absorbance scan was acquired. Again, 
absorbance scans were measured from 200 to 800 nm. The final assay solutions generally contain 100 μM 
PAR, 50 mM HEPES, 5.4 M GdnHCl, pH 8.2.  
2.2.3 Pyrogallol activity assay  
 The pyrogallol assay indirectly measures the activity of SOD1 by monitoring the autoxidation of 
pyrogallol by superoxide (the substrate for SOD1) (143). The assay involves a reference scan and an 
inhibition scan. The reference scan measures the autoxidation of pyrogallol in the presence of catalase. 
The inhibition scan measures the rate of autoxidation of pyrogallol in the presence of catalase and holo 
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SOD1. A unit is defined as the amount of SOD1 required to reduce the rate of autoxidation by 50% in 3 
mL of buffer. Briefly, in a polystyrene cuvette, 30 μL of bovine liver catalase (Sigma, St. Louis MO) in 
50 mM potassium phosphate buffer (pH 7.5) and 75 μM of 8 mM pyrogallol (Sigma, St. Louis MO) in 10 
mM HCl, were added to 3 mL of assay buffer (50 mM Tris, 1 mM diethylenetriaminepentaacetic acid 
(DTPA), pH 8.2, 25 °C) just prior to addition of SOD1. The cuvette was covered with parafilm and mixed 
rapidly by inverting the cuvette 3 – 4 times. The absorbance at 450 nm was measured over 2 minutes 
providing the inhibition scan. The reference scan was obtained as described above without the addition of 
SOD1.  
2.2.4 Differential scanning calorimetry 
 Differential scanning calorimetry (DSC) measurements were performed, as described previously 
(6), using a MicroCal LLC VP-DSC (MicroCal Inc., Northampton MA). SOD1 samples (0.4 – 0.7 mg 
mL
-1
) were buffered in 20 mM HEPES, pH 7.8. Samples were degassed for 1 minute prior to loading. 
Buffer/buffer baselines were determined for each experiment and subtracted from protein/buffer scans. 
Data were normalized for protein concentration. Experiments used a scan rate of 1 °C min
-1
. 
2.3 Results and Discussion 
2.3.1 Crow method  
 The Crow method for metal analysis involves the use of two chelators; NTA and EDTA (see 
section 2.1.4) (122). The difference in absorbance at 500 nm upon the addition of NTA and EDTA is 
proposed to represent the amount of Zn and Cu present in the sample, respectively (see above). However, 
the results here show that NTA is not entirely specific for Zn, as described below. Extinction coefficients 
were determined by measuring the absorbance at 500 nm as a function of known metal concentration in 
the absence of chelators. Under the assay conditions the extinction coefficients for Cu and Zn were 
determined as 36,397 M
-1
cm
-1
 and 83,240 M
-1
cm
-1
, respectively. The Cu extinction coefficient matches 
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very well with the value reported previously, however, the Zn extinction coefficient is larger (122) 
Different values for extinction coefficients have been reported previously (122, 139). These values are 
sensitive to pH, which could account for the variability (122). It is for this reason that standard curves are 
often prepared daily when using a chromogenic chelator for metal analysis.  
The changes in the absorption spectra of Cu and Zn in the presence of PAR upon the addition of 
NTA and EDTA are illustrated in Figure 2.2. Crow et al. (122), stated that NTA cannot remove Cu from 
PAR:Cu; however, in the presence of Cu (20 μM) NTA will chelate approximately 5% of the metal 
(Figure 2.2 A). On the other hand, in the presence of Zn (20 μM) NTA is only able to chelate 
approximately 93% of the metal (Figure 2.2 B), even though NTA is in 40-fold excess over Zn and 8-fold 
excess over PAR.  
 
Figure 2.2 - Specificity of the chelators used in the Crow method. (A) Changes in the absorption spectrum of free 
PAR (100 μM) upon the addition of Cu (20 μM), NTA (0.8 mM) and EDTA (0.8 mM). (B) Changes in the 
absorption spectrum of free PAR upon the addition of Zn (20 μM), NTA (0.8 mM) and EDTA (0.8 mM). The 
decrease in absorbance at 500nm (ΔAbs500) is converted to the concentration of metal bound by each chelator using 
equation 2.1 and the respective extinction coefficient. The percent of metal bound by each chelator is calculated as 
([metal bound by chelator] / [total metal])*100%.  
 
In the Crow assay, the difference in absorbance caused by NTA is converted to a Zn 
concentration using the Zn extinction coefficient and the difference caused by EDTA is converted to a Cu 
concentration using its extinction coefficient (122). It should be noted that for this analysis, when only 
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one metal is present (as in Figure 2.2), the extinction coefficient of that metal was used to calculate 
concentration in both steps. To analyze the generality of the chelating trend discussed above, the percent 
of total metal bound by each chelator was determined at 4 different concentrations of Cu and Zn 
independently (Table 2.1). Overall, it appears that in the presence of any concentration of Cu NTA will 
bind approximately 5% of the metal and EDTA will bind the remaining Cu. In the presences of Zn, NTA 
will bind approximately 94% of the metal and EDTA will chelate the remainder.  
Total [Cu] 
(μM) 
% bound 
by NTA 
% bound 
by EDTA 
Total [Zn] 
(μM) 
% bound 
by NTA 
% bound 
by EDTA 
5 4.95 87.92 5 93.22 8.42 
10 3.85 104.68 10 93.35 10.81 
15 4.76 96.53 15 94.51 10.25 
20 4.95 94.79 20 93.11 9.85 
Average 4.62 95.98 Average  93.55 9.83 
Table 2.1 - Chelating properties of NTA and EDTA in the presence of varying concentrations of Cu and Zn. The 
decrease ΔAbs500 is converted to the concentration of metal bound by each chelator using Eq. 2.1 and the respective 
extinction coefficient. The percent of metal bound by each chelator was calculated as ([calculated metal bound by 
chelator] / [total metal])*100%. The total calculated metal in some cases is greater than 100%. The reason for this is 
unknown as trace metals were accounted for (see section 2.2.2) however these data were obtained from only one 
experiment and should be completed in triplicate. All samples contain 100 μM PAR, 50 mM HEPES, 5.4 M 
GdnHCl, pH 8.2.  
 
This method however was developed to test the metallation status of a protein that binds two 
different metals. To test its efficacy under these conditions it is applied to various combinations of both 
Cu and Zn in solution. When the concentration of Zn is much greater than the concentration of Cu the 
error, especially for Cu, is the largest. On the other hand, when the concentration of Zn is much smaller 
than Cu or the concentration of both metals is equal, the error is reduced. However in almost every 
condition the calculated Zn value is lower than expected and the Cu value is higher than expected.  
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Actual 
 [Cu] (μM) 
Actual  
[Zn] (μM) 
Calculated 
[Cu] (μM) 
Calculated 
[Zn] (μM) 
Calculated  
% Cu 
Calculated  
% Zn 
5 20 9.81 ± 0.51 18.25 ± 0.56 196.17 ± 10.10 91.24 ± 2.80 
10 15 12.79 ± 0.56 14.10 ± 0.04 127.90 ± 5.64 93.99 ± 0.28 
15 10 16.27 ± 0.58 9.79 ± 0.03 108.44 ± 3.88 97.85 ± 0.25 
20 5 19.64 ± 0.43 5.18 ± 0.15 98.22 ± 2.14 103.55 ± 3.06 
5 5 5.84 ± 0.06 5.30 ± 0.08 116.77 ± 1.17 105.84 ± 1.53 
10 10 11.46 ± 0.12 9.90 ± 0.17 114.57 ± 1.16 98.99 ± 1.70 
12.5 12.5 14.38 ± 0.60 12.07 ± 0.12 115.07 ± 4.82 96.59 ± 0.95 
 
Table 2.2 - Accuracy and precision of the simultaneous determination of Cu and Zn using the Crow PAR assay 
protocol. Each value represents the mean ± the standard deviation of two independent experiments. The percent 
metal was calculated as ([calculated metal] / [actual metal])*100%. All samples contain 100 μM PAR, 50 mM 
HEPES, 5.4 M GdnHCl, pH 8.2. 
 
The results can be explained by the chelation trend identified above and the differences in the 
extinction coefficients of each metal. When the concentration of Zn is high, NTA does not bind all of it 
and the remaining Zn is bound by EDTA. This causes the decrease in absorbance upon the addition of 
EDTA to be greater than it should be. This error is then magnified in the metal calculation as the amount 
of Zn miscalculated as Cu is exaggerated. The decrease in absorbance upon stripping say 1 μM of Zn 
from PAR will be over 2-fold greater than the decrease caused by the removal of 1 μM of Cu since the 
extinction coefficient of PAR2:Zn is over 2-fold larger than that of PAR:Cu. Therefore the concentration 
of Cu calculated will be equal to the amount of Cu present plus the amount of Zn not bound by NTA 
multiplied by a factor of 2.3 (this is equal to the ratio of the extinction coefficients). When the 
concentration of Zn is low relative to Cu, NTA will bind some of the Cu present. This will result in a 
lower than expected Cu value and a higher than expected Zn value. However, in this case the error in the 
Zn value will be underestimated again due to the relative magnitudes of the extinction coefficients of each 
metal. When the concentrations of both metals in solution is equal the calculated metal content is more 
accurate, although still generally some of the Zn is miscalculated as Cu likely because the NTA does not 
bind all the Zn.  
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  Overall the results show that there is variability of the proportion of metals chelated by NTA 
depending on the sample conditions. The type and amount of metal bound by NTA is dependent upon the 
concentration of metals present in solution. As a consequence, the error in the calculated metal content 
follows a clear trend, illustrated in Figure 2.3. In the case of a protein that binds two metals in equal 
concentration this method is fairly accurate but as a more general method for metal quantitation it is not 
reliable. In terms of SOD1, mismetallated or undermetallated species have been implicated as playing a 
role in disease. It is therefore of great importance to characterize accurately the metallation state of these 
species, however by their nature the concentration of the two metals will not be equal limiting the 
applicability of this method.  
 
Figure 2.3 - Trend in the error of calculated metal using the Crow protocol with unequal metal concentrations. The 
actual concentrations of the metals are given by horizontal lines, and calculated concentrations are given by blue and 
red bars for Zn and Cu, respectively.  When the Zn concentration is high relative to Cu concentration, Cu is greatly 
overestimated and Zn is underestimated. Conversely, at relatively high Cu levels, Cu is slightly underestimated and 
Zn slightly overestimated. All samples contained 100 μM PAR, 50 mM HEPES, 5.4 M GdnHCl, pH 8.2.   
 
2.3.2 Säbel method  
The fitting routine described by Säbel et al. (139) requires the determination of the extinction 
coefficient of all three PAR species (free PAR, PAR2:Zn and PAR:Co) in solution. A number of manual 
processing steps (subtraction of the free PAR signal and multiplication to reflect the same concentration 
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of [PAR]0) are required to do this and create sources of possible error. This method was optimized 
specifically for the determination of Zn and cobalt in solution. For this developed application, this method 
is fairly accurate with the expected and calculated values generally within 10% and the standard deviation 
usually below 10% (Figure 2.4) (139).   
 
Figure 2.4 - Metal determination of Zn and Co with PAR using the Säbel Method. The concentrations of each metal 
in solution are given on the x-axis as Zn, Co (μM). Numbers were taken from Säbel et al., 2009 (139) and are the 
average of three independent trials. Shown off scale is the error bar for the 7 μM Zn and 2 μM cobalt condition at 
130%.  
 
One of the main factors contributing to the success of this method is the different spectral features 
of the PAR2:Zn and PAR:Co complexes. At the same concentration, PAR2:Zn has a significantly higher 
absorbance peak than PAR:Co, which exhibits a wider peak (Figure 2.5). Analysis of the efficacy of this 
method with Cu and Zn was not completed herein as it has already been completed in the Siemann lab. 
The fits, precision and accuracy were relatively poor, which was attributed to the PAR:Cu absorbance 
peak having more extensive overlap with the PAR2:Zn peak (Figure 2.5), preventing good resolution of 
the two species (Stefan Siemann, personal correspondence).   
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Figure 2.5 - The absorption spectra of PAR (50 μM) with in the presence of 10 μM Zn, Co, Ni or Cu. The 
absorbance of free PAR has been manually subtracted. Figure taken from Säbel, C.E. 2010 (140).  
 
 This method proves to be fairly accurate under the specific conditions for which it was 
developed; however as a more general method it is not ideal. It appears that this method is limited by the 
spectral features of some PAR-metal complexes. Further, the amount of manual processing reduces the 
ease of use and increases the possibility of introducing error.  
2.3.3 Mulligan method 
 The linear equation-based method published by Mulligan et al. (125) did not provide any details 
on its accuracy but did state that the values obtained were similar to the those obtained using the Crow 
method. The results above (section 2.3.1) show that the Crow method is not always accurate. The 
accuracy of the Mulligan method is therefore analyzed below. For each experiment, the values of mCu,490, 
mCu,520, mZn,490 and mZn,520  (see section 2.1.4) were determined on the same day from a standard curve of 
the absorbance at each specified wavelength versus concentration. Representative determinations of 
mCu,490, mCu,520, mZn,490 and mZn,520 are shown in Figure 2.6.  From day to day these values did not change 
significantly.  
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Figure 2.6 - Standard curves of PAR:Cu and PAR2:Zn absorbance as a function of concentration for 490 nm and 520 
nm. These representative curves are the average of 4 independent experiments. All samples contain 50 μM PAR, 50 
mM HEPES, 5.4 M GdnHCl, pH 8.2.   
 
 To test the efficacy of this method, solutions of known concentrations of Cu and Zn (total metal 
equal to 10 μM) were analyzed (Table 2.3). This method proves to be quite accurate under these 
conditions as in most cases the calculated concentrations are within 5% of the expected values. The 
standard deviation of three independent trials is also quite low indicating a high level of precision. It 
should be noted that a change in the binding stoichiometry between PAR and Zn is clearly evident in 
standard curves when PAR is not in great enough excess (data not shown). For example, in the presence 
of 50 μM PAR the absorbance at both 490 and 520 nm increases linearly upon the addition of up to 25 
μM Cu. On the other hand, under the same conditions the Zn standard curves begin to curve significantly 
above 15 μM. Therefore, one needs to be careful about the total metal present in solution in relation to the 
amount of PAR present. In this analysis, the total metal was not above 10 μM so the absorbance changes 
with concentration were linear; however, to test the assay at higher metal concentrations the PAR 
concentration was increased (100 μM). 
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Actual  
[Cu] (μM) 
Actual  
[Zn] (μM) 
Calculated 
[Cu] (μM) 
Calculated 
[Zn] (μM) 
Calculated 
% Cu 
Calculated  
% Zn 
0 10 -0.20 ± 0.15 10.19 ± 0.42 - 101.94 ± 4.18 
2 8 1.80 ± 0.12 8.13 ± 0.35 90.04 ± 5.95 101.68 ± 4.37 
  4*   6* 3.79 ± 0.02 6.51 ± 0.11 94.67 ± 0.41 108.52 ± 1.84 
6 4 5.87 ± 0.19 4.02 ± 0.07 97.88 ± 3.18 100.60 ± 1.84 
8 2 7.81 ± 0.04 1.95 ± 0.08 97.61 ± 0.50 97.88 ± 4.16 
10 0 9.22 ± 1.01 -0.01 ± 0.03 92.21 ± 10.08 - 
 
Table 2.3 - Accuracy and precision of the simultaneous determination of Cu and Zn in solution using the Mulligan 
PAR assay protocol (125). Each value represents the mean ± the standard deviation of three independent trials with 
the exception of one condition where only two trials were completed (marked with an asterisk). All samples contain 
50 μM PAR, 50 mM HEPES, 5.4 M GdnHCl, pH 8.2. The percent metal was calculated as ([calculated metal] / 
[actual metal])*100%. 
 
 At increased metal concentrations this method again proves to be quite accurate (total metal equal 
to 25 μM; Figure 2.7). Overall, this method is well suited to simultaneously quantitate Cu and Zn levels in 
proteins. One drawback is the requirement to construct standard curves for both Cu and Zn with at least 3 
different concentrations daily, which is time consuming. Further, this method relies on the differences in 
absorbance increases at two wavelengths which may not provide good separation of signals for all metals 
(e.g. Cu and cobalt; Figure 2.5).  Thus, as a general method, applicable to a wide variety of metals and 
easily conducted, this method is not ideal.  
 
Figure 2.7 - Accuracy and precision of the simultaneous determination of Cu and Zn in solution using the Mulligan 
PAR assay protocol (125). The concentrations of each metal (25 μM total) in solution are given on the x-axis as Zn, 
Cu (μM). Each calculated value represents the mean ± the deviation of two independent trials. All samples contained 
100 μM PAR, 50 mM HEPES, 5.4 M GdnHCl, pH 8.2. The average deviations are 2.62% and 1.75% for Zn and Cu, 
respectively. The percent metal was calculated as ([calculated metal] / [actual metal])*100%. 
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2.3.4 Modified PAR assay 
2.3.4.1 Method 
 A new method was developed here that uses spectral software (SpectraLab or SpLab created by 
Dmitri Davydov, University of California at San Diego) to distinguish the PAR, PAR:Cu and PAR2:Zn 
absorbance signals (144). This software is freely available for download 
(http://cyp3a4.ucsd.edu/spectralab.html). In SpLab, spectral decomposition is achieved using least squares 
fitting method. This is a mathematical approach that minimizes the sum of the squared deviations (or 
residuals) between the observed (experimental spectrum) and fitted value. Using this software the 
experimental spectrum is fit using a set of absorption spectra for three standards: free PAR, PAR:Cu and 
PAR2:Zn (Figure 2.8 A). Any trace metals present in solution are accounted for in the free PAR standard 
spectrum. 
 
Figure 2.8 - Representative absorption spectra for PAR assay of Cu and Zn. All samples contained 100 μM PAR, 
50 mM HEPES, 5.4 M GdnHCl, pH 8.2. (A) The three standards used to fit experimental spectra. (B) Experimental 
spectra for experiments on known mixtures of Cu and Zn with a total metal concentration of 25 uM. The 
concentration of each metal is given in the legend as Zn, Cu (μM).  
 
A screenshot of the SpLab software is given in Figure 2.9 showing the fit of an experimental 
absorbance spectrum. Under the Data Analysis tab there is an option for “Spectral Decomposition”. This 
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will open the SurFit tab where one can select the standard spectra (by row) for fitting the experimental 
spectrum and the destination for the fitted curve. Upon clicking `run` a SpectraLab window will appear 
which gives the percentage of each standard in the fitted spectrum. The quality of the fit is also given in 
this tab by the squared correlation coefficient. Since the concentration for each standard spectrum is 
known, simple multiplication of the concentration of each spectrum by its percentage in the fitted 
spectrum yields the concentration of each metal in the sample.  
 
Figure 2.9 - Screenshot of SpLab software (144). The standard spectra of PAR, PAR:Cu and PAR2:Zn are shown in 
the upper left panel in black, teal and green, respectively. The experimental spectrum is shown in purple (15 μM Cu, 
10 μM Zn). The fitted spectrum is also plotted but is not visible as it lies directly under the experimental spectrum.  
 
There are some key differences between the modified PAR assay and the one previously 
described by Säbel et al. (see section 2.1.4). First and foremost, this method does not require manually 
created `clean` absorption spectra or knowledge of extinction coefficients. In the Säbel method the 
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experimental spectrum is fit to Eq. 2.3. Instead in the current method the spectrum is simply fit to a linear 
combination of the three standard spectra. In order to have sufficiently large and proportional absorbance 
changes for accurate determination of metal while using minimal protein, the concentration of PAR was 
chosen to be 100 uM with the total metal concentration not exceeding 25 μM to avoid changes in the 
binding stoichiometry of PAR and Zn.  
The most suitable metal concentrations for the PAR:Cu and PAR2:Zn standard spectra was 
determined by fitting known metal samples with standards having a wide range of concentrations (5 – 25 
μM), comparing the agreement with expected values and standard deviations (data not shown). Standards 
of 10 μM Cu and Zn were chosen, however, the differences caused by changing the concentration of the 
standard spectra (from 5 to 25 μM) are small.  The corresponding sample proteins concentration for the 
most accurate analysis was determined by comparing the quality of the fit at various protein 
concentrations while also considering protein conservation. A protein concentration of 5 μM was chosen, 
although higher protein concentrations (up to 10 μM) have very little effect on the quality of the fit.  The 
performance of the developed modified PAR assay is described further below.  
2.3.4.2 Determination of the accuracy and precision of the modified PAR assay 
The accuracy and precision of the modified PAR assay was assessed, as for the other assays 
described in the preceding sections, by analyzing sample solutions with known concentrations of metal 
(Table 2.4). In all cases the actual and calculated values are within 5% and in most cases the standard 
deviation is below 3%. These results reveal that, unlike the previous method that uses a fitting routine 
described above (139), this method is able to separate the signals of Cu and Zn with good accuracy and 
precision even though the absorbance bands of the two metals are not well resolved. 
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Actual 
[Cu] (μM) 
Actual 
[Zn] (μM) 
Calculated 
[Cu] (μM) 
Calculated 
[Zn] (μM) 
Calculated  
% Cu 
Calculated 
 % Zn 
0 25 0.15 ± 0.21 24.87 ± 0.27  - 99.48 ± 1.08 
5 20 4.89 ± 0.33 20.87 ± 0.48 97.71 ± 6.59 104.35 ± 2.41 
10 15 9.68 ± 0.26 15.27 ± 0.11 96.83 ± 2.59 101.80 ± 0.73 
15 10 15.14 ± 0.31 10.17 ± 0.03 100.96 ± 2.04 101.70 ± 0.26 
20 5 20.29 ± 0.12 5.05 ± 0.01 101.47 ± 0.59 100.95 ± 0.16 
25 0 24.87 ± 0.40 0.02 ± 0.06 99.47 ± 1.59 - 
Table 2.4 - Accuracy and precision of the simultaneous determination of Cu and Zn in solution using the modified 
PAR assay with SpLab. Each value represents the mean ± the standard deviation of three independent experiments. 
All samples contain 100 μM PAR, 50 mM HEPES, 5.4 M GdnHCl, pH 8.2. 
 
Previously developed methods describe the successive scanning of PAR absorption spectra as a 
function of time to monitor changes in absorbance upon the addition of chelators or protein unfolding, for 
example (122, 125). To determine if successive scanning has any effect on the modified PAR assay, the 
absorbance peak of PAR2:Zn was monitored as a function of time. The results reveal that over a 20 
minute period, the absorbance decreases. This was independently repeated over a 5 minute time frame 
and the results were the same. In the second case, the absorbance at λmax decreased by 0.01 over the given 
time period equivalent to approximately 0.15 μM Zn. The exact reason for this decrease is unknown; 
however, since PAR has been shown to be unstable under light exposure it is likely that the successive 
scanning is causing photodamage of the PAR (142). For this reason, when sample protein is analyzed 
(described in the following section) it is first incubated in GdnHCl for 40 minutes to allow for full 
denaturation prior before it is mixed with PAR. 
2.3.1.4 Analysis of holo SOD1 using the modified PAR assay 
 Using the optimized PAR assay described above and further detailed in the methods (sections 
2.2.1 and 2.2.2), the metallation state of pWT and 11 different fALS SOD1 mutants obtained by 
overexpression in E. coli was investigated (Figure 2.10). In all cases, the results show that the proteins are 
undermetallated. On average, the proteins contain 66.8% (± 10.8%) Zn and 80.2% (± 11.5%) Cu. This 
result is surprising for three reasons. First, since there is no Cu chaperone present in the expression 
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system to facilitate Cu insertion into the protein it seems more likely that the variants would be deficient 
in Cu. Second, analysis of the activity and global stability of SOD1 (see sections 2.2.3, 2.2.4 and 2.3.1.6), 
which are significantly influenced by the presence of Cu and Zn, respectively, suggests that these samples 
have higher levels of metals than observed in Figure 2.10. For example, pWT which is calculated to have 
only 80% Zn by the PAR assay displays by DSC a Tm of 91.4°C which is comparable to that for fully 
metallated pWT (92°C) (see section 2.3.1.6). Third, ICP-AES metal analysis of SOD1 suggests that for 
typical protein preparations of both pWT and mutant SOD1 in the Meiering lab, Zn incorporation is 
generally equal to or greater than Cu (92). Analysis of the same pWT sample by both methods reveals 
108% Zn and 89% Cu incorporation by ICP-AES and only 79% Zn and 91% Cu incorporation by the 
PAR assay. The calculated Cu is quite similar in both methods however the Zn is much lower in the PAR 
assay. The discrepancy between the methods can be explained by an effect of EDTA, described next. 
 
Figure 2.10 - Metal content of pWT and 11 fALS mutants. Values are calculated as % metal per protein subunit, 
where full metallation corresponds to 100%.  All samples contain 100 μM PAR, 50 mM HEPES, 5.4 M GdnHCl, 5 
μM SOD1, pH 8.2. Values are the average of three samples. The standard deviation is given as error bars.  
  
In order to ensure that the presence of protein in solution does not interfere with the modified 
PAR assay, samples of known metal prepared with added denatured EDTA-free apo pWT were analyzed. 
EDTA is used to prepare apo SOD1, and it binds strongly to SOD1 at low ionic strength (145). EDTA can 
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be removed (see section 2.2.2) to ensure it does not interfere with the assay. Both Cu and Zn were tested 
at two different concentrations in two independent trials with added EDTA-free apo protein. The expected 
and calculated metal concentrations were generally within in 3% indicating that the presence of denatured 
protein does not interfere with the assay (data not shown).   
Further inspection of the results revealed not every holo SOD1 sample had lower Zn levels 
compared to Cu. Rather, protein samples obtained using a different growth protocol involving a fermenter 
as well as remetallated EDTA-free apo pWT samples all had higher Zn levels. Both of these types of 
samples would not have contained EDTA bound to the protein because the chelator is not used in 
fermenter preparations and is removed from the apo samples before remetallation. The presence of EDTA 
bound to apo SOD1 samples would not be surprising since the chelator is directly added to purified 
protein; however, it was not thought previously that the chelator would also be bound to holo SOD1. In a 
typical purification of holo SOD1 using shaker flask culture growth, EDTA is used in an osmotic shock 
step to release the periplasmic fraction of SOD1 (146); at this point there are various proteins and cellular 
components present that may bind EDTA. Further, a number of subsequent purification steps are used to 
obtain pure holo SOD1, so it was not thought that EDTA would be present at any considerable level in 
final holo SOD1 samples.  The results described above suggest otherwise.  
2.3.1.5 Interference in the modified PAR assay by protein-bound EDTA 
 To further investigate the possibility of EDTA as the cause of the low measured levels of Zn for 
the holo SOD1 variants analyzed, the metal chelating preference of EDTA in the absence and presence of 
pWT was analyzed. EDTA has a stronger affinity for Cu (147) which is clearly illustrated by its 
preferential binding of Cu over Zn when only free metals are present in solution (Figure 2.11 A). In the 
presence of holo SOD1 (5 μM) however the opposite trend is observed, although the difference between 
metal preference is not as great (Figure 2.11 B). It has been shown previously that SOD1 binds Cu more 
tightly than Zn (122). In these experiments holo pWT is unfolded in ~7 M GdnHCl for 40 min prior to the 
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addition of PAR-HEPES and EDTA. Based on previous studies of the unfolding kinetics of pWT in the 
Meiering lab, the protein should be fully unfolded after the 40 min incubation. The results here suggest 
that even in the denatured state SOD1 has a strong enough affinity for Cu to alter the observed chelation 
by EDTA. Cu binding to the unfolded state of SOD1 is supported by studies monitoring the unfolding 
kinetics of SOD1 which found that adding Cu prior to unfolding had little to no effect on the unfolding 
rate (126). The results indicate that if EDTA is present in holo SOD1 samples, it would manifest as a 
lower than expected Zn concentration in agreement with what is observed (Figure 2.11 B).  
Metal titrations with holo pWT also reveal an interesting trend that supports the above proposed 
interference of SOD1-bound EDTA in the modified PAR assay. When equimolar Cu and Zn were added 
to samples of holo SOD1, the observed Cu concentration actually decreases slightly and the observed Zn 
concentration is increased, beyond the added amount (by ~30%). One theory that could explain this 
behaviour is that upon the addition of free metals, the EDTA present releases some of the bound Zn to 
chelate the free Cu in solution, for which it has a higher affinity. Lastly, recent size-exclusion 
chromatography experiments on holo SOD1 in the Meiering lab display a characteristic EDTA peak for 
holo SOD1 samples obtained from typical flask preparations (Jessica Rumfeldt, unpublished data). Taken 
together, the results indicate that EDTA bound to holo SOD1 is the reason for the lower than expected 
calculated Zn concentrations. It should be noted that this does not mean that Cu is unaffected by EDTA 
but rather the effects on Zn are more pronounced.  
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Figure 2.11 – Specific chelation of Cu and Zn by EDTA. (A) In the absence of protein with added free Cu (5 μM) 
and free Zn (5 μM). (B) In the presence of 5 uM holo pWT SOD1 at varied EDTA concentrations. All samples 
contain 100 μM PAR, 50 mM HEPES, 5.4 M GdnHCl, pH 8.2. All concentrations are normalized to the initial 
concentration of metal present in solution. The values are the average for three samples. The standard deviation is 
given as error bars.  
 
 Unfortunately, the presence of protein-bound EDTA greatly limits the use of the PAR assay for 
samples of SOD1 that have been exposed to and therefore bound EDTA. To try to circumvent this 
problem for samples of recombinant SOD1 which are routinely being produced and studied by various 
methods in the Meiering lab, osmotic shock in the absence of EDTA was attempted.  This greatly reduced 
the protein yield. Different chelators (NTA and DTPA), as well as additional processing steps (such as 
dialysis of the purified SOD1 against perchlorate (148) were also attempted in hopes to reduce the amount 
of chelator bound to the protein or remove the chelator entirely. In all cases, the Zn levels remained lower 
than Cu and levels of both metals were lower than expected for full metal incorporation of SOD1.  
2.3.1.6 Insights into SOD1 properties from PAR analyses  
 The ability to accurately, reliably and rapidly determine the metal bound to SOD1 is of 
importance for the sensitive comparison between metallation and various biophysical and biochemical 
properties including protein activity, stability and aggregation propensity. Decreased metal binding 
affinity has been proposed to be a general consequence of ALS associated SOD1 mutations and it was 
hoped that the PAR assay would allow for the comparison many mutants to test this theory. Even with the 
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inaccuracy introduced by the presence of EDTA some correlations were identified. DSC scans of pWT 
were completed to assess the stability of SOD1 variants (see section 2.2.4) and a pyrogallol assay was 
used to determine the activity (see section 2.2.3). It should be noted that some of these experiments were 
completed by previous students in the Meiering lab however for comparisons it was ensured that all 
experiments were completed on protein prepared from the same cell culture growth.  
The temperature where half of the protein is unfolded, or Tm, provides a good measure of SOD1 
stability. The results show that there is a fairly strong positive correlation between total metal and global 
stability (Figure 2.12 A). The metal binding mutant G85R (54) is a notable outlier in this correlation. In 
the holo state the Tm for G85R is significantly reduced compared to pWT (by 16.5°C) yet in the apo state 
the Tm is quite similar to pWT (reduced only by 3.8°C) (149). This suggests that the G85R mutation 
disrupts the metal binding region in such a way that the typical stability conferred by metal binding is 
lost. Altered metal binding in this mutant could explain the lower total metal content calculated for G85R 
compared to other mutants (by ~20%; Figure 2.10) and also the lower than expected Tm even when metal 
content is accounted for (Figure 2.12 A). There is also a strong positive correlation between measured Cu 
and specific activity (Figure 2.12 B). This is consistent with the Cu ion being required for catalytic 
activity (see section 1.6.2). In addition, the results indicate that almost every mutant analyzed has reduced 
total metal compared to pWT. This result only holds true if the amount of bound EDTA is comparable in 
each sample, however, the similar sample preparation procedures used for each mutant points to uniform 
EDTA levels. From Figure 2.10, it is clear that for some mutants (e.g. A4S, A4V, G93A, E100G and 
E100K) calculated Zn is considerable lower than calculated Cu (by ~20%). This difference is likely more 
than just the effect of bound EDTA. Decreased affinity for Zn has been observed for A4V (ref Crow), and 
NMR studies of G93A (see Chapter 3) reveal decreased local stability surrounding the zinc binding site in 
this mutant. The results therefore support the theory of altered metal binding in mutants, which may in 
part contribute to the decreased global stability.  
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Figure 2.12 - Correlation plots of SOD1 metal status as calculated using PAR. (A) Correlation of total metal 
(normalized to pWT) and the Tm (measured by DSC with protein concentrations ranging from 0.2 – 1 mg/mL). 
Values are calculated as % metal per protein subunit, where full metallation corresponds to 100%.  Total metal was 
calculated [(% Cu + % Zn)/2] and all values were then normalized to pWT having a total metal of 1. (B) Correlation 
of the % Cu and specific activity (measured by pyrogallol assay). The line of best fit is given by a solid black line. 
The associated equation and R
2
 value is given in the plot area. Data points farthest to the lower left in both panels 
are for G85R, a known metal binding mutant (54). 
 
 2.3.1.7 Summary and future work 
 The optimized PAR assay described herein provides a method for the simultaneous quantification 
of Cu and Zn in solution. This method is accurate and precise and is very easy to use. Further, since the 
fitting routine uses a linear combination of three standard spectra accounting for changes in experimental 
condition is straightforward. One simply needs to obtain the three standard spectra under the new 
conditions and complete the rest of the analysis in a similar way. In good practice standards should be 
made daily. However, with the conditions outlined in the methods section for PAR solution storage and 
the fitting routine described, which uses the entire absorption spectrum instead of 1 or 2 specific 
wavelengths for analysis reducing variability, metal quantitation with standards from the same week has 
proven to be just as accurate as when using standards from the same day (data not shown). Analyses of 
holo SOD1 purified from the periplasm of E. coli (149) reveal that there is EDTA bound to the protein; 
unfortunately the EDTA interferes with the assay by masking metal ions resulting in lower than expected 
calculated metal concentrations. Despite this interference, the assay has proved to be very useful within 
the Meiering lab in many contexts. The assay provides fast and reliable confirmation of the removal of 
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metals for reduced apo preparations of pWT and mutant SOD1 samples used in aggregation studies (83). 
Further, the metal status of inclusion bodies (cytoplasmic aggregates) formed by over-expression of WT 
SOD1 in E. coli has been investigated indicating varying levels of metal incorporation (Johnathan Almey, 
unpublished data).   
Potentially valuable future experiments may be to assess the robustness of this new PAR assay 
method for analyzing other combinations of metals in solution. Based on the absorption bands observed 
for different metals (Figure 2.5), this method should be easily be able to resolve mixtures of Zn and Cu 
(as shown above), Zn and Co, Ni and Cu, and Ni and Co in solution. Since this method is able to 
accurately separate the spectral signals of PAR:Cu and PAR2:Zn, which a previous fitting method has 
failed to do, we are hopeful the accurate determination of other metals in solution will be possible. 
Further, an interesting future experiment using this assay will be to test the propensity of SOD1 mutants 
to loose metals over time compare to pWT. This experiment would be completed in the absence of 
denaturant to quantify the amount of metal released from the protein. The samples could be incubated at 
37°C with aliquots tested as a function of time. If a mutant is more likely to lose metal then it may be 
more likely to populate an aggregation prone state (see section 2.1.2).  
2.4 Conclusions 
 The importance of metalloproteins is reflected by the sheer number of proteins that bind metal 
cofactors (109). The presence or absence of metal cofactors can greatly influence the structure, function 
and flexibility of a metalloprotein. In some cases, such as SOD1, the loss of metal cofactors is proposed 
to lead to protein aggregation and disease (88, 136). It is therefore of utmost importance that when 
analyzing various biophysical and biochemical properties of a protein, or when making comparisons 
between proteins, that the metallation state is known.  
The use of the chromogenic chelator PAR for metal determination in proteins was explored 
herein due its low cost and high sensitivity. The non-selectivity of PAR makes distinguishing between 
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metal ions in solution difficult. A number of methods have been developed to overcome this limitation. 
The Crow method (122) relies on the use of two chelators to mask one of the metals in solution, which is 
shown here to be only partially effective. We further show here that the selectivity of the chelators 
depends on the type and amount of metal in solution and thus only under specific experimental conditions 
is the Crow method reliable (Figure 2.3). The alternative Säbel method uses a linear addition of Beer-
Lambert law to separate the spectral contributions of each metal (139). This method is fairly accurate for 
the determination of Zn and Co in solution but the resolution for Zn and Cu is low (Stefan Siemann, 
personal correspondence). Further, a number of manual processing steps decrease the ease of use and 
increase the possibility of introducing error. A third method developed by Mulligan et al. (125) relies on 
the differential absorbance of Cu and Zn at two specific wavelengths. This method proves to be quite 
accurate at distinguishing between Cu and Zn however use of only two-wavelengths for analysis is not 
compatible for quantification of metals with more similar spectral signals in solution.  
 An alternative method presented herein proves to be very accurate and precise in the 
determination of Cu and Zn in solution. This method uses the spectral software (144), to perform spectral 
decomposition separating the three species contributing to absorbance (PAR, PAR:Cu and PAR2:Zn). 
Analysis only requires the input of three standard absorbance spectra at one concentration. This method is 
quite rugged as changes in the experimental conditions simply need to be accounted for using the 
standards. Comparison of results of the PAR assay using the Mulligan method and that described here 
reveal that while both methods are quite similar in terms of accuracy, more often the standard deviation is 
smaller for analyses using SpLab (Figure 2.13). A method that only uses two wavelengths is inherently 
prone to more errors that one that uses the entire absorption band for analysis and thus the increased 
precision observed in the PAR assay using the SpLab method would likely be more pronounced if there 
were any noise or greater uncertainty in absorbance values.    
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Figure 2.13 - Comparison of the accuracy and precision of metal quantitation using the PAR applying the Mulligan 
and SpLab methods. The concentrations of each metal (25 μM total) in solution are given on the x-axis as Zn, Cu 
(μM). Each calculated value represents the mean ± the deviation of two (Mulligan method) or three (SpLab method) 
independent experiments. All samples contained 100 μM PAR, 50 mM HEPES, 5.4 M GdnHCl, pH 8.2. The percent 
metal was calculated as ([calculated metal] / [actual metal])*100%. The average deviations are 2.62% and 1.80% for 
the Mulligan method and SpLab method, respectively.   
 
The studies herein reveal three important points to consider for the use of PAR in the metal 
determination of proteins. (1) Avoid successive scanning of the protein as this will decrease the 
absorbance; instead let the protein unfold separately first. (2) Ensure that PAR is in at least 2.5 fold molar 
excess over the total metal present to avoid decreasing the PAR2:Zn stoichiometry (122). (3) Be aware of 
the possibility of interfering substances that may spectroscopically silence metal ions. Overall, the results 
indicate that the use of PAR for the determination of Cu and Zn in solution is both accurate and useful for 
different applications.  
 52 
 
 Chapter 3 
Local unfolding and conformational heterogeneity of holo SOD1 
 
3.1 Introduction 
3.1.1 Protein dynamics  
The new view of protein folding occurring via parallel pathways along an energy landscape 
converging at the lowest energy conformation, or native state, can sometimes give the false impression 
that the native state of a protein is static. In reality, the native state generally consists of multiple 
microstates in equilibrium with one another. Each of these states may be close in energy to the lowest 
energy conformation but can have very different structures, due to diverse processes including the 
movement of secondary structural elements, changes in loop conformations and reorientation of side 
chains (150). The transition from ground to low populated excited states typically goes undetected using 
many standard techniques, however, recent advances in NMR spectroscopy have allowed for observation 
of these states (discussed further below) (151, 152). These transiently populated low-energy conformers 
may be important in function or pathology (153, 154). 
Protein function is known to rely on the intricate relationship between sequence, structure, 
stability and flexibility. There is often a trade-off between protein stability and the flexibility required for 
function (150). This increased flexibility can be local or global. For example, the protein SlyD (sensitive 
to lysis D) is a protein folding helper enzyme that has two functional domains (155). The first domain acts 
as a peptidylprolyl isomerase and the second acts as a ubiquitous chaperone. The second domain has 
reduced stability compared to the first. It is believed that this is a consequence of its function and the 
requirement to accommodate a variety of different structures. Even so, the protein displays highly 
cooperative global unfolding and binding studies show that the stability of each domain is linked (155). 
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Thus, even proteins that show cooperative unfolding can have regions with different local stabilities 
which can be functional (described above) or pathogenic (see section 1.4.1). 
Flexibility “hotspots” in proteins have been implicated as sites of protein aggregation (150), such 
as the M80 region in cytochrome c (156). The effects of mutations on the local and global stability of 
proteins are distinct, with even different mutations at the same position resulting in unique changes 
depending on the substituted residue. This phenomenon has been highlighted for a number of proteins, 
including position Y73 in acyl-coenzyme A binding protein (157) and position G93 in SOD1 (82). A 
complete understanding of the folding landscape, including folding intermediates, transition states, and 
high and low energy alternative states, is required to understand not only the relationship between 
mutation and protein stability, flexibility and function but also how protein dynamics may contribute to 
dysfunction and pathology.  
3.1.2 NMR spectroscopy 
Many advances in NMR spectroscopy, such as the development of multidimensional NMR 
methods and high field spectrometers, have made NMR a vital tool in the study of proteins at atomic 
resolution (158). One common use of NMR is the determination of high resolution three dimensional 
(3D) structures of biological molecules in solution. Other uses include measuring protein dynamics, 
protein-ligand interactions and temperature coefficients (159-161).
 
 The NMR experiment requires that 
the protein of interest be placed in a static magnetic field. The unique resonance frequencies of NMR 
active nuclei are detected (upon radiofrequency irradiation). Only nuclei with a non-zero spin quantum 
number have a magnetic dipole moment. The most commonly studied nuclei are of spin ½ such as 
1
H, 
13
C, 
15
N and 
31
P. The chemical shift, δ, is the difference between the absorption frequency of a given 
nucleus and a standard reference nucleus divided by the spectrometer frequency and is given in parts per 
million (ppm) (158).
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In a one-dimensional (1D) NMR spectrum, chemical shift is plotted on the horizontal axis and the 
peak area is representative of the number of nuclei with the same chemical shift. One of the limitations of 
protein NMR is molecular size. The greater number of peaks and lower rotational correlation time 
associated with larger proteins will lead to peak overlap and line broadening , reducing sensitivity (158).
 
One way to overcome this limitation is with multidimensional NMR experiments on high field 
spectrometers. In multidimensional NMR, cross peaks are observed between nuclei that are linked 
through bonds (J-coupling or correlation experiments) or are close in space (Nuclear Overhauser Effect 
experiments). Correlation experiments can be used to analyze through bond and through-space 
interactions between pairs of identical (homonuclear) or different (heteronuclear) nuclei.
 
3D experiments 
can further increase resolution by expanding a two dimensional (2D) spectrum into a third dimension 
allowing overlapping peaks to be separated into layers (158).
 
 
One of the most common 2D experiments is the 
1
H,
15
N-heteronuclear single quantum correlation 
(HSQC) experiment, which provides the “fingerprint” of a protein (158). An HQSC experiment correlates 
protons to their covalently bonded nitrogen atoms producing a cross peak for each backbone amide, with 
the exception of proline.  Cross peaks are also observed for the side chain NH groups of Trp and His, 
Asn, Gln, Arg and Lys. The HSQC experiment can be combined with a Nuclear Overhauser Effect 
experiment (NOESY) to separate the HSQC spectrum into a third dimension. Each plane of a NOESY-
HSQC is a NOESY spectrum of amide protons attached to nitrogens which resonate at a particular 
frequency. Each cross peak in the NOESY spectrum represents protons within ~5 Å of the amide proton 
making this experiment very helpful for making sequence specific resonance assignments of 
1
H-
15
N cross 
peaks (158).  
3.1.3 Temperature coefficients 
The temperature dependence of chemical shift changes, known as the temperature coefficient, for 
an NMR active nucleus can be measured by acquiring spectra at a series of temperatures. Since chemical 
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shift values are sensitive to structural as well as environmental influences, monitoring the change in 
chemical shift with temperature can provide useful structural information at atomic resolution. The 
temperature dependence of amide protons was first described in 1969 (162) and since then much work has 
contributed to the understanding and interpretation of amide proton (N
1
H) temperature coefficients (160, 
163, 164). While great strides have been made in discerning the origins of N
1
H temperature dependences; 
the contributing factors to 
15
N and C
α
H temperature coefficients still remain unclear (165).  
Amide protons almost always show a negative temperature coefficient (normally falling within 
the range of -11 to 1 ppb/K) indicating the proton resonances shift upfield with increasing temperature 
(Figure 3.1) (160). Oshnini and Urry showed in 1969 that amide protons involved in intramolecular 
hydrogen bonds have more positive temperature coefficients indicating that their chemical shift is 
relatively less affected by temperature (162). It is suggested that the observed negative temperature 
coefficients of amide protons is a consequence of the downfield shift caused by hydrogen bonding (163). 
Upon heating, the magnitude of thermal fluctuations in solution becomes larger, causing the length of the 
hydrogen bond to increase. This weakens the hydrogen bond, reducing the associated downfield shift 
resulting in a negative temperature coefficient (upfield shifting resonance). It should be noted that almost 
all amide protons in a protein participate in hydrogen bonds; those that do not participate in an 
intramolecular hydrogen bond often hydrogen bond with bulk water (166). In the latter case, the hydrogen 
bond is weaker and thus the lengthening caused by temperature will be larger resulting in a more negative 
temperature coefficient (Figure 3.1).   
The use of amide proton temperature coefficients for prediction of hydrogen bonds was initially 
analyzed for peptides (167, 168). The correlations between temperature coefficients and hydrogen 
bonding were poor however it was later proposed that the peptides, being less stable than globular 
proteins, were likely undergoing significant loss of secondary structure upon heating which influenced the 
temperature coefficients and reduced the correlation (163, 164). The reliability of temperature coefficients 
as hydrogen bond indicators in proteins was then investigated by analyzing the temperature coefficient of 
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793 amides protons from 14 different globular proteins in relation to hydrogen bonding determined from 
geometric criteria obtained from crystal and/or NMR structures (160). The observed correlations were 
much more convincing showing that if the temperature coefficient is more positive than -4.6 ppb/K there 
is an 85% probability that the amide participates in an intramolecular hydrogen bond (Figure 3.1). The 
reliability of predicting a hydrogen bond increases to 93% if the value is more positive than -4 ppb/K. It 
was found that 82% of all non-intramolecularly hydrogen bonded amides have temperature coefficients 
that fall between -5 and -11 ppb/K (Figure 3.1). Counterintuitively, amide protons participating in strong 
intramolecular hydrogen bonds have larger temperature coefficients than those in weaker intramolecular 
bonds (Figure 3.1). This is because amide chemical shifts are dependent on the inverse third power of 
hydrogen bond lengths (160, 169) and so increasing length has a larger effect on chemical shift for a 
shorter hydrogen bond. Nevertheless, in both cases the temperature coefficient will still most likely be 
more positive than -4.6 ppb/K. Overall, it appears that stable globular proteins provide a better system for 
using amide proton temperature coefficients to predict hydrogen bonds.  
 
Figure 3.1 - Understanding N
1
H temperature coefficients. A value more positive than -4.6 ppb/K (small upfield shift 
with temperature) indicates a high probability of an intramolecular hydrogen bond. Within this range a more positive 
value represents a weak intramolecular hydrogen bond and a more negative value represents a strong intramolecular 
hydrogen bond. A value more negative than -5 ppb/K (large upfield shift with temperature) indicates a high 
probability of a weak intermolecular hydrogen bond (with bulk water).   
 
It should be noted that factors other than hydrogen bonding can also affect amide proton 
temperature coefficients. For example, the ring current of nearby aromatic side chains can deshield amide 
protons resulting in a temperature coefficient similar to that for a hydrogen bonded proton (160). In 
addition, secondary structure can influence the temperature coefficient, with amide protons in α-helices 
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showing coefficients approximately 1 ppb/K more negative than those in β-sheets. This is because amide 
protons in α-helices are less deshielded than in β-sheets (170). It has been shown that there is a weak 
correlation between amide proton temperature coefficients and amide exchange rates (163, 171). While 
both amide proton temperature coefficients and amide exchange rates are thought to be sensitive to 
hydrogen bonding status, the weak correlation could be due to different factors affecting the two methods. 
For example, amide exchange rates are very sensitive to both hydrogen bonding and surface exposure 
whereas temperature coefficients appear to be less sensitive to the surface exposure (163). Further, amide 
exchange rates are sensitive to pH while temperature coefficients do not appear to be affected unless the 
pH change induces conformational rearrangements in the protein (160).  
Newer data reveal conflicting interpretations with regards to hydrogen bonding being the main 
determinant of amide proton temperature coefficients. NMR measurements of the third IgG-binding 
domain of protein G (GB3) show that amide proton temperature coefficients strongly correlate with the 
temperature coefficient of the through hydrogen bond J-coupling value (172), which provides a direct 
measure of amide proton hydrogen bonds (173) and has previously been used to study hydrogen bond 
expansion in ubiquitin (174). This suggests that the change in the strength of the hydrogen bond due to 
thermal expansion is the main contributor to the amide proton temperature coefficient. The authors 
propose that the temperature dependent shift between ordered and disordered states can also contribute to 
the observed coefficient, but to a lesser extent (172). In another study, the temperature coefficients of 
specific residues were studied at different pH values to probe the role of hydrogen bonding (165). Amide 
protons that hydrogen bond to carboxylate side chains are expected to participate in stronger hydrogen 
bonds above the pKa of the carboxylate group. This should be reflected in the temperature coefficient of 
the amide proton however the correlation was poor. The authors concluded that the temperature 
dependence is determined mainly by local unfolding not the strength of the hydrogen bond (165). It was 
proposed that the tendency of amide protons participating in strong intramolecular hydrogen bonds to 
display larger temperature coefficients than those in weaker intramolecular hydrogen bonds is simply 
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because regions with strong hydrogen bonds are more structured, and thus the same fractional loss of 
structure will result in greater chemical shift changes when stronger hydrogen bonds are disrupted (165). 
In either case, whether the N
1
H temperature coefficient is directly or indirectly related to the strength of a 
hydrogen bond, the value nevertheless provides useful information on hydrogen bonding and local 
structure in proteins.  
The temperature coefficients of other nuclei, 
15
N and C
α1
H for example, have been observed to be 
both positive and negative. The range of 
15
N temperature coefficients is 2 times larger than that for amide 
protons, while the range of C
α
H temperature coefficients is 2-3 times smaller (163). There does not appear 
to be any correlation between N
1
H and C
α1
H temperature coefficients for the same residue, and only a 
very weak correlation between N
1
H and 
15
N coefficients. No clear relationship between 
15
N temperature 
coefficients and structure has been found to date (165). Thus, temperature coefficients for N
1
H remain the 
main resource for structural investigations of proteins.   
3.1.4 Non-linear temperature dependence of N
1
H  
 Chemical shift changes with temperature are commonly linear. This has been attributed to the 
thermal expansion coefficient of proteins being constant with temperature and thus any structural changes 
upon heating are linear (163, 175). Despite this fact, studies on a number of proteins have revealed that 
some amide protons do in fact show curved temperature dependences (163, 176-180). This curvature has 
been proposed to arise from the population of a low energy alternative state and therefore can report on 
the conformational heterogeneity of a protein (180, 181). This theory is supported by the high correlation 
observed between residues expected to be involved in an alternative conformation and those that show 
curved temperature dependences for the N-terminal domain of phosphoglycerate kinase, hen egg-white 
lysozyme and bovine pancreatic trypsin inhibitor (180). 
The extent of curvature can provide useful information on a number of factors including the 
difference in free energy between the ground and excited state (discussed further in section 3.3.6.1) (177, 
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178). It is important to stress that lack of curvature does not necessarily mean that the amide proton does 
not access another state. It could be that the energy difference between the two states is simply too great 
or that the amide proton is in exchange with a large number of alternative states, both of which result in a 
linear temperature dependence (180). Thus, no conclusions can be made from lack of curvature. 
Interestingly, since temperature dependences can report on alternative states close in energy to the native 
state, it reports on conformations that may not be observed using amide exchange studies. It has been 
proposed that the high energy and likely extensive structural rearrangement required to allow water access 
into the protein interior make the conformations observed through amide exchange more like unfolding 
intermediates rather than alternative sates (177, 180).  
 Conformational heterogeneity within proteins has been suggested to arise from a variety of 
factors including alternative hydrogen bonding networks possibly due to buried water molecules, 
structural instability, disulphide bond isomerization, disruption of loops and loss or extension of 
secondary structural elements (180). Previous studies reveal that the proportion of N
1
Hs displaying 
curved temperature dependences in proteins can range from, but by no means is limited to, 5 – 40% (163, 
176-180). These residues are often spread throughout the polypeptide chain clustering at the ends of 
secondary structural elements and in loops (178, 180). A comparative study analyzing the streptococcal 
IgG binding B1 domain of proteins G and L showed that residues accessing alternative states do so 
independently based solely on local stability (176). The energy barrier for the local folding from the 
excited state back to the ground state was determined is most cases to be less than 1.5 kcal/mol. Further, 
analysis of the folding pathways of these two proteins reveals that their folding transition states have 
distinct structural differences. Interestingly, on closer inspection, residues displaying curvature were 
concentrated in regions unstructured in the transition state in both cases (176). Characterization of curved 
N
1
H temperature dependences of non-myristoylated and myristoylated neuronal calcium sensor-1 (NCS-
1) revealed that myristolation increases the number of residues accessing alternative states (178). Further, 
it was found that the distribution of residues populating alternative conformations in the Ca
2+
-binding 
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loops myristoylated and non-myristoylated NCS-1 quite different which could explain, in part, the 
differences in their Ca
2+
 binding affinities (178). The identification of low energy alternative states can 
therefore be useful in the understanding the dynamics of the native state, folding pathways and local 
stability.  
A very interesting study on horse cytochrome c found that at least 25% of residues access an 
alternative state under equilibrium conditions (177). These residues cluster in the most destabilized region 
of the protein expected to unfold first based on previous folding studies. In contrast, the most stable 
region expected to fold first and unfold last show very few amide protons with curved temperature 
dependences. Based on simulations, the author proposed that the residue displaying curvature is at the 
middle of a five consecutive amino acid cooperative unit populating a higher energy state. The results 
show that cytochrome c has many local alternative states that are less structured and again accessed 
independently. It was suggested that these alternative states may be the earliest cooperative units of 
unfolding with the unfolding pathway beginning from local breathing motions converging to create low 
energy alternative states, as identified by N
1
H temperature dependences, merging to create higher energy 
states, such as those identified by amide exchange studies, which finally merge resulting in global 
unfolding (177). This model suggests that there may be many competing unfolding pathways involved in 
global denaturation.  
3.1.5 Previous studies on the dynamics/conformational heterogeneity of SOD1 
NMR relaxation experiments can provide information on the dynamics of a protein from the 
picosecond to millisecond time scale. These experiments were employed to monitor the dynamic 
properties of holo SOD1, showing that this very stable protein has a rigid structure (182). The most 
flexible loop is loop I, with most of the mobility being observed for Gly12. All 8 β-strands in the holo 
dimer show comparable flexibility. Relaxation rates suggest the occurrence of conformational exchange 
processes in the dimer (182). Of the residues showing this conformational heterogeneity, over half are 
 61 
 
found in β-strands providing evidence for the existence of breathing motions in the holo dimer. This type 
of dynamic behaviour in β sheets has been proposed for other proteins (183, 184). Residues showing 
conformational exchange also appear to cluster close to Cys57 and Cys146 indicating that isomerization 
of the intramolecular disulfide bond may also contribute to the conformational heterogeneity in SOD1 
(182).  
The dynamics of monomeric holo SOD1 were also studied using a monomer variant containing 
three mutations (F50E, G51E, E133Q) that disrupt the dimer interface (182). The global fold of this 
variant is essentially the same as a single subunit of holo SOD1 however it should be noted that this 
variant is a model and may not behave exactly the same as the native monomer (185). Even in the 
monomeric state, holo SOD1 is fairly rigid. The residues that would normally make up the dimer interface 
have greater mobility in the monomeric variant, as expected. Notably, residues 76-86 and 88-95, which 
are far from the dimer interface, show altered mobility in the dimer compared to the monomer (Figure 
3.2), highlighting propagating structural effects within the monomer (182). In addition, the dimer has 
increased flexibility at residues 131-142 (Figure 3.2) which are part of the active site channel and 
neighbour the catalytically important Arg143 (186). The authors proposed that increased flexibility in this 
region in the dimer may play a role in driving the superoxide anion toward the active site (185). Different 
fALS mutations show further increased flexibility in this region (123, 187) which on the other hand could 
allow non-native substrate access and lead to aberrant enzymatic reactions. It appears that the breathing 
motions observed in the dimer are hampered in the monomer, suggesting that joint motions of the two 
subunits may be involved in the breathing process (182). MD simulations indicated that these breathing 
motions are also hampered in mutants even in the dimeric state (104). The authors propose that these 
breathing motions allow for the release of excess energy and that without this ability energy perturbations 
may be more likely to result in local unfolding. This increased strain within mutant SOD1 favouring local 
unfolding may lead to the solvent exposure of aggregation-prone structural elements.  
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Figure 3.2 - Differences between the S
2
 values of the monomer variant and dimeric holo SOD1. The S
2
 value is the 
square of the generalized order parameter characterizing the amplitude of internal motions. Only residues where the 
S2 value was determined for both forms are included (represented as open circles). The thin black lines show the 
uncertainty of the differences. The thick black line represents a smoothing of the data by averaging over five 
adjacent points (centred at the point of interest). Figure taken from Banci et al., 2000 (182). 
 
NMR relaxation experiments were also employed to analyze the dynamic properties of the fALS 
mutant G93A (95). The results show that holo G93A exhibits higher mobility than WT and significant 
chemical shift and Nuclear Overhauser effect (NOE) differences in loops III and V. These regions make 
up the β-barrel plug, a key stabilizing element in SOD1 (58, 78, 188). The increased mobility and lack of 
observed NOEs indicate deprotection of edge strands and an opening of the β-barrel, which could lead to 
edge-to-edge aggregation (see section 1.6.6). The most flexible β-strand in G93A is the charged edge 
strand β6 (95). Compared to WT, G93A has increased mobility at ~25% of residues throughout the 
structure again indicating that the mutation has propagating effects. Computational work also points to 
increased flexibility compared to WT as a general consequence of mutation, with mutants G37R, A4V, 
and H46R having increased mobility at 64%, 62%, and 53%  of residues, respectively (104). It should be 
noted however, that while the G93A mutation appears to increase dynamics on both a local and global 
scale, there are also regions of the mutant, such as residues 76-84 near the zinc binding site, that are more 
rigid compared to WT (95). A similar trend has been observed computationally for A4V and H46R, 
which also display decreased flexibility in this region (res 70-80) (104). Therefore it appears that often 
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both increases and decreases in mobility are observed experimentally and computationally upon mutation 
of SOD1, as has been reported for other proteins (108, 161).  
Amide exchange studies on holo SOD1 confirm the results of the relaxation experiments 
identifying a fairly rigid structure (189). The majority of amide protons in β-strands exhibit slow 
exchange with the exception of those at the β3–β6 and β5–β6 interfaces, again indicating increased 
dynamics at the edge strands. Amide exchange measurements on G93A show localized destabilization 
surrounding the mutation site, specifically in the β-barrel plug (189). The authors also report propagating 
destabilization of the metal binding site, which is interesting as a number of these residues fall in the 
region described above to be stabilized in mutants in the apo state (res 70-84). Therefore the results reveal 
altered behaviours in the metal binding region of SOD1 in apo and holo states. The results did not reveal 
any changes in the dimer interface which is intriguing as it has been proposed that mutations, regardless 
of the site, have propagating destabilizing effects on the dimer interface (104, 189). As seen in the NMR 
relaxation experiments, regions with increased amide protection in the mutants were observed (189). 
Amide exchange studies of apo A4V also show altered dynamics in the β-barrel plug (51). This is 
surprising as the A4V mutation is in the dimer interface far from the β-barrel plug indicating the presence 
of propagating structural effects. MD simulations confirm these results for A4V, and show the same for 
H46R and G37R (104). Thus, the β-barrel plug may represent a common region of destabilization among 
mutants, while the mutation effects on the dimer interface are more variable. Notably, the β-barrel plug is 
also 1 of 4 segments of SOD1 predicted to have a high aggregation propensity (190).  
Another technique that allows for the determination of short-lived, weakly populated, excited 
states is the Carr-Purcell-Meiboom-Gill (CPMG) 
15
N nuclear spin relaxation experiment (191, 192). This 
method was used to study the conformational heterogeneity of the monomeric apo SOD1 variant (193). 
These experiments provide information on the exchange rate between the native and the excited states, the 
relative populations and the chemical shift for each state. Regions of the protein perturbed in the excited 
state include loops IV, VI and VII, as well as β4, β5, β7, β8, which together make up the C-terminal β-
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sheet. This sheet has been shown to be more dynamic in the apo state via previous computational work 
(49). Additionally, three mutants were studied using CPMG (A4V, G85R and D90A) revealing similar 
residues accessing alternative conformations however these residues showed enhanced structural 
distortion in the excited state and in some cases decreased kinetic barriers between the two states (193). 
The mutations altered local dynamics, with A4V showing increased conformational heterogeneity in β1 
and G85R and D90A in the β-barrel plug. Overall, the authors conclude that the excited state, being 
common to all 4 variants and unstructured likely exposing hydrophobic side chains, may be the state 
responsible for non-native assembly. The conformational heterogeneity of zinc-bound SOD1 was also 
analyzed. Zinc binding confers a great deal of stability and the results reveal that this state does not 
undergo large scale conformational exchange however there is evidence for slow conformational 
exchange between states with small structural changes (193).  
 Taken together, the above-described experimental and computational studies show that holo 
SOD1 has a fairly rigid structure; however, there is a degree of conformational heterogeneity attributed to 
breathing motions. These breathing motions are reduced in the holo monomer indicating that concerted 
communication between the two subunits is involved in the process. Propagating structural effects upon 
monomerization and mutation are evidenced by alterations in the flexibility of residues far from the dimer 
interface and site of mutation, respectively. A number of mutations, studied by a variety of biophysical 
and computational methods, exhibit altered dynamics in the β-barrel plug, indicating a common pattern of 
destabilization. Further, residues that access alternative conformations in the apo monomer appear to 
correlate well with regions of decreased stability based on MD simulations, which has been reported for 
other proteins as well (177). It remains unknown whether residues accessing alternative states will follow 
the same pattern for other, more mature forms of the protein. 
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3.1.6 Chapter Overview 
With the dimeric nature of SOD1 and the number of post-translational modifications the protein 
undergoes there are over 44 different states in which the protein can exist (98). Thus, it is important to 
focus on those states which are believed to be physiologically relevant. Holo SOD1 is often overlooked 
due to its high stability and resistance to denaturation. However, due to recent mounting evidence that 
local unfolding may play a role in protein aggregation and disease (see sections 1.4.1 and 1.6.6), holo 
SOD1 cannot be ruled out. Further, since the most mature state is the major form present in cells (54), 
understanding of altered processes in the holo state of mutants may provide information on the initial 
stages of protein aggregation.  
The determination of N
1
H and 
15
N temperature coefficients has not been reported for any form of 
SOD1. The determination of low energy alternative states has been studied using CPMG experiments on 
the apo and zinc-bound monomer construct at 18°C, 25°C and 32°C (discussed above) but have not been 
described for the holo form. The identification of alternative states through non-linear temperature 
dependences has not been applied to any form of SOD1 to my knowledge. This chapter will describe the 
determination of N
1
H and 
15
N temperature coefficients, as well as the characterization of residues 
accessing low free energy alternative states, for holo-pWT SOD1 by acquiring 2D NMR spectra at a 
series of temperatures. The same studies are also carried out here for the ALS-mutants G93A, E100G and 
V148I in order to assess the differences in structure, dynamics, local stability and conformational 
heterogeneity caused by single site mutations, and the possible implications for protein aggregation. 
These mutants were chosen based on their differences in stability, aggregation propensity, site of mutation 
and change in net negative charge, highlighted in Table 3.1.  
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Mutant Location of 
Mutation 
Aggregation 
Propensity 
Change in 
Net Negative 
Charge 
Disease 
Duration 
(years) 
Holo 
Tm (°C) 
Holo 
ΔTm (°C) 
WT n/a n/a n/a n/a 96.3 n/a 
G93A Loop V (β-plug) High No Change 3.1 92.5 -3.8 
E100G β6 (edge strand) High Reduced 4.7 91.1 -5.2 
V148I β8 (dimer interface) Low No Change 1.7 97.0 +0.7 
 
Table 3.1 – Summary of Mutant Characteristics. Aggregation propensities obtained from Prudencio et al., 2009 
(194). Stability data obtained from DSC simulations at 30 mg/mL (see section 3.3.2). Disease durations obtained 
from Wang et al. 2008 (80). 
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3.2 Methods 
3.2.1 Expression and purification of labeled proteins 
 SOD1 variants were expressed in the E. coli strain BL21. The expression vector pHSOD1ASlacI
q 
contains the sod1 gene (human cytosolic CuZnSOD) and a leader sequence from Photobacterium 
leiognathi which directs the translated protein to the periplasm. The expression vector contains the lac 
repressor and the tacI promoter, and an ampicillin resistance marker gene. Transformation was carried out 
by electroporation as previously described (195). To summarize, BL21 cells were prepared through the 
removal of salt (media) from 1 L of mid to log-phase culture through three centrifugation steps at 4000 x 
g. After each step the cells were resuspended in 1 L, 0.5 L, and 0.25 L of 10% glycerol, respectively. This 
was done to increase the resistance (5000 Ω) of the sample.  
Approximately 1 μg of vector DNA was added to 40 μL of cells, mixed well and added to an 
electroporation cuvette (0.1 cm gap; BioRad Laboratories, Inc., Hercules, CA.). The DNA/cell mixture 
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was subjected to a high electric field (1.8 kV for ~1 s; Eppendorf Eporator, Eppendorf, Hamburg, 
Germany). The cells were immediately placed in 1 mL liquid medium (0.4% (w/v) glucose, 20.0 g 
tryptone, 5.0 g yeast extract, 0.5 g NaCl, 0.01 M MgSO4, per litre) and incubated for ~ 1 hour at 37ᵒC. 
The cells were then centrifuged and plated on Luria Broth (LB) agar containing ampicillin (100 μg/L) and 
incubated overnight at 37ᵒC. Individual colonies were picked and grown in an overnight LB culture 
containing LB culture with ampicillin (100 μg/L). The overnight culture was diluted 1:100 into 1L of M9 
minimal media (Na2HPO4 (6 g/L), KH2PO4 (3 g/L), NaCl (0.5 g/L), 
15
NH4Cl (0.5 g/L), MgSO4 (2mM), 
glucose (4 g/L), thiamine (0.0005 g/L), CaCl2 (0.1 mM)) with ampicillin (100 μg/L). Cultures were grown 
at 25ᵒC with shaking (220 rpm) for ~10 hours until an optical density of ~0.6 absorbance units at 600 nm 
was reached. Protein expression was induced with isopropyethiogalactoside (IPTG, 0.5 mM final 
concentration). CuSO4 (0.1 mM final concentration) and ZnSO4 (0.05 mM final concentration) were 
added at induction. Cells were grown at 25°C for ~36 hours. Cells were harvested by centrifugation (4500 
x g for 20 min) and were stored at -80°C before performing osmotic shock.  
Osmotic shock was completed to release SOD1 from the E. coli periplasm as described 
previously (146). Briefly, cells were resuspended in 10 mM ice-cold Tris-HCl buffer (50 mL for pelleted 
cells from 1L of culture) containing EDTA (15 mM final concentration) and sucrose (20% (w/v) final 
concentration). Cells were gently agitated on ice for 20 minutes and pelleted by centrifugation at 4000 x g 
for 30 minutes. The cell pellet was resuspended in ice-cold deionized milliQ (Millipore Ltd., Bedford, 
MA) water (20 mL for cells pelleted from 1L of culture). Cells were again agitated on ice for 20 minutes 
and centrifuged at 4500 x g for 45 minutes. The soluble periplasmic fraction containing SOD1 was flash 
frozen in liquid nitrogen and stored at -80°C until further purification.  
Hydrophobic interaction chromatography was used to separate SOD1 from native E. coli 
periplasmic proteins. The soluble fraction from osmotic shock was diluted to ~0.8 mg/mL total protein in 
20 mM Tris-HCl, pH 7.0 and heated to 70°C in the presence of CuSO4 (1.4 mM final concentration) to 
ensure full copper insertion into the active site. The heating also acts as a purification step since few 
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proteins are stable at this temperature. After heating, the precipitated protein is separated by 
centrifugation (10 000 x g for 20 minutes) and (NH4)2SO4 was added to the supernatant (3 M final 
concentration). All buffers were filtered through a 0.2 micron low protein binding filter and degassed for 
~20 minutes prior to chromatography. The protein in (NH4)2SO4 was loaded onto a Waters column (2.2 
cm diameter x 10 cm length; Waters Corporation, Mississauga, ON) packed with Poros 20 micron HP2 
(polystyrene-divinylbenzene) hydrophobic interaction chromatography media. SOD1 was eluted using an 
ammonium sulphate (3M (NH4)2SO4 in 20 mM Tris-HCl, pH 8) to buffer (20 mM Tris-HCL pH 8) 
gradient (65% to 35% 3M ammonium sulphate over 4 column volumes). Fractions containing SOD1 were 
pooled and dialyzed against milliQ water using dialysis tubing (Spectra/Por 6-8,000 Da cutoff membrane, 
regenerated cellulose membrane; Millipore, Ltd, Bedford, MA). The holo SOD1 was concentrated to ~6 
mg/mL using an Amicon ultrafiltration device using a 10 000 Da cutoff membrane (Amicon ultrafiltration 
regenerated cellulose membrane, Millipore, Ltd, Bedford, MA). Aliquots of the protein were added to 1.5 
mL Eppendorf tubes and flash frozen in liquid nitrogen and stored at -80°C. 
The purity of SOD1 was >95% as determined by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). Metal content was determined qualitatively from the NMR spectrum. For 
NMR experiments purified 
15
N-labeled pWT or mutant SOD1 was exchanged into buffer (20 mM Hepes, 
pH 7.8; four 1:8 dilutions) using a Millipore centrifuge tube (Ultracel 3K, Millipore Ireland, Ltd.) to a 
final concentration of ~30 mg/mL and a final volume of ~450 μL. The copper was reduced by addition of 
5 mM sodium isoascorbate. Reduction to Cu
1+
 avoids paramagnetic ling broadening caused by Cu
2+
. After 
the addition of D2O (37.5 μL) the sample was transferred to a 5 mm NMR tube.  
3.2.2 NMR experiments 
NMR experiments for three variants (pWT, G93A and E100G) were carried out on a Bruker 
Avance spectrometer operating at 600 MHz with a triple-resonance (TXI) 5 mm probe with pulse field 
gradients along the x, y and z-axes (Bruker, Billerica, MA, USA). The set temperature was varied from 
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25°C to 75°C at 10°C increments. The actual sample temperature was verified using a standard curve 
provided by Bruker (T= (4.218 -Δ)/0.009132) based on chemical shift separation of resonances in 80% 
ethylene glycol (DMSO-d6) and a thermocouple. The actual sample temperatures ranged from 24 - 84°C 
at ~12°C increments.  Chemical shifts were referenced according to the internal spectrometry frequency 
calibrations. NMR data were processed using the Bruker software and analyzed using computer aided 
resonance assignment software (CARA) (196). For 2D heteronuclear experiments 
15
N decoupling during 
acquisition was achieved using the GARP sequence (Shaka et al., 1985 jess). Water suppression was 
achieved using gradients until a set temperature of 55°C (actual sample temperature 61.5°C) (see A2.1 for 
pulse program). Above this temperature, water suppression was achieved using presaturation (see A2.2 
for pulse program). Two-dimensional 
1
H-
15
N HSQC spectra were acquired using INEPT magnetization 
transfers (197).  
NMR experiments for V148I were carried out on a Bruker Avance spectrometer operating at 500 
MHz with a triple-resonance (TXI) 5 mm  probe with pulse field gradients along the z-axis (Bruker, 
Billerica, MA, USA). The set temperature was varied from 25°C to 80°C at 5°C increments. The actual 
sample temperature was verified as described above and ranged from 24.5°C to 87.5°C at ~5.7°C 
increments. Spectra were acquired as described above with the exception that water suppression was 
achieved with a single z-gradient at all temperatures (see A2.3 for pulse program). A three-dimensional 
15
N-NOESY-HSQC spectrum (see A2.4 for pulse program) of V148I was collected on the spectrometer 
operating at 600 MHz (as described above) with a mixing time of 125ms. The total time for the 
experiment was approximately 3 days.  
3.2.3 Resonance assignments 
 Sequence specific resonance assignments were determined previously for pWT SOD1 and the 
mutants G93A and E100G at 25 °C, pH 7.8 (6). Resonance assignments for V148I were made in a similar 
way as for G93A and E100G by a 
15
N-NOESY-HSQC experiment at 25°C, pH 7.8. NOE cross peaks 
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were used to assign the peaks that shifted upon mutation and confirm the assignment of those that did not 
shift. The uncertainties in N
1
H and 
15
N chemical shifts estimated as 0.005 and 0.03 ppm, respectively, by 
comparing chemical shift values of two independent experiments under the same conditions,  
3.2.4 Temperature dependence of 
1
H-
15
N crosspeaks of holo SOD1s 
 NMR samples of pWT and mutant dimeric holo SOD1 (final concentration ~30 mg/mL) in D2O 
were equilibrated at each temperature for a minimum of 20 minutes. Each spectrum took approximately 
20 minutes with 8 scans. All peaks in the spectra were picked manually and the chemical shifts at each 
temperature were recorded. For each spectrum the N
1
H chemical shifts were referenced to water, the 
resonance of which was independently determined at each temperature. The chemical shift of water has a 
strong temperature dependence of approximately -10.3 ppb/K (198). For spectra acquired on the 600 MHz 
spectrometer, the resonance of water shifted linearly downfield with temperature by ~0.31 ppb/K. A 
water correction of -10.7 ppb/K was applied to the determined slopes (see below) to account for this 
downfield shift and the true temperature dependence of water. For spectra obtained on the 500 MHz 
spectrometer the resonance of water varied non-linearly with temperature. The chemical shift values were 
therefore referenced after acquisition so that the resonance of water was set to the same value of 4.69 ppm 
at each temperature. A water correction of -10.39 ppb/K was then applied. For each residue, the N
1
H and 
15
N chemical shifts were plotted as a function of temperature and fit to a straight line. The slope of this 
line represents the temperature coefficient, commonly given in ppb/K. Deviations from linearity 
(residuals) were calculated by subtracting the observed chemical shift from the straight line. Residuals 
were plotted against temperature and fit to a quadratic equation: 
           Eq. 3.1 
The quadratic coefficient, a, provides a measure of the magnitude of curvature. The residuals for each 
residue were also examined visually for curvature. Simulations of experimental curvature were calculated 
 71 
 
using Equation 3.5 as described in section 3.3.6.1, with individual parameters varied systematically (see 
figure legend for a full description). 
3.3 Results 
3.3.1 Backbone amide resonance assignments 
 Resonance assignments were previously obtained for pWT at pH 7.8, 25°C with 135 of the 148 
non-proline backbone amides assigned (6). Due to peak overlap, only 117 were sufficiently well resolved 
to be followed with confidence with increasing temperature. A similar number of amides were 
definitively assigned and followed in G93A (128 amides) and E100G (108 amides). The spectrum of 
V148I at pH 7.8, 25°C has not previously been assigned. A NOESY-HSQC experiment was used to make 
assignments. Again 117 residues were adequately resolved to be assigned and followed with increasing 
temperature.  
 The 
1
H,
15
N-HSQC spectra of mutants G93A, E100G and V148I are very similar to that of pWT. 
The effect of mutation on the chemical shift of each backbone amide at 24°C is illustrated in Figure 3.3 
using the weighted average difference (ΔavgHN) in chemical shift between pWT and mutant.  
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Figure 3.3 - Changes in chemical shift between pWT and mutants at pH 7.8, 24°C. (A) G93A (B) E100G and (C) 
V148I. Chemical shift changes, ΔavgHN, are calculated as [{(ΔN
1
H)
2
 + (Δ15N/5)2)}/2]1/2 and shown as vertical black 
bars. Shown off scale for G93A is residue 93 at 1.0 ppm, and for E100G residue 100 at 1.6 ppm.  
 
Backbone amides with significant changes in electronic environment or conformation compared 
to pWT are for the most part in close to proximity to the mutation site. Residues with significant chemical 
shift changes are mapped onto the 3D ribbon structure (Figure 3.4). Predominantly, residues displaying 
the largest differences cluster near the site of the mutation with residues showing smaller changes 
propagating throughout the structure. There are 20 residues in G93A with significantly altered shifts 
(ΔavgHN > 0.3) compared to pWT, 8 of which with ΔavgHN > 1.  This mutation is at a highly conserved 
site in loop V. E100G has the least variation with only 9 amides showing changes greater than 0.3 ppm, 
and the mutated residue being the only site with ΔavgHN > 1. This is noteworthy as E100G is the most 
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destabilized of the three mutants studied. The site of the mutation is highly exposed on the monomer 
surface, far from the dimer interface.  V148I is the most affected, with 32 amides significantly altered, 5 
of which display ΔavgHN > 1. Residue 148 is located in the dimer interface, a region shown to have high 
connectivity with distal regions of the protein (104), and so it is perhaps not surprising that a mutation in 
this region results in increased propagating effects throughout the protein. 
 In all three mutants, two residues have consistently altered shifts: Cys 146 (ΔavgHN ≥ 0.9) and 
Gly10 (ΔavgHN ≥ 0.7). Cys146 is located in β8 close to the dimer interface and participates in an 
intermolecular disulfide bond that contributes to the stability of SOD1. It has been proposed that 
mutations predispose SOD1 to more easily undergo disulphide reduction (199). Gly10 is located in loop I. 
The amide proton of Lys9 participates in a hydrogen bond with the oxygen of Cys146. The chemical shift 
of Gly10 could be affected by an altered interaction between these two residues. While the observed 
structural changes around Cys146 in all three mutant cannot confirm that mutants are more prone to 
disulphide reduction it is an interesting result.   
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Figure 3.4 - Ribbon diagram of pWT SOD1 indicating significant chemical shift changes (ΔavgHN > 0.3) caused by 
mutations at 24°C (A) G93A (B) E100G and (C) V148I. The main chain of the mutation site is coloured cyan. Pink 
is used to highlight residues with ΔavgHN between 0.3 - 0.7. Deep pink is used to highlight residues with ΔavgHN 
between 0.7 – 1. Red is used to highlight residues with ΔavgHN > 1. Dark grey is used to highlight residues with no 
significant change (ΔavgHN < 0.3). Light grey is used to highlight residues where no data is available. Bound copper 
(turquoise) and zinc (black) are represented as spheres. The ribbon diagram was generated using MOLMOL (61) 
and PDB file 1SOS (62).  
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3.3.2 DSC simulations  
 DSC allows for direct measurement of the heat associated with intra- and inter-molecular 
interactions in solution as a function of temperature providing information on the energetics (ΔG, ΔH, ΔS, 
etc.) of protein folding. The energetics of oligomeric protein folding are further complicated by the added 
step of protein association (81). For oligomeric proteins displaying 2-state behaviour, as is the case of 
SOD1 (see section 1.6.5.), the temperature where half of the protein is unfolded (Tm) is protein 
concentration dependent. Previous DSC analyses in the Meiering lab on holo pWT and mutants have been 
carried out at concentrations ranging from 0.1 – 5 mg/mL. In order to model the global stability of pWT, 
G93A, E100G and V148I under the conditions used in this study (~30 mg/mL), simulations of the 
unfolding energetics for each variant at the desired concentration were carried out (Figure 3.5; See the 
figure legend for thermodynamic parameters used). For pWT, G93A, E100G and V148I the Tm was found 
to be 96.3°C, 92.5°C, 91.1°C and 97.0°C, respectively (6, 82) (unpublished). Interestingly, the disease 
causing mutant V148I is more stable than pWT, again suggesting that global stability may not be the 
main determinant of protein aggregation, which has also been proposed for pathogenic lysozyme 
mutations (34). The simulations show that the fraction of globally unfolded protein at the highest 
temperature studied for the most destabilized mutant (E100G) is ~3%.  One can therefore conclude that 
observed chemical shift changes in the NMR experiments are essentially exclusively caused by local and 
not global unfolding.  
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Figure 3.5 - Thermal denaturation of holo SOD simulated for 30 mg/mL protein. (A) Cp,total vs. temperature. Thermal 
denaturation of holo pWT (82), G93A (82) and E100G (6) has been shown to fittable by a 2-state transition between 
folded dimer and 2 unfolded metal bound monomers, N2  2U (between 0.1 and ~4 mg/mL). 2-state behaviour has 
not been confirmed for V148I due to lack of data but was assumed. Simulations were performed using equations 1-
12 (81). In these simulations the reference temperature (Tref) was defined as the temperature where the protein is half 
unfolded (Tm). The Tm and ΔHTm were interpolated for 0.5 mg/mL using data ranging from 0.1 to at least 2 mg/mL. 
For pWT Tm = 92.1°C, ΔHref = 256.3 kcal (mol dimer)
-1. 
For E100G Tm = 86.4°C, ΔHref = 219.4 kcal (mol dimer)
-1
. 
For G93A Tm = 87.6°C, ΔHref = 211.7 kcal (mol dimer)
-1
. For V148I Tm = 92.5°C,  ΔHref = 236.6 kcal (mol dimer)
-1
. 
The ΔCp = 2.75 kcal (mol dimer)
-1
 °C
-1
 previously determined for holo pWT (82). (B) The fraction of unfolded 
protein vs. temperature. The thick black arrow and dashed line represents the highest temperature NMR spectrum 
recorded for pWT, G93A and E100G. The thin arrow and dash-dotted line represents the highest temperature 
acquired for V148I. The fraction of globally unfolded protein at the highest temperature studied is 0.2%, 2%, 3% 
and 1% for pWT, G93A, E100G and V148I, respectively. DSC simulations were completed by Dr. Jessica 
Rumfeldt.  
 
3.3.3 N
1
H temperature coefficients 
3.3.3.1 pWT 
Of the 117 backbone amides analyzed for pWT, at higher temperatures (≥36.5°C) the signals for 
19 amides are no longer observable. This may occur due to increased chemical and/or conformational 
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exchange. Chemical exchange occurs when the amide proton exchanges with the protons of solvent water. 
Under conditions of fast chemical exchange (when the intrinsic exchange rate is much greater than the 
difference in frequency between the amide proton and solvent) (158), the observed resonance for the 
proton is a weighted average of the two exchanging states. Since water is in great excess (~55 M 
compared to ~1.9 mM protein), the averaged resonance becomes essentially that of bulk water and 
consequently the signal in the amide region is no longer observed. The amide protons of residues shielded 
from solvent will not show this behaviour (200). Thus, the loss of a proton signal at increased temperature 
due to chemical exchange can mean one of two things: (1) the intrinsic exchange rate of the amide proton 
with water has surpassed the threshold making it fast on the NMR timescale and thus the signal a 
weighted average dominated by bulk water or (2) a conformational change in the protein structure has 
increased the solvent accessibility of the amide proton allowing it to enter into fast exchange with water 
(200). If the amide proton is fully solvent accessible to begin with (at low temperature) then condition 1 is 
likely the reason for the disappearance of the cross peak at increased temperature. If it is not originally 
solvent accessible then both scenarios described above must be true in order for chemical exchange to be 
the cause of signal loss. The temperature at which a given amide proton may become in fast exchange 
with solvent can be estimated using predicted exchange rates for random coil peptides with the server 
program sphere (201, 202). 
Conformational exchange occurs when the amide proton is populating two different 
conformational states (158). For the peak to disappear due to conformational exchange the amide proton 
would be in intermediate exchange on the NMR timescale. Intermediate exchange occurs when the 
exchange rate is similar to the difference between the resonance frequencies of the two exchanging 
conformations. This will cause significant line broadening and loss of the signal if the two conformations 
have sufficiently different chemical shifts (158). For experiments on holo SOD1, it is difficult to say 
whether signal loss is definitively due to chemical or conformational exchange. However, since the 
protein remains significantly structured at all temperatures studied (see above), and as such the chemical 
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shift difference between alternative conformations is likely small, it seems more plausible that chemical 
exchange is the cause of signal loss. From this point forward it will be said that the crosspeaks for these 
amide protons have disappeared, however the different factors contributing to the lack of observation will 
be considered. 
An overlay of the acquired 
1
H,
15
N-HSQC spectra as a function of temperature (Figure 3.6) 
illustrates the temperature dependences of the observed amide crosspeaks. The crosspeaks appear to move 
downfield (left) with temperature however this is a consequence of the N
1
H shifts being referenced to 
water (~4.7 ppm) at each temperature (see section 3.2.4). The chemical shift of water has a strong 
temperature dependence (198) which is not accounted for in the acquired spectra. When the appropriate 
water correction is applied the crosspeaks move upfield (right), as expected.  
 
Figure 3.6 - Overlaid 
1
H,
15
N-HSCQ spectra of holo pWT SOD1 (20mM Hepes, pH 7.8) acquired at different 
temperatures. Temperatures and associated peak colours are given on the left. The raw experimental data shows the 
amides shifting downfield (left) with temperature. This is a consequence of referencing the chemical shifts to water 
(~4.7 ppm) at each temperature, which has a strong temperature dependence. After acquisition, a water correction 
was applied resulting in a negative (upfield) shift with temperature (see section 3.2.4), as expected. Different amides 
show different temperature dependences, as can be observed for the well resolved crosspeaks.  
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Amide proton temperature coefficients were determined for 98 of the 148 non-proline residues 
(Table A1.1). The values range from -1.16 ppb/K to -11.04 ppb/K, all of which are within the limit of 
values that have been observed for other proteins (160). There does not appear to be a correlation between 
N
1
H temperature coefficients and amino acid type or secondary structure. There is a correlation with 
hydrogen bonding based on crystal structure data (PDB 1SOS). Approximately 62% of all residues with 
amide protons predicted to participate in a hydrogen bond based on the crystal structure have temperature 
coefficients more positive than -5 ppb/K and those that  do not cluster in regions of the protein thought to 
have reduced local stability (Table A1.1; section 3.1.5 and below). Comparison of temperature 
coefficients with amide exchange rates previously determined in the Meiering lab under the same buffer 
conditions at 25°C (6) does not reveal a correlation (Figure 3.7; see table A1.2 for amide exchange rates).  
 
Figure 3.7 - Correlation between measurable amide exchange rates (min
-1
) and N
1
H temperature coefficients for 
pWT. The line of best fit obtained by linear regression is given by a black solid line. The associate equation and R
2
 
value is given in the plot area. 
 
On further inspection there does appear to be a qualitative correlation with exchange behaviour, 
with the exception of the “too fast to measure category” which only has 6 residues (Table 1, Table A1.2.). 
Comparative analysis reveals that ~70% of residues with N
1
H temperature coefficients more negative 
than -6 pbb/K, and 78% of residues that disappear at increased temperatures, exchange in the dead time 
(Table A1.1, Table A1.2). Amide protons that exchange in the dead time in most cases are solvent 
exposed and not protected by a hydrogen bond. Since most of the residues that disappear at increased 
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temperatures also exchange in the dead time, the disappearance of the cross peak is most likely to occur 
due to fast exchange with water. For pWT, there are four residues that disappear but do not exchange in 
the dead time: Ile18, His46, Cys146 and Gln153. The N
1
H of each of these residues is expected to be 
hydrogen bonded. Since Ile18 and Gln153 are both surface exposed, it could be that loss of protective 
hydrogen bonds at increased temperature allows for the N
1
Hs to enter into fast exchange with solvent 
resulting in signal loss. His46 and Cys146 on the other hand are both buried within the core of pWT and 
thus chemical exchange seems less plausible. Both of these residues partake in important stabilizing 
interactions within pWT as His46 is a copper binding ligand and Cys146 forms an intramolecular 
disulphide bond. For these two residues conformational exchange could be the cause of signal loss if 
altered metal interactions or disulphide bond isomerization is occurring. Conformational exchange in 
residues surrounding the disulphide bond has been observed in NMR relaxation experiments on the 
monomer construct (182).  
Exchange Behaviour Average N
1
H temperature 
coefficient 
Number of Residues 
Too slow to measure -4.40 ± 1.06 ppb/K 31 
Measurable -4.82 ± 1.38 ppb/K 36 
Too fast to measure -3.69 ± 1.66 ppb/K 6 
Exchanged in the dead time -5.81 ± 2.08 ppb/K 29 
 
Table 3.2 - Average N
1
H temperature coefficients for residues in pWT with different amide exchange behaviour. 
See table A1.2 for residue specific amide exchange rates and exchange behaviour classifications. 
 
The N
1
H temperature coefficient of each residue was mapped onto the 3D ribbon structure of 
pWT (Figure 3.8). Overall, 54% of the residues followed have coefficients more positive than -5 ppb/K 
indicating that holo pWT is still fairly structured even at 84°C. This is consistent with holo SOD 
remaining highly folded, as indicated by DSC experiments and simulations. Residues with N
1
H 
temperature coefficients more negative than -5 ppb/K in pWT cluster at the ends of β-strands, in loops 
and specifically in edge strands β1, β5 (bottom half in Figure 3.8) and β6. The unfolding pathway of holo 
pWT has previously been described as 2-state with a cooperative transition from folded dimer to unfolded 
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monomers (81). The NMR experiments completed here provide a higher resolution picture of the 
initiation of the thermal unfolding transition, which appears to begin with partial loss of structure at 
various sites throughout the protein (discussed below).  
 
Figure 3.8 - N
1
H temperature coefficients of pWT at pH 7.8. Hydrogen bonds are represented by thin red lines. The 
bond between the backbone carbonyl C and O is represented by thin grey lines. Description of the colour scheme is 
given in the legend on the right. Grey indicates residues for which no data are available. The ribbon diagram was 
generated using MOLMOL (61) and PDB file 1SOS (62).  
 
It has been observed previously that ~82% of amide protons that do not participate in a hydrogen 
bond have a temperature coefficient between -5 and -11 ppb/K (160). Based on this cut-off and crystal 
structure data, pWT appears to lose 29 hydrogen bonds before global unfolding (Figure 3.9). The “loss” 
of a hydrogen bond suggests that it is either not present in solution to begin with (thus only present in the 
crystal structure) or that it is lost early in the unfolding pathway of pWT. The free energy of breaking one 
hydrogen bond has been estimated at ~1 kcal/mol (203). It should be noted that there is some inherent 
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error in using this cut-off, however, the clustering of residues with lost hydrogen bonds as well as the 
comparison with other residue-specific data (amide exchange and relaxation experiments; see below) is 
convincing. The structural implications are discussed next.   
 
Figure 3.9 - Cartoon representation of hydrogen bonding in pWT SOD1. Each circle represents a residue in the 
protein. Circles that lie on arrows represent residues in β-strands. Circles with ‘P’ in the center represent proline 
residues. Hydrogen bonds (based on crystal structure data PDB 1SOS) are given by solid black lines connected to 
the NH and pointing towards the oxygen acceptor. Hydrogen bonds coloured red are expected to be lost in the pWT 
unfolding pathway prior to global unfolding based on N
1
H temperature coefficients using a cut-off of -5 ppb/K. 
Dark grey circles represent residues that disappear at higher temperatures. Light grey circles represent residues that 
were not followed. In both cases no information on the hydrogen bonding status could be obtained. 
 
Loop II in pWT only has one stabilizing hydrogen bond (Gly27).  The loss of this hydrogen bond, 
as well as three others (Gln22 and Val29) at the ends of the β-strands before and after this loop, suggests 
increased mobility in this region. β5 runs from the hydrophobic interior of pWT out to the exterior 
wrapping around the β-sheet edge to help protect the core of the protein. β6 is a charged strand that is 
believed to help prevent edge-to-edge aggregation and again protect the hydrophobic core. The N
1
H 
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temperature coefficients reveal significant loss of hydrogen bonding for the solvent-exposed protective 
portion of β5 and most of β6 suggesting early steps of the unfolding pathway may involve local unfolding 
at these edge strands and deprotection of the hydrophobic interior. In addition, the results suggest there is 
loss of hydrogen bonding at 5 (Gly51, Ile113, Gly114, Gly150 and Ile151) of the 15 residues that make 
up the dimer interface, as well as Ile112 which sits very close to the interface. The residues identified 
above form the top section of the dimer interface (as in Figure 3.8) indicating that there may be structural 
perturbations occurring early in the unfolding pathway in this region.  
The long loops (loops IV and VII) also show a significant loss of structure. In loop IV, this loss is 
found mainly in the second half of the loop which forms the zinc binding site; approximately half of the 
stabilizing hydrogen bonds are lost. It should be noted that of the remaining 5 hydrogen bonds in this 
region, three (His71, Gly72 and His76) have N
1
H temperature coefficients that are within 0.5 ppb/K of 
the cut-off. Loop VII is characterized by two segments, the N- and C-terminal, which lead into and out of 
a short α-helix, respectively. The C-terminal segment is tethered to the N-terminal segment through three 
main hydrogen bonds: Glu121-Ser142, Lys122-Ala140 and Asp125-Gly138. The N
1
H temperature 
coefficients indicate that these hydrogen bonds are lost. In addition, there appears to be loss of hydrogen 
bonding with three residues disappearing near the helix suggesting loss or perturbation of this structure. 
In the native state, this helix creates a negatively charged dipole that is involved in binding the positively 
charged Zn
2+
 (120). The loss of structure in loops VI and VII point to significantly reduced shielding of 
the zinc-binding site in pWT at high temperatures. Overall, it appears that the monomer β-barrel core of 
pWT remains stable up to 84°C with local unfolding occurring at the periphery, specifically in edge 
strands, loops and the dimer interface.  
The application of an algorithm that assesses the propensity for disorder within proteins, PONDR 
(204), reveals that β5, β6, loop VII and more significantly loop IV are expected to be natively disordered 
(205). This is noteworthy as these regions are essentially the same as those shown to have reduced local 
stability from the analysis of N
1
H temperature coefficients.  Further, amide exchange studies from our 
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and another lab also indicate decreased local stability at the edge strands (6, 189). Our studies reveal that 
many of the amides in β strands have exchange rates that are too slow to measure. However, in the 
protective half of β5 and in β6 the exchange rates are measureable (faster) suggesting reduced local 
stability. The transition state of the apo monomer variant has been analyzed using ɸ-value analysis. In this 
construct, β5 and β6 are also unstructured indicating that these regions are generally last to fold and so 
likely the first to unfold (52). This analysis also revealed that the long loops IV and VII are disordered in 
the apo transition state. It is known that upon metal binding these loops gain a significant amount of 
structure (120). Described earlier in Chapter 2 (section 2.1.2), experiments monitoring the unfolding 
kinetics of holo SOD1 indicate that the zinc binding site becomes unstructured early in the unfolding 
pathway (52) with zinc loss often preceding copper loss (125, 126). In another study which analyzed how 
the folding kinetics of SOD1 are affected by zinc binding, the authors alternatively proposed that the zinc 
binding site is formed in the transition state for both the apo and metal bound state of the monomer 
construct (205). This was based on zinc significantly increasing the rate of folding however the extent of 
structure formation is unclear. The N
1
H temperature coefficients found here reveal that loop IV and VII 
become disordered early in the unfolding pathway, which points towards the zinc binding site likely being 
unstructured in the transition state of holo pWT, consistent with the previous kinetic studies of holo 
SOD1 (125, 126).   
It should be noted that, since temperature coefficients are almost always negative and the sign of 
the coefficient is representative of directionality (upfield vs. downfield) not the magnitude of the shift, 
when comparing mutants to pWT a “larger or increased” temperature coefficient is one in which the 
absolute value is larger. Therefore, a coefficient of -7 ppb/K is larger than one of -3 ppb/K as it indicates a 
larger upfield shift with temperature.  
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3.3.3.2   G93A  
G93 is located in the solvent-exposed β-barrel plug and more specifically is a conserved residue 
in a tight turn that has been found to be a hotspot for fALS mutations (82). Mutation decreases the Tm by 
3.8°C. Of the 128 residues followed in G93A, 28 disappear at increased temperatures. Amide proton 
temperature coefficients were calculated for 100 of the 148 non-proline residues, 85 of which could be 
directly compared to pWT. Overall, comparison of N
1
H temperature coefficients indicates that the local 
stability of G93A is very similar to that of pWT. There are, however, marked differences close to the site 
of the mutation. Most of these residues show increased N
1
H temperature coefficients and are found in the 
β-barrel plug indicating decreased stability in this region upon mutation. In parallel to what has been seen 
both computationally and experimentally, G93A also exhibits sites with decreased temperature 
dependences indicating more stable regions compared to pWT. The site specific results are described in 
detail next.  
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Figure 3.10 - Changes in N
1
H temperature coefficients for G93A. (A) Differences in the temperature coefficients 
between pWT and the ALS mutant G93A mapped onto the 3D ribbon structure of holo SOD1 (PDB 1SOS). The 
main chain of the mutation site is shown in thick lines and coloured blue. Hydrogen bonds are represented by thin 
red lines. The bond between the backbone carbonyl C and O is represented by thin grey lines. Red commonly 
indicates disruption of hydrogen bonding/structure in the mutant relative to pWT, while blue commonly indicates 
stronger hydrogen bonding/structure formation; there are exceptions depending on the absolute value of the 
temperature coefficient (see Figure 3.1 and main text). Grey indicates residues for which no data are available. Dark 
grey indicated residues that disappear in both pWT and G93A. Black indicates residues that disappear in G93A but 
not in pWT. (B) Values of the N
1
H temperature coefficient differences between pWT and G93A. A positive value 
indicates an increased temperature coefficient for G93A. Horizontal bars indicate β-strands. 
 
In G93A, residues Ile35, Leu38, Asp90, Asp92, Val94 and Gly150 have larger N
1
H temperature 
coefficients by at least 0.3 ppb/K compared to pWT (coloured orange/red in Figure 3.10). Most of these 
residues also show significant chemical shift changes from pWT at 25°C (Figure 3.4 A). Leu38 is located 
in loop III, which makes up half of the β-barrel plug. In pWT the amide proton of Leu38 hydrogen bonds 
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to the oxygen of Gly93 (Figure 3.9) and is the only residue in the loop to participate in a hydrogen bond. 
It is not surprising that mutation at Gly93 may alter the local conformation and disrupt this hydrogen 
bond. This was confirmed through comparison of the N
1
H temperature coefficient of Leu38, which is 
significantly increased (by 2.48 ppb/K) in G93A. Unfortunately, there are no other probes in this loop to 
better understand the change in stability but it seems safe to say that loss of the hydrogen bond will likely 
increase mobility. There are two hydrogen bonds between Asp90 and Val94, which help to stabilize the 
tight turn (loop V) between β5 and β6 which makes up the other half of the β-barrel plug. The N1H 
temperature coefficients for these residues indicate that these hydrogen bonds are either not formed in 
G93A or are lost early in the unfolding pathway (only one is lost in pWT), signifying a reduction of local 
structure in loop V in the mutant. In addition, the significantly increased temperature coefficient of Asp92 
(by 4.30 ppb/K) for G93A and the disappearance of the cross peak for Lys91, which is observed at all 
temperature in pWT, further supports increased dynamics in loop V. Alteration in the structure and 
dynamics of loop III and V have previously been reported in other NMR studies (see section 3.1.5) (95). 
The increased N
1
H temperature coefficient at Ile35 actually represents a strengthening of the hydrogen 
bond with Ala95. This is because in both pWT and G93A the coefficients fall in the region where the 
amide proton is likely to be hydrogen bonded and within this range an increased coefficient actually 
represents a stronger hydrogen bond (see section 3.1.3 and Figure 3.1).  This increased stability at this 
residue could be compensatory for the increased dynamics observed in the β-barrel plug (see discussion). 
There does not appear to be significant changes in the loops or dimer interface upon mutation, with the 
exception of an increased temperature coefficient towards the C-terminus, at Gly150, suggestive of an 
increase in mobility.  
 As for pWT, amide exchange rates have been measured previously for G93A in the Meiering lab 
(6). Residues with larger N
1
H temperature coefficients upon mutation correlate well with those displaying 
increased exchange rates, confirming increased dynamics in the β-barrel plug. Residues that have smaller 
N
1
H temperature coefficients by greater than 0.3 ppb/K in G93A include Val14, Phe20, Gly33, Glu77, 
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Ala93, Ala95 and Ile113 (coloured light/dark blue in Figure 3.10). Two of these residues, Gly33 and 
Ile113, also exhibit decreased exchange rates (Table A1.2.). Three of these residues, Val14, Phe20 and 
Glu77, did not have measureable exchange rates in either case so a comparison is not possible. Val14 is 
located in loop I and interacts with Leu38 (188). It could be that altered dynamics at Leu38 allow for 
stronger stabilizing interactions with Val14 decreasing its observed N
1
H temperature coefficient. Glu77 is 
located in loop IV and is in a region that has been proposed to have decreased mobility in mutants (95, 
104). Lastly, Ala93 and Ala95 have significantly decreased N
1
H temperature coefficients, although amide 
exchange studies reveal increased exchange rates at these residues. Ala93 is the mutated residue and here 
the reduced temperature coefficient actually represents a weakening of the hydrogen bond (see Figure 3.1; 
Table A1.1) between the N
1
H of Ala93 and the oxygen on Asp90, consistent with the amide exchange 
results. Ala95 is located in β6 and although the coefficient is smaller in G93A, in both mutant and pWT 
the temperature coefficient is ≤ -6.5 ppb/K suggesting no formation of the hydrogen bond with oxygen of 
Ile35. It could be that the increased dynamics in the β-barrel and at Val94 result in some compensatory 
stabilization at Ala95. This proposal is supported by the strengthening of the hydrogen bond between 
Ile35 and Ala95 (see above).   
There are 11 cross peaks that disappear at increased temperature in G93A but remain visible at all 
temperatures in pWT. These residues are spread throughout the structure but are mainly found in loops. A 
greater proportion of residues in loops IV and VII disappear in the mutant compared to pWT, which 
already has a large number of amides that disappear. Interestingly, the N
1
H temperature coefficients for 
the surrounding residues do not indicate enhanced loss of structure in these loops for the mutant. 
However, the increased proportion of residues that disappear itself suggest loss of structure allowing for 
increased conformational, or perhaps more likely chemical exchange. A number of the residues that 
disappear surround the zinc binding site (Glu78, His80, Ser134, Thr137) suggesting enhanced flexibility 
in this region. Propagating effects in the metal binding region of G93A have also been observed through 
amide exchange (189).  
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In summary, the observations described above suggest that in addition to reducing global 
stability, the G93A mutation reduces the local stability of the β-barrel plug. There is also evidence to 
suggest the mutant has increased flexibility in loops IV and VII which could lead to enhanced 
deprotection of the zinc binding site.  Increased flexibility in loop VII has been proposed to lead to non-
native substrate access to the active site and aberrant chemistry which can be damaging to the protein. 
Further, both of these loops have been shown to form non-native interactions in the crystal structures of 
apo mutant SOD1 and thus increased flexibility could lead to unwanted protein association (89).  
3.3.3.3 E100G 
Glu100 is located in β6 and mutation from Glu to Gly decreases the net negative charge of the 
protein and disrupts a salt bridge between Glu100 and Lys30. E100G is the most globally destabilized 
mutant studied herein with ΔTm = -5.2°C. This destabilization may seem surprising since the mutation is 
located in an edge strand where the main chain of the residue points out toward solvent. However, an 
interesting computational study identifying the key residues involved in the folding of SOD1 found most 
of these residues lie on the surface of the protein and not in the hydrophobic core (206). Further, each 
residue is involved in a contact with an oppositely charged amino acid. Disruption of the key electrostatic 
interaction between Glu100 and Lys30 may be a main cause of the observed decrease in stability.
 
N
1
H 
temperature coefficients were determined for 91 of the 108 amide protons followed in E100G as 17 
disappeared at increased temperatures. This allowed for the direct comparison of 81 residues with pWT. 
The temperature coefficients for E100G indicate a similar pattern of local unfolding to pWT, however, 
there are distinct differences clustering near the mutation site and distal in the β-barrel plug. Similar to 
G93A, residues in E100G exhibit both increased and decreased N
1
H temperature coefficients compared to 
pWT, described further below.  
 
 90 
 
 
Figure 3.11 - Changes in N
1
H temperature coefficients for E100G. (A) Differences in the temperature coefficients 
between pWT and the ALS mutant E100G mapped onto the 3D ribbon structure of holo SOD1 (PDB 1SOS). The 
main chain of the mutation site is shown in thick lines and coloured blue. Hydrogen bonds are represented by thin 
red lines. The bond between the backbone carbonyl C and O is represented by thin grey lines. Red commonly 
indicates disruption of hydrogen bonding/structure in the mutant relative to pWT, while blue commonly indicates 
stronger hydrogen bonding/structure formation; there are exceptions depending on the absolute value of the 
temperature coefficient (see Figure 3.1 and main text). Grey indicates residues for which no data are available. Dark 
grey indicated residues that disappear in both pWT E100G. Black indicates residues that only disappear in E100G. 
(B) Absolute values of the N
1
H temperature coefficient differences between pWT and E100G. A positive value 
indicates an increased temperature coefficient for E100G. Horizontal bars indicate β-strands.  
 
 In E100G, residues Val31, Leu38, Val94, Val103, Ile104 and Gly150 have significantly more 
negative (by 0.3 ppb/K) N
1
H temperature coefficients compared to pWT (coloured orange/red in Figure 
3.11). The edge strand β6 shows local unfolding in pWT (section 3.3.3.1). Upon mutation the extent of 
unfolding does not appear to change, however, two residues (Val103 and Ile104) in loop VI, which 
directly follows β6 and the site of the mutation, exhibit significantly different stability. In pWT the amide 
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protons of Val103 and Ile104 hydrogen bond to the sidechain oxygen of Asp101 (Figure 3.9). The N
1
H 
temperature coefficients indicate that in the mutant there is a strengthening of the hydrogen bond between 
Val103 and Asp101 and a loss of the hydrogen bond between Ile104 and Asp101. Increased dynamics at 
Ile104 is supported by previous amide exchange measurements which show that the exchange rate of this 
amide is ~19 times greater in E100G compared to pWT (Table A1.2 (6)). The results here show that there 
is altered mobility in the N-terminal portion of loop VI in E100G, which has been proposed as an 
amyloidogenic fragment in SOD1 (190). In the crystal structure of pWT, the N
1
H of Val29 hydrogen 
bonds to carbonyl oxygen of Asp101 and vice versa. These hydrogen bonds are lost early in the unfolding 
pathway of pWT suggesting increased disorder at the end of β3. This loss of structure extends further 
down into the β3 strand in E100G. The disruption of the salt bridge between Lys30 and position 100 upon 
mutation removes a stabilizing interaction in this region. This likely influences the hydrogen bond 
between Val31 and Ile99, which according to the N
1
H temperature coefficient of Val31 is lost in E100G 
but not pWT. Interestingly Gly150, as seen in G93A, has a larger temperature coefficient which could 
suggest increased mobility in the dimer interface upon mutation.  
 An interesting finding was that the structural effects caused by mutation appear to propagate into 
the β-barrel plug. Specifically, the temperature coefficients of Leu38 and Val94 (coloured red in Figure 
3.11) increase by 1.07 ppb/K and 3.44 ppb/K, respectively, in the mutant. This suggests a loss of the 
hydrogen bond between Leu38 and Gly93 which links loops III and V, as well as loss of the hydrogen 
bond between Val94 and Asp90 which helps to stabilize the tight turn in loop V (based on the -5 ppb/K 
cut off, Figure 3.1). Interestingly, Gly37 and Gly93 (also located in the β-barrel plug) have decreased N1H 
temperature coefficients. This could be due to a compensatory effect due to the increased mobility 
observed at Leu38, which has been seen in other NMR studies (108). The amide proton of Gly93 
participates in a hydrogen bond with Asp90 in the pWT crystal structure (PDB 1SOS). The decreased 
temperature coefficient in this case, however, represents a weakening of the hydrogen bond (since in both 
G93A and pWT the value lies below the -4.6 ppb/K cut off; see above). The results indicate that while the 
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extent of destabilization appears to be smaller in E100G, in both G93A and E100G mutation alters the 
dynamics in the β-barrel plug. Altered dynamics in this region for a number of mutants has been shown 
both computationally and experimentally (section 3.1.5).  
A number of residues (Ala6, Gly27, Gly33, Gly37, Glu78, Gly93, Leu106, Ile113, Gly129 and 
Gly147 (coloured light/dark blue in Figure 3.11) have significantly reduced N
1
H temperature coefficients 
(by 0.3 ppb/K) in E100G. The reduction in the temperature coefficient however does not alter the 
predicted hydrogen bonding status, with the exception of Gly33 and Ile113. Based on N
1
H temperature 
coefficients, the hydrogen bond between Gly33 and Val97 is lost in pWT but maintained in both G93A 
(see section 3.3.3.2) and E100G. Previous amide exchange studies reveal this residue also exhibits a 
slower exchange rate in both mutants. Ile113 is located in the C-terminal end of loop VI. Amide exchange 
results are in agreement with a stronger hydrogen bond as the exchange rate of Ile113 is ~2 times slower 
in the mutant. On the other hand, the reduced N
1
H temperature coefficients for 4 of the 10 residues listed 
above (Ala6, Gly93, Leu106 and Gly147) actually signify a weakened hydrogen bond. Gly93 is in the β-
barrel and Leu106 in the N-terminal portion of loop VI, both regions discussed above as having decreased 
local stability in E100G. Ala6 and Gly147 are both close to the dimer interface indicating that the 
mutation can have propagating effects on the hydrogen bonding network within the subunit. The 
remaining four residues (Gly27, Gly37, Glu78, Gly129) indicate some degree of maintenance in the 
mutant and are spread throughout the polypeptide chain highlighting that there are also propagating 
stabilizing effects upon mutation. One of these, Glu78, is in a region expected to have increased stability 
in mutants and neighbours Glu77 which was shown to have increased stability in G93A.  
There are 8 peaks that disappear in E100G but remain visible at all temperatures in pWT (Gly10, 
Gly24, Asn53, Lys91, Gly100, Ser134, Thr137 and Ala140; Table A1.1). Of these 8 residues, 6 (Gly10, 
Gly24, Lys91, Gly100, Ser134, Thr137 and Ala140) also disappear in G93A. Again the residues are 
spread throughout the polypeptide chain but mainly found in loops, with the exception of Lys91 and 
Glu100 which are found in edge strands β5 and β6, respectively. It is noteworthy that 3 of the 8 residues 
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that disappear in E100G are in loop VII in or near the helix that serves as a cap of the zinc binding site. 
The increased loss of structure in this region in both mutants suggests that increased flexibility in the loop 
VII could be a general consequence of mutation.  
With the exception of the three residues described earlier there does not appear to be a correlation 
between amide exchange rates and N
1
H temperature coefficients in E100G. Comparison of the amide 
exchange rates of pWT and E100G reveals very few differences between the two variants. E100G, despite 
being the most destabilized, is structurally very similar to pWT, evidenced by the small differences in 
chemical shift changes at 25°C (Figure 3.4 B) and similar exchange behaviour. The lack of correlation 
could simply be a consequence of the absence of observed differences from pWT in the amide exchange 
studies suggesting that the determination of N
1
H temperature coefficients may be better able to 
differentiate subtle structural differences. 
3.3.3.4 V148I 
 Val148 is located in β8 and its hydrophobic side chain forms part of the dimer interface. Mutating 
Val148 to Ile introduces a bulkier hydrophobic side chain at the interface. DSC simulations reveal that 
V148I is actually more stable than pWT as the Tm is increased by 0.7°C (Figure 3.5). At 24°C a relatively 
large proportion of residues exhibit significant chemical shift changes, more than for the two destabilized 
mutants discussed above. The N
1
H temperature coefficients were determined for 101 of the 117 residues 
followed in V148I. At increased temperature the crosspeaks for 16 residues disappeared. It was possible 
to directly compare the N
1
H temperature coefficients for 86 residues with pWT. Analysis of the N
1
H 
temperature coefficients of V148I reveals a similar pattern of local stability as pWT however overall the 
mutant tends to have smaller coefficients (Figure 3.12), consistent with the increased stability observed by 
DSC. 
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Figure 3.12 - Changes in N
1
H temperature coefficients for V148I. (A) Differences in the temperature coefficients 
between pWT and the ALS mutant V148I mapped onto the 3D ribbon structure of holo SOD1 (PDB 1SOS). The 
main chain of the mutation site is shown in thick lines and coloured blue. Hydrogen bonds are represented by thin 
red lines. The bond between the backbone carbonyl C and O is represented by thin grey lines. Red commonly 
indicates disruption of hydrogen bonding/structure in the mutant relative to pWT, while blue commonly indicates 
stronger hydrogen bonding/structure formation; there are exceptions depending on the absolute value of the 
temperature coefficient (see Figure 3.1 and main text). Grey indicates residues for which no data are available. Dark 
grey indicated residues that disappear in both pWT V148I. Black indicates residues that only disappear in V148I. 
(B) Absolute values of the N
1
H temperature coefficient differences between pWT and V148I. A positive value 
indicates an increased temperature coefficient for V148I. Horizontal bars indicate β-strands.  
 
There are four residues (Leu38, Ser59, Gly129, and Val147) that have significantly increased (by 
0.3 ppb/K) N
1
H temperature coefficients in V148I (coloured orange/red in figure 3.12). Two of these, 
Ser59 and Val147, are close to the site of the mutation in the dimer interface and the other two, Leu38 and 
Gly129, are distal. Val147 is located in β8 next to the site of the mutation and participates in a hydrogen 
bond with Leu117 in the pWT crystal structure (Figure 3.9). The increased N
1
H temperature coefficient 
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actually reveals a strengthening of this hydrogen bond. On the other hand, it appears that even in V148I 
the hydrogen bond between Leu38 and Gly93 is broken, suggesting again weakened interactions in the β-
barrel plug.  The increased temperature coefficients of Ser59 (loop IV) and Gly129 (loop VII) suggest 
increased disorder at these specific residues also. In contrast, 45 residues display significantly decreased 
(by 0.3 ppb/K) N
1
H temperature coefficients in V148I. This is a considerably larger proportion than for 
the other two mutants studied here. Comparison of the absolute N
1
H temperature coefficients of pWT and 
V148I reveals that for 56% of these residues, the decreased temperature coefficient actually represents a 
weakening of a hydrogen bond (Figure 3.1). In only three cases, Lys30, Gly33, and Ile149 (Figure 3.12), 
is the decreased temperature coefficient indicative of the preservation of a hydrogen bond lost in pWT. 
Lys30 and Gly33 are both in β3 and participate in hydrogen bonds with β2 and β6, respectively, 
suggesting increased stability in β3. Ile149 is next to the site of the mutation and hydrogen bonds to 
Arg115 (Figure 3.9). The strengthening of the hydrogen bond between Val147 and Leu177, as well as the 
preservation of the hydrogen bond between Ile149 and Arg115, suggest that there is an increase in the 
local stability near the mutation.    
There are 6 residues (Ala6, Gly10, His48, Ser111, Ile113, Ser134;Table A1.1.) that disappear in 
V148I that remain visible at all temperatures in pWT. Only 2 of these residues (Gly10 in β1 and Ser134 
in loop VII) also disappear in the other mutants. Unlike the other variants studied, in V148I two residues 
(Ser111 and Ile113) in the C-terminal end of loop VI disappear. This loop forms a portion of the dimer 
interface. The loss of signal for these residues suggests that this loop has increased disorder in V148I. 
Thus, although it appears there may be a gain of structure surrounding the mutation site it may be at the 
expense of the stability of a neighboring region in the dimer interface. The number of residues that 
disappear in loop VII in V148I is comparable to pWT. 
It should be noted that spectral acquisition was completed on a different spectrometer (see section 
3.2.2 and 3.2.4) for V148I and while much care was taken to ensure the data were acquired through 
identical means (sample temperatures, pulse programs, methods of water suppression, etc.) there is some 
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variability which could in part explain the observed differences. Unfortunately, amide exchange studies 
have not previously been completed on holo V148I precluding comparison between the two methods.  
3.3.5 
15
N temperature coefficients 
3.3.5.1 pWT 
 
15
N temperature coefficients were determined for pWT and the three mutants discussed above. In 
pWT the temperature coefficients range from -21.5 ppb/K to 28.18 ppb/K. The mutants display a similar 
range of values which are comparable to what has been reported previously for the B1 domain of protein 
G (G B1) (165). The factors that contribute to 
15
N temperature coefficients remain unclear (165). There 
does not appear to be a correlation between the sign or magnitude of the temperature coefficient and 
amino acid type or secondary structure. There is a weak correlation between N
1
H and 
15
N temperature 
coefficients (Figure 3.13 A) which was also observed for protein G B1. Crystallographic temperature 
factors, or B-factors, provide information on the relative vibrational motions within a protein (180). 
Residues with large B-factors are commonly found in more flexible regions of a protein. For pWT there is 
no correlation between B-factors and 
15
N temperature coefficients (Figure 3.13 B). 
15
N chemical shifts 
depend on a number of factors including the conformation and side-chain structure. This makes 
15
N 
chemical shifts useful in distinguishing between secondary structural elements in proteins (207). 
15
N 
chemical shifts can also be affected by electrostatic interactions and hydrogen bonding. Due to the latter, 
it is surprising that 
15
N temperature coefficients do not correlate more strongly with hydrogen bonding 
status (208) and consequently N
1
H temperature coefficients.  
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Figure 3.13 - Correlation plots for 
15
N temperature coefficients of pWT, pH 7.8. (A). Correlation of 
15
N and N
1
H 
temperature coefficients. (B) Correlation of 
15
N and B-factors (PDB 1HL5). The line of best fit obtained by linear 
regression is given by a black solid line. The associate equation and R
2
 value is given in the plot area.  
 
The calculated 
15
N temperature coefficients were mapped onto the 3D ribbon structure of pWT 
(Figure 3.14). Since the significance, if any, of the sign of the 
15
N temperature coefficient remains 
unknown only the magnitude was considered. Unlike for N
1
H temperature coefficients, residues at the 
ends of secondary structural elements, in loops and in the dimer interface display both small and large 
15
N 
temperature coefficients. There are small clusters of residues with similar magnitude 
15
N temperature 
coefficients in pWT. This is observed near the β-barrel plug with some residues (Gly37, Leu38, Gly41, 
Lys91, and Val94) displaying large 
15N temperature coefficients (≥ 9 ppb/K) however there are also 
residues with small coefficients (≤ 6 ppb/K) in the region (Asp92, Gly93). Similarly, Asp52 and Asn53, 
as well as Val5 and Ala6, which lie across the dimer interface, all display large 
15
N temperature 
coefficients. In contrast, the top-half of β5, which shows predominantly large N1H temperature 
coefficients, is dominated by residues with small 
15
N temperature coefficients. The residues comprising 
the hydrophobic core of the dimer interface (described in section 3.3.3.1) also show mainly small 
15
N 
temperature dependences. The regions described above have decreased local stability based on N
1
H 
temperature coefficients in pWT. The results indicate that although residues in these regions have similar 
temperature dependences, there is no clear correlation between the magnitude of the 
15
N temperature 
coefficient and the extent of the structural and/or environmental changes it reports on.  
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Figure 3.14 - 
15
N temperature coefficients of pWT at pH 7.8. Hydrogen bonds are represented by red sticks. The 
carbonyl oxygen is represented by grey sticks. Description of the colour scheme is given in the legend on the right. 
Grey indicates residues for which no data is available. The ribbon diagram was generated using MOLMOL and PDB 
file 1SOS.  
 
3.3.5.2 G93A, E100G and V148I 
  The 
15
N temperature coefficients of G93A, E100G and V148I were calculated and compared 
with pWT. Since the uncertainty in 
15
N chemical shifts was determined to be ± 0.03 ppm, a larger cut-off 
was chosen for significant temperature coefficient differences (3 ppb/K). The changes in temperature 
coefficients for each residue were mapped onto the 3D structure for each of the mutants (Figure 3.15). 
Residues exhibiting different 
15
N temperature dependences for the most part cluster close to the site of the 
mutation with V148I showing the highest degree of propagating effects through the structure. A similar 
pattern of behaviour was seen in V148I for chemical shift changes at 25°C (Figure 3.4 C) and N
1
H 
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temperature coefficients (Figure 3.12). It is interesting to note that in most cases the 
15
N temperature 
coefficient is reduced in the mutants. This again points to the idea that the magnitude of 
15
N temperature 
coefficients may not correlate with the extent of structural and/or environmental changes in the protein.  
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Figure 3.15 - Ribbon diagram of pWT SOD1 indicating residues with significantly different 
15
N temperature 
coefficients in (A) G93A (B) E100G and (C) V148I. Residues with 
15
N temperature coefficients decreased by at 
least 3 ppb/K compared to pWT are coloured blue. Residues with 
15
N temperature coefficients increased by at least 
3.0 ppb/K compared to pWT are coloured red. Residues numbers are given in for those with significant changes. 
Dark grey is used to highlight residues with no significant change (i.e. within ± 3.0 ppb/K of pWT). Light grey is 
used to highlight residues where no data are available. Bound copper (turquoise) and zinc (black) are represented as 
spheres. The mutated residue is shown in stick representation in cyan. The ribbon diagram was generated using 
MOLMOL and PDB file 1SOS.  
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 There are 7 residues with significantly different 
15
N temperature coefficients compared to pWT in 
G93A. Two of these (Ala6 and Val94; red in Figure 3.15) exhibit increased temperature dependences 
while the remainder (Val 14, Asn53, Glu77, Asp92 and Gly93; blue in Figure 3.15) have reduced 
temperature dependences. Most of these residues also have significantly different N
1
H temperature 
coefficients and are local to the mutation site. Three of the residues (Val14, Glu77 and Asn53) are distal 
from the mutation site. Val14, as described earlier, interacts with Leu38 in the β-barrel plug which has 
altered dynamics in G93A (188). Glu77 is in a region shown to have decreased mobility in mutants (see 
sections 3.3.3.2 and 3.3.3.3) (95, 104). Lastly, Asn53 is in the dimer interface which has been proposed to 
be weakened in mutants (81, 93). The same level of changes in 
15
N temperature coefficients is observed 
for E100G. Two residues (Gly73 and Ile99; red in Figure 3.15) display increased temperature 
dependences and five (Val29, Leu84, Asp90, Val97 and Ala123; blue in Figure 3.15) have reduced 
values. Here there does not appear to be a correlation between residues displaying different N
1
H 
temperature dependences, however, the residues with altered 
15
N temperature dependences do cluster 
close to the site of the mutation. Further, 4 of the 7 residues identified for E100G have altered amide 
exchange rates (Table A1.2) compared to pWT however in only two cases were the differences large 
enough to be considered significant (6). In V148I, the number of residues with significant differences 
climbs to 21 with 4 displaying increased temperature coefficients. A large proportion of these residues 
(17; 81%) also have significantly altered N
1
H temperature dependences. It should be noted that the lack 
of correlation for E100G and the high correlation for V148I between N
1
H and 
15
N temperature 
dependences in part could be a product of how many residues display significant changes in each mutant.  
Taken together, the results indicate that while the factors contributing to 
15
N temperature 
coefficients remain unknown, residues with altered coefficients correlate well with those shown to be 
perturbed through other methods and expected to be structurally affected by mutation. It has been claimed 
that 
15N temperature coefficients are “essentially uninterpretable” (165), however, the studies here 
indicate that 
15
N temperature dependences likely report on genuine differences in proteins. Further 
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investigations of the factors that govern 
15
N temperature coefficients, disentangling the relationship 
between the sign and magnitude of the coefficients and the related type and extent of conformational 
deformation, still remains essential to their use in structural analyses. 
3.3.6 Non-linear N
1
H temperature dependences 
3.3.6.1 Theoretical model for curved temperature dependence 
 The temperature dependence of chemical shifts is expected to be linear since the expansion 
coefficient of proteins is constant with temperature (see section 3.1.4). In contrast, non-linear behaviour 
has been observed in a number of proteins well below the global unfolding temperature. Baxter and co-
workers proposed that this non-linearity is an indication of the amide group accessing an alternative state 
(165). If an amide proton is able to access another conformation, it will only result in curvature if the two 
conformations are in fast exchange on the NMR timescale and thus the observed peak is a weighted 
average of the two states (158). One state can be referred to as the ground state (state 1) and the other as 
the higher energy alternative state (state 2). Each state is assumed to have a linear temperature 
dependence of chemical shifts as follows: 
        
       Eq. 3.2 
        
      Eq. 3.3 
where δ1(T) and δ2(T) are the chemical shifts at a given temperature (T),   
  and   
  are the initial chemical 
shifts and g1 and g2 are the temperature coefficients of the ground and alternative states, respectively. 
These two states are separated by a free energy difference, ΔG, given by Eq. 1.1. The observed chemical 
shift, δobs, is dependent upon the populations of the ground and alternative state, p1 and p2, respectively:  
  
  
     ( 
  
  
)                                                                                                                                    Eq. 3.4 
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Therefore, the observed chemical shift (δobs) is given by: 
                                                                                                                                            Eq. 3.5 
     
(  
     ) [   
       
        ]
           
                                                                                                      Eq. 3.6 
where R is the gas constant. The extent of curvature is dependent upon the differences in δᵒ and g, as well 
as the ΔG between the two states.  
It has been proposed that the alternative state has local structural rearrangement with different 
hydrogen bonding compared to the ground state resulting in different chemical shifts and/or temperature 
gradients (177). In order to provide a clear understanding of how differences in these values as well as 
various thermodynamic parameters affect curvature, observed chemical shifts were simulated using 
typical values (177). The residuals (deviations from linearity) were calculated to illustrate the curvature 
(Figure 3.16). The ground state chemical shift was initially taken to be 8.5 ppm with a temperature 
coefficient of -2 ppb/K. The shift of the alternative state was set to 8.0 ppm with a temperature coefficient 
of -7 ppb/K. The thermodynamic parameters for the simulations were taken from Mulder et al., where an 
excited state of the L99A mutant of T4 lysozyme was characterized (209). The values, estimated to 
represent loss of a hydrogen bond, are ΔG = 2 kcal/mol, ΔH = 7.1 kcal/mol and TΔS (25°C) = 5.1 
kcal/mol.  
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Figure 3.16 - Theoretical curved temperature dependence of N
1
H accessing an excited state. (A) Simulations of the 
dependence of N
1
H chemical shift variation with temperature on the difference in free energy between the ground 
and alternative state. δ1
°
 = 8.5 ppm, g1 = -2 ppb/K. δ2
°
 = 8.0 ppm,
 
g2 = -7 ppb/K. ΔS = 17.2 cal/mol K
-1
 and ΔH = 6.1, 
7.1, 8.1, 9.1 and 10.1 kcal/mol corresponding to ΔG = 1, 2, 3, 4 and 5 kcal/ mol, respectively. The calculated δobs 
values were fit using linear regression to a straight line. The deviations from linearity (δlinfit - δobs) are plotted against 
temperature. (B) Simulations of the dependence of N
1
H chemical shift variation with temperature on the chemical 
shift difference between the ground and excited state. δ1
°
 = 8.5 ppm, g1 = -2 ppb/K. δ2
°
 is varied from 7 to 10 ppm at 
0.5 ppm increments, g2 = -7 ppb/K. The number given in the figure legend is δ2
° 
- δ1
°. ΔG = 2 kcal/mol 
corresponding to ΔH = 7.1 kca/mol and ΔS = 17.2 cal/mol K-1. (C) Simulations of the dependence of N1H chemical 
shift variation with temperature on the difference in the g between the ground and excited state. The g values are 
given in the figure legend for the ground and alternative states. δ1
°
 = 8.5 ppm, δ2
°
 = 8.0 ppm. ΔG = 2 kcal/mol 
corresponding to ΔH = 7.1 kca/mol and ΔS = 17.2 cal/mol K-1. (D) Simulations of the dependence of N1H chemical 
shift variation with temperature on differences in ΔH and ΔS, given in the figure legend as ΔH, ΔS. ΔG is 
maintained at 2 kcal/mol. δ1
°
 = 8.5 ppm, g1 = -2 ppb/K. δ2
°
 = 8.0 ppm,
 
g2 = -7 ppb/K. 
 
The simulations reveal that the curvature is a result of the complex interplay between the 
associated shift differences, temperature coefficients and thermodynamic parameters. The curvature is 
most pronounced when the difference in free energy between the two states is small and becomes 
 105 
 
essentially negligible at ΔG ≥ 5.0 kcal/mol (Figure 3.16 A). Other parameters can affect this limit, 
however. For example, if the chemical shift of the alternative state is shifted upfield by a very large 
amount or its gradient is significantly more negative, higher energy states may be observed (Figure 3.16 
B, C). An increase in ΔH and ΔS will also increase the observed curvature (Figure 3.16 D). In most cases, 
the curvature is concave (negative value of a in Eq. 3.1) however the curvature can be convex (positive 
value of a in Eq. 3.1). The latter happens when the chemical shift of the alternate state is shifted 
downfield by ≥ 1.0 ppm or the temperature coefficient of the alternative state is much more positive 
(smaller) than for the ground state. The second scenario may represent the alternative state being more 
structured (as it is less affected by temperature).  
Some assumptions may be made to obtain set limits on the ΔG difference between the two states 
for residues with observed curvature in proteins. The typical conformation-dependent range of chemical 
shifts in backbone amide protons is approximately 1-2 ppm (180). However, since the alternative state is 
thought to be the result of a small, local conformational change for up to 5 residues, the difference in 
chemical shift between the two states is likely smaller. An upfield shift of 0.5 ppm towards random coil 
for the alternative state (i.e. from 8.5 to 8.0 ppm) was therefore assumed.  It has been proposed that the 
alternative state likely exhibits alternative hydrogen bonding patterns (180). Therefore, one can assume a 
more structured ground state with an average temperature coefficient for a hydrogen bonded proton of -2 
ppb/K. The alternative state can be chosen to have an average temperature coefficient for a proton not 
participating in a hydrogen bond, -7 ppb/K. The thermodynamic parameters can be described as in the 
study of the excited state of T4 lysozyme (see above) (209). The parameters described above are the same 
as those used in the simulation to illustrate how differences in ΔG affect curvature (Figure 3.16 A). The 
extent of curvature can be quantified by the quadratic coefficient (a) which can be obtained by fitting the 
residual values (deviations of observed shifts from linearity, δlinfit - δobs) to the quadratic equation (see 
methods). Consistent with Figure 3.16 A, there is a correlation between a and ΔG (Figure 3.17). It should 
be noted that due to the small magnitude of the residual curvature and the experimental uncertainties in 
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N
1
H chemical shifts (0.005 ppm), as well as the assumptions discussed above, this analysis simply 
provides an estimate of the difference in ΔG between the ground and alternative state.  
 
Figure 3.17 - Correlation between the quadratic coefficient (a) and the ΔG difference between the ground and 
alternative state for simulated residual chemical shift values. The line of best fit obtained by linear regression is 
given by a black solid line. The associate equation and R
2
 value is given in the plot area. 
 
3.3.6.2 Residues displaying curved temperature dependences in SOD1 
 The observed N
1
H chemical shifts of pWT at each temperature were fit to a straight line. The 
residuals (deviations from linearity) were calculated and plotted as a function of temperature (Figure 
3.18). For each residue, the residual values were fit to the quadratic equation. To assess curvature, the 
residuals were visually inspected considering the associated a value, the quality of the fit and the 
uncertainties in the measured N
1
H chemical shifts. This method, albeit somewhat subjective, has been 
used previously to assess curved temperature dependences (163, 177, 179, 180). The results indicate that 
in pWT 50 out of the 153 residues (~33%) are accessing an alternative state. Of these residues displaying 
curvature, 94% had concave curvature. Simulations (Figure 3.16) reveal that this likely represents a more 
disordered alternative state in pWT. Residues accessing alternative states have N
1
H temperature 
coefficients spanning the entire range seen in pseudo WT, with approximately half less positive than -5 
ppb/K. The majority of residues in pWT are accessing an alternative state estimated to have a free energy 
difference from the ground state of 2 – 3.5 kcal/mol. 
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Figure 3.18 - Plots of residual N
1
H chemical shift against temperature for representative residues in pWT. The 
graphs are labelled with residue number and asterisk is used to highlight residues characterized as having curved 
temperature dependences. The vertical axis has a total range of 0.04 ppm. The horizontal axis covers the temperature 
range 297-357 K. Scales of the plots are comparable to those used in previous studies (178-180).  
 
 Residues accessing alternative states are spread throughout the entire polypeptide chain of pWT 
in both β-strands and loops (Figure 3.19). Based on the crystal structure, the amide proton of 59% of 
residues in pWT is expected to participate in an intramolecular hydrogen bond. The higher percentage of 
hydrogen bonded residues accessing alternative states (76%) could suggest that the higher energy state 
may be achieved through loss of a hydrogen bond. Overall β-sheet 1 (β-strands 1, 2, 3 and 6) shows more 
conformational heterogeneity than β-sheet 2 (β-strands 4, 5, 7 and 8). This is consistent with the N1H 
temperature coefficients indicating that sheet 1 is less stable (see section 3.3.3.1). Specifically, residues 
accessing alternative states cluster in β3, β4, β6 and to some extent β1. It has previously been shown that 
regions with decreased stability in proteins tend to be more significantly populated with residues 
accessing alternative states (177). Also, β1, β3 and β6 lose structure first in the unfolding pathway of 
pWT (section 3.3.3.1), which may reflect increased conformational heterogeneity in these strands.   
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Figure 3.19 - Cartoon representation of pWT highlighting residues with curved N
1
H temperature dependences. Each 
circle represents a residue in the protein. A solid border indicates the amide
 
proton of that residue participates in a 
hydrogen bond. A dashed border indicates it does not. Circles that lie on top of arrows represent residues in β-
strands. Hydrogen bonds are represented as solid black lines connected to the N
1
H and pointing towards the oxygen 
acceptor. Circles with ‘P’ in the center represent proline residues which have no amide proton. Circles with stars in 
the center represent metal binding residues. Light purple indicates residues that appear to have linear temperature 
dependences. Yellow, orange and red indicates residues estimated to access an alternative state with a ΔG of 0 – 2 
kcal/mol, 2 – 3.5 kcal/mol, and 3.5 – 5 kcal/mol, respectively. Dark grey indicates residues that disappear at 
increased temperatures. White indicates residues for which there are no data. Beige is used to indicate residues that 
do not fall into any of the above categories.  
 
A number of resides in β4 (of sheet 2) appear to be accessing a higher energy state. The N1H 
temperature coefficients reveal that β4 is relatively stable with slight loss of structure at the ends of the 
strand. However, residues in the strand populate alternative conformations estimated between 2 and 5 
kcal/mol. Two residues in β4, His46 and His48, are metal binding residues. A definitive explanation for 
 109 
 
the increased conformational heterogeneity in β4 cannot be given however one possibility is that altered 
or weakened metal binding at increased temperatures may affect this strand which contains a greater 
proportion of metal binding residues than any other strand. Altered or weakened metal binding at 
increased temperatures is supported by the significant degree of conformational heterogeneity observed in 
loop IV, specifically near the zinc binding site (residues 63 - 82). Residues in this region are found to 
have reduced stability based on N
1
H temperature coefficients (section 3.3.3.1, Figure 3.8). Loop IV 
contains three metal binding residues (metal binding residues are marked with stars in Figure 3.19), 
including His80 which exhibits significant curvature and His63 which disappears at increased 
temperatures. The zinc binding site is also protected by loop VII. In this loop, five residues have curved 
temperature dependences and five disappear. Interesting, most of the residues that access an alternative 
state are located in the N-terminal half of the loop and most of the residues that disappear are in the C-
terminal half. This suggests that there is increased disorder in the C-terminal half of the loop and is 
supported by N
1
H temperature coefficients which reveal that many of the hydrogen bonds that tether this 
half of the loop to the N-terminal half are lost. Taken together, the results suggest that there is a 
significant amount of conformational heterogeneity in the two long loops (loops IV and VII), especially in 
the regions that protect the zinc binding site. Overall, the residues accessing alternative states correlate 
well with regions of the protein expected to have decreased local stability based on N
1
H temperature 
coefficients and previous experimental work (6, 189). A negative correlation between local stability and 
conformation heterogeneity has also been observed in cytochrome c (177). 
Analysis of G93A reveals that 47 (31%) residues have curved temperature dependences which is 
quite similar to what is seen for pWT (Figure 3.20). As a whole, the results indicate the mutant is able to 
access higher energy alternative states. Regions of G93A showing conformational heterogeneity are 
similar to those identified in pWT, with the exception of β4. In this mutant, most residues in β4 appear to 
have linear temperature dependences with the exception of the first and last in the strand. This does not 
necessarily mean that these residues are not accessing alternative states but could mean that the strand is 
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significantly disordered or residues are accessing higher energy conformations (> 5 kcal/mol) not 
observable by this method (180).  Analysis of N
1
H temperature coefficients reveal that this core strand is 
stable and so disorder is likely not the cause. Three metal binding residues disappear in G93A (opposed to 
two that disappear in pWT) which could indicate loss of structure surrounding the metal binding site. 
Further, loop IV shows less conformational heterogeneity in the zinc binding region (residues 63 – 82) 
however five residues disappear in this region compared to the three that disappear in pWT. Lack of 
structure would likely increase both chemical and conformational exchange as it would increase solvent 
accessibility as well as allow for the population of significantly different conformational states, and as 
such would likely result in signal loss. The larger number of residues that disappear in loop IV point to 
increased disorder in the region surrounding the zinc binding site in G93A compared to pWT, which 
could cause the linear temperature dependences observed in G93A in this region (Figure 3.20). Loop VII 
shows a similar number of residues accessing alternative states in G93A however six residues in and 
around the helix in this loop disappear, again pointing to a loss of structure and deprotection of the zinc 
binding site.  Finally, residues 50-53 in the dimer interface appear to be accessing an alternative 
conformation that differs from pWT since the two of the residues have a different sign of curvature. This 
result suggest that there may be propagating structural effects in the dimer interface for G93A. 
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Figure 3.20 - Cartoon representation of G93A highlighting residues with curved N
1
H temperature dependences. 
Each circle represents a residue in the protein. A solid border indicates the amide proton of that residue participates 
in a hydrogen bond. A dashed border indicates it does not. Circles that lie on top of arrows represent residues in β-
strands. Hydrogen bonds are represented as solid black lines connected to the N
1
H and pointing towards the oxygen 
acceptor. Circles with ‘P’ in the center represent proline residues which have no amide proton. Circles with stars in 
the center represent metal binding residues. Residues are coloured as in Figure 3.19.  
 
 Analysis of the conformational heterogeneity in E100G reveals 47 (31%) of residues access 
alternative high energy conformations. Again, these residues cluster in the regions identified to have high 
conformation heterogeneity in pWT but they are estimated to have larger ΔG differences (Figure 3.21). 
One exception is β3 which is dominated by residues with linear temperature dependences. This strand 
neighbours the strand that contains the mutation. Again, this could represent one of three situations: the 
residues are not accessing alternative conformations; the strand is accessing a number of different 
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conformations (disordered); or the residues are accessing higher energy conformations > 5 kcal/mol. At 
this point it is difficult to identify which is the case, however, analysis of N
1
H temperature coefficients 
reveals increased loss of structure at β3 compared to pWT (see section 3.3.3.3, Figure 3.11). Loop IV has 
the largest proportion of residues displaying curved temperature dependences out of the all of the variants 
analyzed, clustering in the dimer interface (residues 49 - 61) and at the zinc binding site (residues 63 – 
82). The results indicate that this loop contains a significant number of residues accessing an alternative 
state but likely remains more structured in E100G than G93A and similar to pWT. This is supported by 5 
residues (His63, Asn65, Lys75, Glu78 and His80; Table A1.1) disappearing in G93A in this loop near the 
zinc binding site while only 2 disappear in E100G (Asn65, Lys75; Table A1.1). There are 7 residues that 
display convex curvature (Val14, Gly16, Phe20, Glu40, Asp52, Glu78 and Gly129) in E100G opposed to 
the 3 in pWT (Val14, Gly100 and Ser134). These residues are spread throughout the polypeptide chain 
and are found mainly in loops. Simulations suggest that the altered curvature may report on a more 
structured alternative state. Consistent with this, most of these residues have smaller N
1
H temperature 
coefficients. Interestingly, 3 of the residues (Glu40, Asp52 and Glu78) with convex curvature are directly 
beside a residue accessing a high energy alterative state and therefore for these residues the altered 
curvature may represent compensatory stabilization in the mutant (108).  
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Figure 3.21 - Cartoon representation of E100G highlighting residues with curved N
1
H temperature dependences. 
Each circle represents a residue in the protein. A solid border indicates the amide proton of that residue participates 
in a hydrogen bond. A dashed border indicates it does not. Circles that lie on top of arrows represent residues in β-
strands. Hydrogen bonds are represented as solid black lines connected to the N
1
H and pointing towards the oxygen 
acceptor. Circles with ‘P’ in the center represent proline residues which have no amide proton. Circles with stars in 
the center represent metal binding residues. Residues are coloured as in Figure 3.19.  
 
 DSC simulations and analysis of N
1
H temperature coefficients reveal that the fALS mutant V148I 
is more stable than pWT (Figure 3.5). In agreement with this, V148I has the smallest number of residues 
(44, 29%) accessing alternative conformations. As for the other mutants, the residues that do show 
conformational heterogeneity in this mutant are accessing higher energy states than seen in pWT. 
Somewhat surprisingly, V148I appears to have the largest proportion of residues accessing alternative 
states with ΔG of 3.5 - 5 kcal/mol. These residues cluster in the same regions as in pWT, however, as in 
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G93A, β4 in V148I is dominated by residues with linear temperature dependences. V148I has the largest 
proportion of residues with convex curvature, most of which have smaller N
1
H temperature coefficients 
compared to WT. Loop VII (which precedes the strand that contains the mutation) exhibits significantly 
less conformational heterogeneity than in the other variants with only two residues (Glu121 and Gly129) 
accessing an alternative conformation and only three residues (Asn131, Ser134 and Ser142) disappearing 
at increased temperatures. This suggests greater stability in the electrostatic loop for this mutant even 
compared to pWT. Near position 148 in pWT a number of residues have curved temperature dependences 
however this is not the case in V148I. Although this could indicate increased disorder for the mutant in 
this region, due to the higher stability of V148I by DSC and stronger hydrogen bonding in this region 
(determined from N
1
H temperature coefficients), it is plausible that these residues simply do not display 
conformation heterogeneity in V148I.  
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Figure 3.22 - Cartoon representation of V148I highlighting residues with curved N
1
H temperature dependences. 
Each circle represents a residue in the protein. A solid border indicates the amide proton of that residue participates 
in a hydrogen bond. A dashed border indicates it does not. Circles that lie on top of arrows represent residues in β-
strands. Hydrogen bonds are represented as solid black lines connected to the N
1
H and pointing towards the oxygen 
acceptor. Circles with ‘P’ in the center represent proline residues which have no amide proton. Circles with stars in 
the center represent metal binding residues. Residues are coloured as in Figure 3.19.  
 
Overall, a similar number of residues show access of higher energy alternative states in pWT and 
the three disease-associated mutants described above. Comparison of curvature results with N
1
H 
temperature coefficients indicate that regions with decreased local stability also display larger 
conformational heterogeneity, which is structurally reasonable and has previously been observed for other 
proteins (177). Interestingly, the results show that as a whole, mutants appear to be accessing high energy 
alternative states compared to pWT. This is true even for V148I which has been shown to have greater 
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global stability than pWT. It remains unknown whether or not the ability to access higher energy 
alternative states is a general consequence of mutation, however, the results here point to this being true 
regardless of global stability.  
3.4 Discussion  
 Considerable information can be obtained from monitoring the temperature dependences of the 
1
H-
15
N cross peaks of proteins. Since more is known about the factors that underlie N
1
H temperature 
coefficients, these remain the main source of information for structural interpretations (165), however, the 
results here show that differences in 
15
N temperature coefficients are likely reporting on genuine 
differences between proteins as well (see section 3.3.5.2). In this analysis, hydrogen bonds are deemed 
“lost” if they are predicted to form based on crystal structure data but have a high probability of not 
occurring based on N
1
H temperature coefficients. Differences in the predicted hydrogen bonding status 
between crystal structure data and N
1
H temperature coefficients can be caused by one of two scenarios: 
(1) the hydrogen bond observed in the crystal structure is simply not formed in solution at any 
temperature or (2) the hydrogen bond is disrupted early in the thermal unfolding of pWT. NMR 
temperature dependence studies indicate that the thermal unfolding process of holo pWT begins with 
“fraying” of the structure at its periphery. In particular, a significant loss of hydrogen bonding is observed 
at edge strands β5 and β6, as well as in the long loops IV and VII (Figure 3.9). Disruption of the hydrogen 
bonding network in the dimer interface is also observed which could suggest a weakening of the interface 
at increased temperatures. Previous NMR relaxation experiments monitoring the backbone dynamics of 
holo SOD1 indicate that all β-strands in the dimer have equal flexibility at 25°C (182). Therefore, the loss 
of hydrogen bonding observed by temperature coefficients at the β3 - β6 and β5 - β6 interfaces is likely a 
result of the second scenario indicating hydrogen bonds are lost at increased temperatures and reflect 
decreased local stability in the edge strands.  
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Overall, β-sheet 1 (β-strands 1-3, 6) appears to be more perturbed by temperature than β-sheet 2 
(β-strands 4, 5, 7 and 8) in holo pWT (Figures 3.8 and 3.9). This is interesting as the opposite has been 
observed for apo SOD1, with β-sheet 2 having decreased stability (49). The conflicting results can be 
resolved by considering how metal binding affects the structure of SOD1. Out of the 7 metal binding 
residues in SOD1, 4 are located in β-sheet 2 while none are in β-sheet 1. Upon metal binding, β-strands 4 
and 7 become significantly more structured (120). Metal binding also favours dimerization which helps to 
protect the edge strand β8 located in the dimer interface (54, 189). The increased structural integrity 
conferred to β-sheet 2, as compared to β-sheet 1, upon metal binding can explain the observed differences 
in local unfolding between the holo and apo forms of SOD1.  
Curved N
1
H temperature dependences can reveal population of an alternative state close in 
energy to the ground state. A number of studies have found that a significant proportion of residues in 
proteins access these alternative states, highlighting the dynamic nature of proteins in solution (163, 176-
178, 180). An interesting finding was the correlation between residues populating alternative 
conformational states and the unfolding pathway in cytochrome c (177). The folding of this protein has 
been studied extensively and regions expected to fold last displayed the highest population of residues 
with curved temperature dependences. It was proposed that residues displaying curvature may represent 
the earliest cooperative unfolding unit of a protein. Kinetic studies of holo pWT SOD1 reveal that β5 and 
β6 are unstructured in the transition state (126). Loop IV (discussed further below), which precedes β5, 
and loop VII are also fairly unstructured in the transition state. These regions are thus likely the last to 
fold in the SOD1 pathway and here were shown to have the highest population of residues with curved 
temperature dependences (Figure 3.19). These results are consistent with the results for cytochrome c and 
thus likely represent the earlier cooperative unfolding units in holo pWT. 
Analysis of metal binding affinity reveals that copper binds more strongly to SOD1 than zinc 
(122). This is structurally reasonable as zinc-coordinating residues are found mainly in loop IV while 
copper coordinating ligands are found mainly in core β-strands (Figure 1.4) (58). Previous kinetic studies 
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monitoring the unfolded pathway of holo SOD1 show that the major unfolding pathway involves dimer 
dissociation to form a monomer intermediate, followed by monomer unfolding (126). Both metals remain 
bound throughout dimer dissociation; with zinc dissociation occurring from the monomer intermediate 
and copper dissociation later from the unfolded monomer. Monitoring the effect of metals on the 
unfolding kinetics revealed that the copper binding site is largely structured in the monomer unfolding 
transition state however the zinc site is only partially formed (126). Since most of the copper binding 
ligands are located in the core β-strands of β-sheet 2, this suggests that the monomer core is likely formed 
early in the folding pathway. Again, based on N
1
H temperature coefficients and curved temperature 
dependences, the core of the SOD1 monomer is shown to remain fairly structured with little 
conformational heterogeneity up to 84°C.  
As mentioned above, loop IV contains most of the zinc binding residues and upon metal binding 
becomes highly structured (120). The increased flexibility observed in this loop at high temperature may 
therefore indicate altered/weakened metal binding. This may also explain the increased conformational 
heterogeneity observed in β-strand 4 (Figure 3.19), which is expected to be structured in the holo state but 
disordered in the apo state. The majority of residues in loop IV display concave curvature with 
temperature which commonly represents a less structured alternative state and is consistent with the loss 
of hydrogen bonding indicated by N
1
H temperature coefficients. It is interesting to note that concomitant 
with the increased disorder in the zinc binding site there is increased disorder at the dimer interface, 
suggesting coupling between these regions. Metal binding is known to promote dimerization and vice 
versa (54). Thus, disorder in one of these sites could promote disorder in the other. This is consistent with 
the major unfolding pathway of holo SOD1 which has been shown to involve dimer dissociation followed 
by rapid zinc loss as the first steps (125).  
It is important to note there is no indication of metal loss in the NMR experiments conducted 
here, despite the increased disorder in the metal binding region. In the HSQC spectrum of pWT, Gly61 
(located in loop IV) has a well resolved cross peak that shows distinct chemical shift changes upon metal 
 119 
 
binding. Considering this, even at the highest temperature studied, metals appear to remain bound to 
pWT. Lack of metal loss is also consistent with the extremely high affinity of the SOD1 for metals (122) 
and the observation that metals appear to remain bound to globally thermally unfolded SOD1 (82). Also, 
analysis of the pWT HSQC spectrum at 24°C (obtained upon cooling after heating to 84°C) reveals that 
any spectral changes observed in pWT are reversible. Overall, the results of the NMR temperature 
dependence studies of pWT not only identify regions of decreased local stability but suggest that the 
conformational ensemble in solution contains several conformations close in free energy to the native 
state making the ensemble one with high structural entropy (210).  
3.4.1 Mutational effects on local unfolding of SOD1 
Disease-associated mutants G93A, E100G and V148I all display similar local unfolding patterns 
to pWT, but also have distinct differences surrounding the mutation site. Interestingly, in all three mutants 
altered dynamics are observed in the β-barrel plug which could represent a common propagating 
structural effect upon mutation, however, the extent of destabilization differs between mutants. As may be 
expected based on the site of mutation, G93A displays the greatest flexibility at the β-barrel plug (Figure 
3.10). It appears that mutation from Gly to Ala in loop V significantly disrupts the local hydrogen 
bonding network decreasing the stability in this region. In addition, G93A exhibits even greater disorder 
surrounding the zinc binding site when compared to pWT. This is evidenced by the larger proportion of 
residues that disappear at increased temperature in loops IV and VII in the mutant. Signal loss can be the 
result of either chemical or conformational exchange (see section 3.3.3.1), both of which can be promoted 
by loss of structure. Aggregation studies of holo G93A reveal a shorter lag time prior to the onset of 
aggregation than observed for pWT (92). It could be that propagating destabilizing effects in the metal 
binding region favour zinc loss in G93A, a process known to promote protein aggregation. 
Destabilization of the metal binding region for G93A has also been observed in amide exchange studies 
(189).  
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Based on DSC and chemical denaturation (6, 149) (see also section 3.3.2), mutation of Glu to Gly 
at position 100 destabilizes SOD1 more than the other mutants studied here. Counterintuitively, the H
1
N 
temperature coefficients, conformational heterogeneity and amide exchange rates observed for E100G are 
most similar to pWT of any of the mutants studied. Gly has a relatively high degree of conformational 
freedom compared to other amino acids and therefore introducing Gly at the end of β6 likely increases 
mobility near the site of the mutation. Interestingly, the mutated Gly residue disappears at increased 
temperature suggesting that there may be a high degree of conformational exchange. In addition, Asp101, 
which neighbours Gly100, is the acceptor of 3 hydrogen bonds from the N
1
Hs of Val29, Val103 and 
Ile104. In E100G two of these hydrogen bonds are lost, in agreement with increased mobility surrounding 
the mutation site. The results indicate that the disorder observed at edge strand β6 is increased in E100G, 
as well as in β3 and loop VI (see section 3.3.3.3).  
By DSC, the third mutant, V148I, is globally more stable than pWT (Figure 3.5). The NMR 
results indicate that upon mutation, almost one third of residues display decreased N
1
H temperature 
coefficients; however, in over half of these, the smaller coefficient is indicative of a weaker hydrogen 
bond. It appears that introduction of the bulkier hydrophobic side chain into the dimer interface 
significantly affects the hydrogen bonding network extending throughout the protein. This is physically 
reasonable as the dimer interface has been identified as a region with high connectivity to distal areas in 
the protein (104). It should be noted however, that since there were differences in data acquisition for 
V148I (see sections 3.2.2 and 3.2.4), to have the full confidence in the results the variable temperature 
NMR experiment for V148I should be repeated on the same spectrometer with identical pulse programs, 
acquisition parameters and temperatures. 
The results for both E100G and V148I suggest that local stability may not always be 
representative of global stability. V148I, for example, despite displaying a significant proportion of 
residues with weaker hydrogen bonds has increased global stability. NMR relaxation experiments 
analyzing changes in backbone mobility of the peptidyl-prolyl isomerase Pin1 upon binding of different 
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ligands revealed an interesting trend in protein stability (108). Here, ligand binding results in regions of 
the protein having both increased and decreased flexibility. It was found that stiffening along a conduit of 
hydrophobic residues that linked the domain interface to the active site was positively correlated with 
binding affinity. In addition, in many cases residues with increased flexibility directly neighboured 
residues with decreased flexibility. A similar trend of both increased and decreased flexibility upon 
mutation is observed in holo SOD1 mutants. In G93A, for example, the increased dynamics in the β-
barrel plug is accompanied by a strengthening of the hydrogen bond between Ile35 and Ala95 (located in 
β6 next to the β-barrel plug). Also, residues with increased stability upon mutation are not always local to 
the mutation, but rather for all three mutants can be found at various locations throughout the protein. 
Increases as well as decreases in local stability upon mutation were also observed in amide exchange 
experiments of holo SOD1 mutants (6). Thus, measurements of global stability do not give the full picture 
regarding changes in protein structure; as NMR studies reveal that mutations can cause complex changes 
in local stability that propagate through the structure (6, 108), which may provide insight into aggregation 
mechanisms. 
3.4.2 Conclusions and implications for SOD1 aggregation 
The thermal unfolding of both WT and mutant SOD1 begins with loss of structure at edge strands 
β5 and β6. The decreased local stability observed in this region suggests that the edge strands may 
undergo local unfolding in response to environmental perturbations. Loss of these protective edge strands 
may expose the hydrophobic core of the SOD1 monomer, which could provide a site for non-native 
interactions. These edge strands have been proposed to act as “gatekeepers” preventing the aggregation of 
SOD1 (52, 105); however, the location of these strands at the periphery of the structure make them logical 
candidates for spontaneous unfolding in the rapidly interconverting ensemble of conformers found in 
solution (205). These NMR experiments suggest that upon heating, conformers with disorder at the edge 
strands become significantly more populated and longer lived. Further, loss of the continuous hydrogen 
bonding network around the β-barrel cylinder puts SOD1 at risk for edge-to-edge aggregation (see section 
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1.6.6). The long loops IV and VII also become disordered early in the thermal unfolding, especially for 
G93A. These loops have been shown previously to form non-native contacts in apo SOD1 assemblies and 
local unfolding in these loops could lead to protein aggregation (89). In pWT, the structural integrity of 
the β-barrel plug is maintained despite the increased mobility observed at the edge strands. The opposite 
is true for each of the mutants analyzed here (G93A, E100G and V148I). Specifically, in all 3 mutants 
increased mobility is observed at Leu38 (the “plug” residue, see section 3.3.3), which fills a cavity formed 
by surrounding residues (58, 78). Loss of structural integrity at the β-barrel plug in combination with the 
increased mobility at the edge strands suggest an increased opening of the two β-sheets and greater 
solvent exposure of the hydrophobic interior in mutant SOD1. These findings are in agreement with MD 
simulations that reveal altered dynamics in the β-barrel plug for A4V, H46R and G37R (104), which may 
point to a common pathway for mutant SOD1 aggregation. 
CPMG experiments of the apo monomer variant of WT and mutant SOD1 reveal that generally 
there appears to be increased structural distortion in an excited state of mutant SOD1s compared to WT 
(193).  Analysis of residues with curved temperature dependences reveals a similar trend with holo SOD1 
mutants being able to access higher free energy alternative states compared to pWT.  Another possibility 
is that protein aggregation may not be the result of local unfolding but rather occur via non-native 
association of these transiently populated higher energy conformations. The structure of the alternative 
state observed in these experiments is unknown, however direction of curvature (see section 3.3.6.1) 
suggests that for almost every reside the alternative state is more disordered. It could be that aggregation 
is more likely to occur from higher energy alternative states which are more easily accessed by mutant 
SOD1.  
3.4.3 Future work  
 In this chapter, NMR temperature-dependence experiments have been described for analyzing the 
stability and dynamics of SOD1. Analysis of N
1
H temperature coefficients have allowed for a residue-
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specific picture of the subglobal disruption of structure in SOD1, with identification of regions having 
decreased local stability. In addition, the dynamic behaviour of SOD1 was characterized by assessing 
residues displaying curved temperature dependences providing information on high free energy 
alternative states. The application of these experiments to additional fALS mutants will further aid in the 
understanding of how point mutations affect the local stability of SOD1. Analysis of common and distinct 
structural changes between mutants may help to explain their common (aggregation) and distinct 
(duration) disease characteristics. Further, the study of additional mutants will allow for expansion of the 
comparative analysis between local and global stability which may help to elucidate the role of local 
flexibility in protein folding, protein engineering and protein aggregation.  
 It would also be of interest to analyze how metal loss affects the structure of SOD1. The 
experiments herein and previous experiments indicate that zinc is likely lost first in the unfolding pathway 
SOD1. It would be interesting to conduct NMR experiments on apo and copper bound SOD1 to see how 
the pattern of local unfolding is affected by loss of zinc. It should be noted that these experiments may be 
more difficult for a number of reasons. First, assignments would need to be completed at 25°C for SOD1 
in the altered metal states. Second, since the protein is less structured in more immature or mismetallated 
forms, peak overlap would present a larger problem increasing the difficulty of following peaks with 
temperature. Lastly, a smaller temperature range would need to be used to avoid global unfolding as well 
as smaller temperature increments to ensure accurate tracking of the peaks. However, with careful 
consideration I believe these experiments would provide important information of how metallation affects 
the hydrogen bonding network throughout SOD1, local stability, the unfolding pathway and access of 
high energy alternative states which again would be instrumental in the greater understanding of SOD1 
aggregation.   
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3.5 Insights into SOD1 metal binding from PAR assay and NMR analyses combined 
 In the apo and holo forms, SOD1 displays striking differences in stability, activity and flexibility 
(81, 88). In most cases the binding of metal cofactors to proteins increases thermodynamic stability, 
which is especially true for SOD1 (81, 109). This is because metal binding results in significant 
structuring of the protein, especially in β4, β7, loop IV and loop VII (120). Mutations on the other hand 
have been shown to increase the flexibility of SOD1 on both a local and global scale (104). It may be true 
that the increased flexibility caused by mutation predisposes mutants to more easily lose metals; a general 
consequence proposed to be a result of mutation (122). The NMR temperature dependence experiments 
completed here show decreased local stability surround the zinc binding site but there is no indication of 
metal loss. Previous studies monitoring the unfolding kinetics of SOD1 reveal that zinc loss precedes 
copper loss (125, 126). These results combined suggest that increased flexibility surrounding the zinc 
binding site may precede zinc loss and therefore there may be a negative correlation between flexibility in 
the metal-binding site and metal affinity. 
The NMR temperature dependence experiments reveal that the effects of mutations propagate, 
with residues throughout the structure displaying both increased and decreased flexibility. Based on this 
result, it is structurally reasonable that regardless of the site of mutation, mutants could display 
altered/weakened metal binding. In addition, since the zinc binding residues are located in loops shown 
here to have decreased local stability, the predisposition of mutants to more easily lose zinc upon 
environmental perturbations is a logical hypothesis. Metal quantitation using the PAR assay (Chapter 2) 
indicates that mutants may have reduced zinc incorporation compared to copper. Interestingly, G93A 
which shows even greater disorder in the zinc binding site compared to pWT (based on NMR temperature 
dependence studies), also displays significantly reduced zinc incorporation (by ~11%) as measured by 
PAR. 
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 The metal-binding mutant G85R is an interesting variant as the comparative analysis of the 
correlation between metallation and global stability suggests that the typical stability conferred to SOD1 
by metal binding is lost in this mutant (see section 2.3.1.6). NMR temperature dependence studies were 
attempted to investigate the local stability of this mutant, however, the HSQC at 25°C revealed 
incomplete metallation and extensive peak overlap prevented any further analysis. A valuable study 
would be to test if the extent of disorder observed in the zinc binding site of SOD1 mutants from NMR 
temperature dependence studies correlates with the amount of zinc lost from the protein under native 
conditions (see section 2.3.1.7 for proposed experiment). Additional mutants would need to be analyzed 
to improve the reliability of any such correlation; however, the results may provide knowledge on 
whether the increased disorder observed at the zinc binding site at high temperature is representative of 
the rapid structural fluctuations occurring in the conformational ensemble present in solution under native 
conditions.   
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Appendix 1 – Residues specific variable temperature NMR data for holo SOD1s 
 
Table A1.1 - N
1
H and 
15
N temperature coefficients of holo SOD1s. The N
1
H of residues that participate in a 
hydrogen bond are marked with a ‘y’ and those that do not with an ‘n’ (based on crystal structure data, PDB 1SOS).  
UA represents unassigned residues. OL represents residues with overlapping cross peaks. D represents residues that 
disappear at increased temperature. PRO represents proline residues which have no amide proton.  
Residue # Structure 
H-
bond 
N1H Temperature Coefficient 
(ppb/K) 
15N Temperature Coefficient 
(ppb/K) 
pWT G93A E100G V148I pWT G93A E100G V148I 
ALA 1 N n UA UA UA UA UA UA UA UA 
THR 2 N n UA UA -8.93 UA UA UA -14.31 UA 
LYS 3 B1 n -6.51 -6.69 OL -6.52 -5.63 -2.7 OL 1.16 
ALA 4 B1 y OL -2.83 D OL OL 10.81 D OL 
VAL 5 B1 y -5.65 -5.61 -5.57 -5.36 -14.24 -13.76 -13.09 -12.42 
ALA 6 B1 y -4.2 -4.21 -3.78 D 9.04 3.83 9.77 D 
VAL 7 B1 n OL -6.71 OL OL OL 4.86 OL OL 
LEU 8 B1 y -5.26 -5.23 -5.05 -5.09 3.84 4 6.58 6.19 
LYS 9 loop I y OL OL OL -5.49 OL OL OL 1.38 
GLY 10 loop I n -5.9 D D D 9.79 D D D 
ASP 11 loop I n UA UA UA UA UA UA UA UA 
GLY 12 loop I n D D D D D D D D 
PRO 13 loop I n PRO PRO PRO PRO PRO PRO PRO PRO 
VAL 14 B2 n -7.11 -6.32 -6.89 -6.71 -10.69 -6.81 -8.53 -7.83 
GLN 15 B2 y -3.31 -3.4 OL -2.85 3.94 4.65 OL 8.23 
GLY 16 B2 y OL -3.01 OL OL OL 10.78 OL OL 
ILE 17 B2 y -3.31 -3.52 -3.21 -3.37 3.64 3.16 4.81 6.69 
ILE 18 B2 y D -4.64 -5.44 OL D 4.01 -9.33 OL 
ASN 19 B2 y OL D OL -3.49 OL D OL 11.1 
PHE 20 B2 y -2.81 -2.49 -2.64 -2.04 14.69 13.59 15.24 15.74 
GLU 21 B2 y -4.5 -4.55 -4.69 -4.36 2.06 2.79 2.38 3.22 
GLN 22 B2 y -6.63 -6.64 -6.56 -6.11 -10.49 -9.48 -9.15 -6.7 
LYS 23 loop II n UA UA UA UA UA UA UA UA 
GLU 24 loop II n -3.32 D D OL 18.99 D D OL 
SER 25 loop II n UA UA UA UA UA UA UA UA 
ASN 26 loop II n D D D D D D D D 
GLY 27 loop II y -6.21 -6.25 -5.7 -5.91 -1.31 -0.28 -3.27 -2.46 
PRO 28 loop II n PRO PRO PRO PRO PRO PRO PRO PRO 
VAL 29 B3 y -6.93 -6.97 -7.15 -6.76 -2.46 -2.13 1.25 -1.06 
LYS 30 B3 y -4.96 -4.87 OL -4.47 3.55 2.87 OL 5.53 
VAL 31 B3 y -3.95 -3.87 -4.9 -3.63 9.57 12.06 7.51 13.56 
TRP 32 B3 y OL OL OL OL OL OL OL OL 
GLY 33 B3 y -5 -4.06 -3.87 -3.86 3.52 5.13 3.17 2.81 
SER 34 B3 n -3.34 -3.22 -3.09 -2.68 -0.03 0.17 0.21 0.74 
ILE 35 B3 y -3.33 -3.73 -3.17 -2.98 -4.77 -5.34 -2.06 0.48 
LYS 36 B3 y OL OL OL OL OL OL OL OL 
GLY 37 loop III n -5.21 OL -4.65 -5.06 17.31 OL 16.14 14.76 
LEU 38 loop III y -4.45 -6.93 -5.52 -5.31 -15.54 -16.51 -12.61 -13.64 
THR 39 loop III n OL -12.73 OL OL OL 0.26 OL OL 
GLU 40 loop III n D D -5.48 D D D 4.09 D 
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GLY 41 B4 y -6.14 -6.08 -5.99 -5.81 -15.33 -16.87 -14.98 -14.57 
LEU 42 B4 n OL OL OL -8.16 OL OL OL 2.73 
HIS 43 B4 y -4.94 -5.24 -4.98 -4.65 7.42 7.11 8.21 6.69 
GLY 44 B4 y -3.87 -3.67 -3.74 -3.4 11.75 10.92 8.95 11.02 
PHE 45 B4 y -3.76 -3.79 -3.78 -3.61 6.27 5.11 7.98 8.14 
HIS 46 B4 y D -3.58 -3.05 OL D 12.8 12.59 OL 
VAL 47 B4 y -4.05 -4 -3.88 -3.48 8.34 8.38 10.63 13 
HIS 48 B4 y -6.34 D OL D 3.97 D OL D 
GLU 49 B4 y -4.05 -4.13 -4.15 -3.7 2.41 2.03 3.57 3.81 
PHE 50 loop IV y OL -5.15 OL -5.28 OL 7.82 OL 7.44 
GLY 51 loop IV n -5.29 -5.26 -5.25 -5.22 -21.47 -21.72 -20.46 -18.86 
ASP 52 loop IV y -2.57 -2.55 -2.47 -1.6 17.41 15.57 17.99 20.03 
ASN 53 loop IV n -11.04 -11.11 D OL -20 -14.53 D OL 
THR 54 loop IV y -3.33 -3.37 -3.4 -3.05 -2.35 -2.66 -0.17 11.34 
ALA 55 loop IV y D D D -6.31 D D D -8.45 
GLY 56 loop IV y OL -3.6 OL -4.41 OL 9.91 OL -0.89 
CYS 57 loop IV n UA UA UA UA UA UA UA UA 
THR 58 loop IV n UA UA UA UA UA UA UA UA 
SER 59 loop IV n -2.17 D OL -3.17 8.29 D OL 11.53 
ALA 60 loop IV y -3.97 -3.98 -3.92 -3.17 0.12 0.24 1.05 -2.27 
GLY 61 loop IV n -4.22 -4.13 -4.13 -3.98 6.31 6.16 3.98 4.46 
PRO 62 loop IV n PRO PRO PRO PRO PRO PRO PRO PRO 
HIS 63 loop IV n D D OL D D D OL D 
PHE 64 loop IV y UA UA UA UA UA UA UA UA 
ASN 65 loop IV n D D D -4.46 D D D 8.19 
PRO 66 loop IV n PRO PRO PRO PRO PRO PRO PRO PRO 
LEU 67 loop IV n -6.57 -6.56 -6.67 -6.48 -4.42 -3.6 -3.76 -3.13 
SER 68 loop IV y OL -3.38 OL -2.87 OL -7.84 OL 0.37 
ARG 69 loop IV y -5.45 -5.4 -5.35 -5.08 -2.8 -2.51 -0.63 -0.46 
LYS 70 loop IV y -7.17 -7.08 -7.1 -7.02 7.98 8.69 9.42 9.66 
HIS 71 loop IV y -4.95 -4.93 -4.85 -4.72 13.08 13.86 12.24 14.19 
GLY 72 loop IV y -4.52 -4.46 -4.32 -4.28 -4.69 -3.82 -5.41 -5.51 
GLY 73 loop IV y -5.98 -6.01 -5.82 -5.88 13.36 12.19 9.89 9.88 
PRO 74 loop IV n PRO PRO PRO PRO PRO PRO PRO PRO 
LYS 75 loop IV n D D D D D D D D 
ASP 76 loop IV y -4.69 -4.62 -4.57 -4.5 2.44 0.6 2.66 2.8 
GLU 77 loop IV n -8.1 -4.83 OL OL -10.69 6.47 OL OL 
GLU 78 loop IV n -9.13 D -5.57 -9.07 -2.41 D 0.57 -0.76 
ARG 79 loop IV n -4.07 -3.91 -3.84 -3.75 -14.65 -13.82 -13.36 -13.4 
HIS 80 loop IV n -4.23 D -4.27 -4.05 5.28 D 7.62 7.88 
VAL 81 loop IV y -3.74 -3.63 -3.66 -3.42 -0.92 -0.62 0.38 2.07 
GLY 82 loop IV y -5.31 -5.33 -5.4 -4.95 9.43 7.69 7.84 6.36 
ASP 83 B5 y -3.1 -3.2 -3.02 -2.81 8.56 8.39 8.4 10.41 
LEU 84 B5 y -2.7 -2.74 -2.55 -2.34 8.2 8.09 11.25 11.44 
GLY 85 B5 n OL -4.19 -4.05 OL OL 0.39 -5.88 OL 
ASN 86 B5 n -6.37 D -6.25 -6.17 3.07 D 4.12 4.47 
VAL 87 B5 y -4.32 -4.28 -4.14 -4.01 4.73 6.9 5.14 5.19 
THR 88 B5 n -6.85 -6.86 -6.86 -6.44 0.4 1.26 1.88 2.99 
ALA 89 B5 y -6.53 -6.64 -6.49 -6.18 1.7 -0.22 1.26 3.01 
ASP 90 loop V y -5.86 -6.21 -5.83 -5.6 -4.35 -3.73 1.33 -2.86 
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LYS 91 loop V n -6.02 D D -5.59 10.27 D D 14.38 
ASP 92 loop V n -3.88 -8.18 -3.61 -3.57 -3.52 3.39 -1.9 -1.8 
GLY 93 loop V y -4.24 -3.24 -3.64 -3.82 -5.95 -1.59 -8.65 -7.79 
VAL 94 B6 y -3.64 -5.33 -7.08 -3.32 9.18 -2.96 6.42 11.56 
ALA 95 B6 y -7.3 -6.51 -7.24 -7.31 -8.42 -8.74 -6.82 -5.63 
ASP 96 B6 n -6.2 -6.07 OL -6.15 4.15 2.61 OL 5.7 
VAL 97 B6 y -5.21 -5.45 -5.03 -4.82 -8.9 -9.48 -5.79 -4.76 
SER 98 B6 n OL -3.55 OL D OL 7.98 OL D 
ILE 99 B6 y -5.11 -5.11 -5.1 -4.72 -1.85 -2.4 -6.11 1.81 
GLU 100 B6 n -8.24 D D -7.52 -2.81 D D -4.78 
ASP 101 B6 y -5.77 -5.67 OL -5.34 -11.09 -10.44 OL -7.79 
SER 102 loop VI n D D OL D D D OL D 
VAL 103 loop VI y -2.34 -2.18 -4.37 -1.99 2.13 1.82 3.55 4.99 
ILE 104 loop VI y -4.74 -4.69 -5.06 -4.63 10.36 9.44 11.34 10 
SER 105 loop VI y OL OL OL OL OL OL OL OL 
LEU 106 loop VI y -3.67 -3.5 -3.27 -3.24 6 6.33 6.92 7.56 
SER 107 loop VI y D D D -4.63 D D D 14.47 
GLY 108 loop VI n UA UA UA UA UA UA UA UA 
ASP 109 loop VI n UA UA UA UA UA UA UA UA 
HIS 110 loop VI n D D OL OL D D OL OL 
SER 111 loop VI y -3.7 -3.66 -3.58 D 11.05 9.37 8.52 D 
ILE 112 loop VI y -5.39 -5.37 -5.56 -5.26 -4.64 -5.3 -4.89 -4.97 
ILE 113 loop VI y -5.15 -4.62 -4.57 D -0.15 1.28 2.39 D 
GLY 114 loop VI y -6.24 -6.36 -6.35 -6.34 2.47 2.33 1.08 2.9 
ARG 115 B7 n -4.06 -4.1 -4.07 -4.04 1.74 0.8 0.99 1.5 
THR 116 B7 y -3.74 -3.65 -3.61 -3.29 9.02 9.61 8.73 10.13 
LEU 117 B7 y -4.08 -4.16 -3.98 -4.05 0.64 0.62 1.29 3.02 
VAL 118 B7 y OL OL OL -3.21 OL OL OL 8.24 
VAL 119 B7 y -3.36 -3.51 -3.27 -2.92 11.3 10.24 13.27 13.7 
HIS 120 B7 y -3.56 OL -3.35 OL 5.52 OL 7.28 OL 
GLU 121 loop VII y -5.78 -5.84 -5.76 -5.57 0.25 -0.32 1.02 2.46 
LYS 122 loop VII y -5.38 -5.26 -5.38 -5.3 4.86 6.03 5.26 4.87 
ALA 123 loop VII n -7.95 -7.93 -7.7 -7.96 3.05 2.44 6.26 4.98 
ASP 124 loop VII y -7.16 -7.07 -7.06 -6.84 4.53 5.09 6.89 7.17 
ASP 125 loop VII y -5.66 -5.55 -5.64 -5.21 -0.45 0.68 2.32 3.66 
LEU 126 loop VII y -4.81 -4.69 -4.63 -4.53 -1.27 -1.65 -1.25 -0.27 
GLY 127 loop VII y -1.63 -1.62 -1.45 -1.24 18.28 16.91 15.62 15.62 
LYS 128 loop VII y -2.43 -2.44 -2.33 -2.1 2.43 2.06 2.25 3.41 
GLY 129 loop VII y -7.44 -7.14 -6.62 -8.17 5.79 4.74 5.63 -5.56 
GLY 130 loop VII n UA D UA UA UA D UA UA 
ASN 131 loop VII n D D D D D D D D 
GLU 132 loop VII n OL D OL OL OL D OL OL 
GLU 133 loop VII n OL OL OL OL OL OL OL OL 
SER 134 loop VII y -7.11 D D D 11.6 D D D 
THR 135 loop VII n D D -3.28 D D D 6.05 D 
LYS 136 loop VII y D -3.47 -2.82 -3 D 4.72 7.73 1.99 
THR 137 loop VII y -3.97 D D -3.6 12.34 D D 9.65 
GLY 138 loop VII y OL -3.49 OL -3.56 OL 13.59 OL 8.19 
ASN 139 loop VII y -1.16 -1.19 -1.04 -0.75 28.18 26.88 25.46 26.23 
ALA 140 loop VII n -2.78 -2.72 D -2.54 7.49 8.16 D 8.64 
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GLY 141 loop VII n D D -5.93 -6.4 D D -6.61 -1.42 
SER 142 loop VII n D D D D D D D D 
ARG 143 B8 n UA UA UA UA UA UA UA UA 
LEU 144 B8 y -4.49 -4.41 -4.38 -4.08 8.92 10.78 9.34 11.86 
ALA 145 B8 n -3.6 -3.58 -3.43 -3.36 1.79 3.02 1.84 1.88 
CYS 146 B8 y D -5.96 -6 -5.8 D 12.36 8.9 12.83 
GLY 147 B8 y -3.08 -3.19 -2.22 -3.56 7.36 6.17 5.29 2.4 
VAL 148 B8 n -6.19 -6.4 OL OL 4.3 3.07 OL OL 
ILE 149 B8 y -4.68 -4.66 -4.72 -4.28 6.26 4.4 6.84 9.39 
GLY 150 B8 y -5.03 -5.73 -5.92 -4.99 -0.74 -2.59 -0.99 -0.03 
ILE 151 B8 n -6.62 -6.57 -6.58 OL 4.64 4.36 5.93 OL 
ALA 152 C y -2.98 -2.96 -2.94 -2.41 6.66 8.27 8.82 11.97 
GLN 153 C n D -8.05 OL -7.54 D -9.54 OL -4.69 
 
Table A1.2 - Amide exchange rates for holo SOD1s at 25°C, pH 7.8. Values taken from Rumfeldt, 2006 (JR thesis). 
Residues that were not assigned, exchanged in the dead time, too fast to measure, had a measureable exchange rate, 
and were too slow to measure are represented by NA, DT, too fast, measureable and too slow, respectively.   
amino acid 
pWT G93A E100G 
Category kex (min
-1) Category kex (min
-1) Category kex (min
-1) 
ALA 1 NA 
 
  NA 
 
  NA 
 
  
THR 2 NA 
 
  NA 
 
  DT ≥ 1.00E-01 
LYS 3 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ALA 4 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
VAL 5 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
ALA 6 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
VAL 7 measureable  6.25E-03 measurable = 9.38E-04 measurable = 1.67E-03 
LEU 8 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
LYS 9 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLY 10 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ASP 11 NA 
 
  NA 
 
  DT ≥ 1.00E-01 
GLY 12 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
PRO 13 proline 
 
  proline 
 
  proline 
 
  
VAL 14 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLN 15 measureable  5.75E-03 measurable = 1.13E-03 measurable = 4.61E-03 
GLY 16 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ILE 17 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ILE 18 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
ASN 19 too slow ≤ 6.00E-06 too slow ≥ 6.00E-06 too slow ≤ 6.00E-06 
PHE 20 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
GLU 21 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
GLN 22 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
LYS 23 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLU 24 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
SER 25 NA 
 
  NA 
 
  NA 
 
  
ASN 26 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLY 27 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
PRO 28 proline 
 
  proline 
 
  proline 
 
  
VAL 29 measureable  7.96E-05 too slow ≤ 6.00E-06 measurable = 1.23E-03 
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LYS 30 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
VAL 31 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
TRP 32 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
GLY 33 measureable  4.93E-03 measurable = 6.91E-04 measurable = 3.11E-03 
SER 34 measureable  1.23E-02 measurable = 1.21E-02 measurable = 1.30E-02 
ILE 35 measureable  3.11E-05 measurable = 4.46E-05 too slow ≤ 6.00E-06 
LYS 36 measureable  4.17E-05 measurable = 2.29E-04 measurable = 1.94E-05 
GLY 37 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
LEU 38 measureable  1.85E-04 measurable = 7.31E-04 measurable = 1.14E-04 
THR 39 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLU 40 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLY 41 measureable  3.28E-02 too fast ≈ 5.00E-02 too fast ≈ 5.00E-02 
LEU 42 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
HIS 43 too slow ≤ 6.00E-06 measurable = 2.09E-05 too slow ≤ 6.00E-06 
GLY 44 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
PHE 45 too slow ≤ 6.00E-06 measurable = 1.21E-05 too slow ≤ 6.00E-06 
HIS 46 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
VAL 47 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
HIS 48 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
GLU 49 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
PHE 50 measureable  6.81E-04 measurable = 1.56E-04 measurable = 2.88E-04 
GLY 51 measureable  2.38E-03 measurable = 2.77E-03 measurable = 1.76E-03 
ASP 52 measureable  2.52E-03 measurable = 1.26E-03 measurable = 1.62E-03 
ASN 53 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
THR 54 DT ≥ 5.00E-01 too fast ≈ 5.00E-02 DT ≥ 1.00E-01 
ALA 55 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLY 56 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
CYS 57 NA 
 
  NA 
 
  NA 
 
  
THR 58 NA 
 
  NA 
 
  NA 
 
  
SER 59 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ALA 60 too fast ≈ 5.00E-02 too fast ≈ 5.00E-02 too fast ≈ 5.00E-02 
GLY 61 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
PRO 62 proline 
 
  proline 
 
  proline 
 
  
HIS 63 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
PHE 64 NA 
 
  NA 
 
  NA 
 
  
ASN 65 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
PRO 66 proline 
 
  proline 
 
  proline 
 
  
LEU 67 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
SER 68 DT ≥ 5.00E-01 DT ≥ 1.00E-01 too fast ≈ 5.00E-02 
ARG 69 measureable  2.72E-02 measurable = 6.63E-03 too fast ≈ 5.00E-02 
LYS 70 DT ≥ 5.00E-01 too fast ≈ 5.00E-02 DT ≥ 1.00E-01 
HIS 71 measureable  2.14E-04 measurable = 1.14E-04 measurable = 1.68E-04 
GLY 72 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
GLY 73 measureable  2.49E-04 measurable = 4.26E-05 measurable = 3.50E-04 
PRO 74 proline 
 
  proline 
 
  proline 
 
  
LYS 75 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ASP 76 too fast ≈ 5.00E-02 too fast ≈ 5.00E-02 DT ≥ 1.00E-01 
GLU 77 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLU 78 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ARG 79 too fast ≈ 5.00E-02 measurable = 1.45E-02 measurable = 3.06E-02 
 143 
 
HIS 80 too slow ≤ 6.00E-06 measurable = 1.48E-05 too slow ≤ 6.00E-06 
VAL 81 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLY 82 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
ASP 83 too slow ≤ 6.00E-06 measurable = 1.59E-05 too slow ≤ 6.00E-06 
LEU 84 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
GLY 85 too slow ≤ 6.00E-06 measurable = 1.64E-05 too slow ≤ 6.00E-06 
ASN 86 DT ≥ 5.00E-01 too fast ≈ 5.00E-02 DT ≥ 1.00E-01 
VAL 87 too slow ≤ 6.00E-06 measurable = 2.73E-05 too slow ≤ 6.00E-06 
THR 88 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ALA 89 measureable  4.16E-04 measurable = 2.48E-04 measurable = 2.38E-04 
ASP 90 too fast ≈ 5.00E-02 DT ≥ 1.00E-01 too fast ≈ 5.00E-02 
LYS 91 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ASP 92 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLY 93 measureable  2.29E-02 DT ≥ 1.00E-01 measurable = 1.52E-02 
VAL 94 measureable  9.85E-03 DT ≥ 1.00E-01 measurable = 6.63E-03 
ALA 95 measureable  2.29E-03 measurable = 4.77E-03 measurable = 1.55E-03 
ASP 96 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
VAL 97 measureable  5.51E-04 measurable = 1.09E-04 measurable = 4.13E-04 
SER 98 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ILE 99 measureable  2.21E-03 measurable = 1.94E-04 measurable = 8.08E-03 
GLU 100 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ASP 101 measureable  9.47E-03 measurable = 2.19E-03 NA 
 
  
SER 102 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
VAL 103 measureable  8.32E-03 measurable = 9.12E-03 measurable = 4.93E-03 
ILE 104 measureable  1.40E-05 measurable = 1.17E-05 measurable = 2.63E-04 
SER 105 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
LEU 106 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
SER 107 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLY 108 NA 
 
  NA 
 
  NA 
 
  
ASP 109 NA 
 
  NA 
 
  DT ≥ 1.00E-01 
HIS 110 NA 
 
  DT ≥ 1.00E-01 DT ≥ 1.00E-01 
SER 111 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ILE 112 measureable  6.41E-05 too slow ≤ 6.00E-06 measurable = 4.76E-05 
ILE 113 measureable  1.07E-04 measurable = 2.47E-05 measurable = 5.26E-05 
GLY 114 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
ARG 115 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
THR 116 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
LEU 117 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
VAL 118 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
VAL 119 too slow ≤ 6.00E-06 measurable = 1.65E-05 too slow ≤ 6.00E-06 
HIS 120 NA 
 
  NA 
 
  too slow ≤ 6.00E-06 
GLU 121 measureable  2.49E-03 measurable = 3.69E-04 measurable = 1.28E-03 
LYS 122 measureable  4.98E-04 measurable = 8.44E-05 measurable = 3.23E-04 
ALA 123 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ASP 124 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
ASP 125 measureable  5.15E-04 measurable = 1.64E-04 measurable = 5.13E-04 
LEU 126 measureable  1.38E-04 measurable = 2.39E-05 measurable = 6.23E-05 
GLY 127 measureable  5.90E-04 measurable = 8.13E-05 measurable = 3.90E-04 
LYS 128 too fast ≈ 5.00E-02 measurable = 1.10E-02 too fast ≈ 5.00E-02 
GLY 129 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
 144 
 
GLY 130 NA 
 
  DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ASN 131 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLU 132 NA 
 
  NA 
 
  NA 
 
  
GLU 133 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
SER 134 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
THR 135 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
LYS 136 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
THR 137 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLY 138 measureable  2.99E-02 measurable = 5.21E-03 measurable = 1.80E-02 
ASN 139 too fast ≈ 5.00E-02 measurable = 1.35E-02 measurable = 3.43E-02 
ALA 140 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
GLY 141 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
SER 142 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ARG 143 NA 
 
  NA 
 
  NA 
 
  
LEU 144 measureable  1.89E-04 measurable = 4.23E-05 measurable = 5.28E-05 
ALA 145 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
CYS 146 too fast ≈ 5.00E-02 too fast ≈ 5.00E-02 too fast ≈ 5.00E-02 
GLY 147 too slow ≤ 6.00E-06 measurable = 1.70E-05 too slow ≤ 6.00E-06 
VAL 148 DT ≥ 5.00E-01 DT ≥ 1.00E-01 DT ≥ 1.00E-01 
ILE 149 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
GLY 150 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 too slow ≤ 6.00E-06 
ILE 151 measureable  1.24E-03 measurable = 4.68E-04 measurable = 7.76E-04 
ALA 152 measureable  1.98E-03 measurable = 8.95E-04 measurable = 1.17E-03 
GLN 153 measureable  1.56E-02 measurable = 9.15E-03 measurable = 7.92E-03 
 
Table A1.3 -  pWT residual curvature. The quadratic coefficient (a) obtained by fitting residual data to the quadratic 
equation and associated R
2
 value is given. Only residues for which crosspeaks were observed at all temperature are 
included.  
 
24°C 36.5°C 49.5°C 61.5°C 72.5°C 84°C 
  
Res R1 R2 R3 R4 R5 R6 a R2 
1 
        
2 
        
3 0.0068 -0.0098 0.0025 -0.0002 -0.0022 0.0029 
-6.53E-
06 0.9970 
4 
        
5 0.0089 -0.0031 -0.0055 -0.0091 0.0004 0.0083 
-1.83E-
05 0.9998 
6 0.0056 -0.0013 -0.0019 -0.0100 0.0015 0.0061 
-1.30E-
05 0.9996 
7 
        
8 0.0101 -0.0041 -0.0065 -0.0094 0.0023 0.0077 
-1.92E-
05 0.9996 
9 
        
10 0.0135 -0.0066 -0.0084 -0.0080 -0.0023 0.0118 
-2.50E-
05 0.9996 
11 
        
12        
 
13 
        
 145 
 
14 -0.0063 -0.0005 0.0080 0.0040 0.0034 -0.0085 1.55E-05 0.9994 
15 -0.0006 0.0046 -0.0015 -0.0059 0.0003 0.0031 
-4.39E-
06 0.9996 
16 
        
17 0.0001 -0.0026 0.0034 -0.0021 0.0042 -0.0030 2.57E-06 0.9997 
18 
        
19 
        
20 0.0008 -0.0027 0.0046 -0.0038 0.0008 0.0004 
-4.60E-
07 0.9997 
21 0.0062 -0.0033 -0.0048 -0.0025 0.0006 0.0038 
-1.04E-
05 0.9999 
22 0.0144 -0.0049 -0.0081 -0.0184 0.0052 0.0118 
-2.94E-
05 0.9968 
23 
        
24 0.0037 -0.0042 -0.0004 0.0000 -0.0009 0.0018 
-4.34E-
06 0.9998 
25 
        
26 
        
27 0.0075 -0.0015 -0.0073 -0.0076 0.0037 0.0052 
-1.51E-
05 0.9993 
28 
        
29 0.0042 -0.0029 -0.0011 -0.0010 -0.0047 0.0055 
-7.93E-
06 0.9991 
30 0.0081 -0.0033 -0.0058 -0.0090 0.0060 0.0039 
-1.46E-
05 0.9991 
31 0.0119 -0.0018 -0.0132 -0.0083 0.0009 0.0104 
-2.48E-
05 0.9998 
32 
        
33 0.0165 0.0006 -0.0114 -0.0281 0.0005 0.0219 
-4.29E-
05 0.9970 
34 0.0035 -0.0027 -0.0001 -0.0070 0.0069 -0.0006 
-4.83E-
06 0.9993 
35 0.0065 -0.0044 -0.0007 -0.0074 0.0006 0.0053 
-1.18E-
05 0.9997 
36 
        
37 0.0093 -0.0042 -0.0060 -0.0062 -0.0009 0.0081 
-1.75E-
05 0.9999 
38 -0.0050 -0.0040 0.0071 0.0200 -0.0174 -0.0006 1.43E-05 0.9936 
39 
        
40 
        
41 0.0089 -0.0042 -0.0050 -0.0084 0.0027 0.0061 
-1.62E-
05 0.9994 
42 
        
43 0.0051 0.0000 -0.0024 -0.0104 0.0008 0.0069 
-1.35E-
05 0.9994 
44 0.0032 -0.0015 -0.0028 -0.0019 0.0012 0.0017 
-5.45E-
06 1.0000 
45 0.0062 -0.0042 -0.0041 -0.0020 0.0012 0.0029 
-9.23E-
06 0.9998 
46 
        
47 0.0045 -0.0026 -0.0023 -0.0036 0.0014 0.0027 
-7.59E-
06 0.9999 
48 0.0032 -0.0045 0.0010 -0.0008 0.0000 0.0010 
-3.11E-
06 0.9995 
 146 
 
49 0.0045 -0.0015 -0.0021 -0.0035 -0.0044 0.0069 
-1.05E-
05 0.9998 
50 
        
51 0.0075 -0.0040 -0.0029 -0.0061 -0.0018 0.0073 
-1.44E-
05 0.9998 
52 -0.0006 -0.0011 0.0014 0.0048 -0.0059 0.0014 1.70E-06 0.9996 
53 0.0033 -0.0011 -0.0017 0.0031 -0.0138 0.0102 
-9.34E-
06 0.6033 
54 0.0036 -0.0024 -0.0007 -0.0024 -0.0024 0.0042 
-6.95E-
06 0.9999 
55 
        
56 
        
57 
        
58 
        
59 -0.0404 0.0661 0.0040 -0.0307 -0.0140 0.0151 1.17E-05 0.9618 
60 0.0036 -0.0044 -0.0001 -0.0024 0.0045 -0.0012 
-2.84E-
06 0.9995 
61 0.0044 -0.0028 -0.0007 -0.0042 -0.0010 0.0043 
-8.27E-
06 0.9999 
62 
        
63 
        
64 
        
65 
        
66 
        
67 0.0108 -0.0038 -0.0083 -0.0069 -0.0026 0.0107 
-2.17E-
05 0.9999 
68 
        
69 0.0042 -0.0022 -0.0011 -0.0052 0.0005 0.0038 
-8.26E-
06 0.9998 
70 0.0144 -0.0057 -0.0110 -0.0098 0.0009 0.0113 
-2.70E-
05 0.9994 
71 -0.0018 0.0040 0.0017 -0.0034 -0.0052 0.0048 
-2.56E-
06 0.9990 
72 0.0009 -0.0040 -0.0009 0.0111 -0.0070 -0.0001 3.02E-06 0.9981 
73 0.0086 -0.0025 -0.0053 -0.0078 -0.0030 0.0101 
-1.88E-
05 0.9998 
74 
        
75 
        
76 0.0057 -0.0012 -0.0032 -0.0081 0.0009 0.0060 
-1.28E-
05 0.9998 
77 0.0020 -0.0046 0.0011 -0.0028 0.0107 -0.0064 2.44E-06 0.9891 
78 0.0076 -0.0009 -0.0096 -0.0048 0.0024 0.0053 
-1.52E-
05 0.9953 
79 0.0070 -0.0002 -0.0072 -0.0078 0.0010 0.0071 
-1.61E-
05 0.9999 
80 0.0070 -0.0053 -0.0014 -0.0039 -0.0028 0.0064 
-1.19E-
05 0.9997 
81 0.0024 0.0003 -0.0034 -0.0010 -0.0016 0.0033 
-5.93E-
06 1.0000 
82 0.0020 0.0003 0.0012 -0.0062 -0.0031 0.0058 
-7.45E-
06 0.9994 
83 0.0026 -0.0025 0.0003 -0.0026 0.0009 0.0013 
-3.77E-
06 0.9999 
84 0.0044 -0.0027 -0.0018 -0.0039 0.0010 0.0029 -7.62E- 0.9999 
 147 
 
06 
85 
        
86 0.0034 -0.0015 -0.0023 -0.0035 0.0021 0.0018 
-6.11E-
06 0.9998 
87 0.0035 -0.0018 0.0001 -0.0044 -0.0023 0.0050 
-7.85E-
06 0.9998 
88 0.0080 -0.0030 -0.0052 -0.0081 0.0021 0.0062 
-1.56E-
05 0.9994 
89 0.0116 -0.0023 -0.0122 -0.0072 -0.0004 0.0105 
-2.38E-
05 0.9997 
90 0.0031 0.0015 0.0004 -0.0106 -0.0024 0.0082 
-1.18E-
05 0.9985 
91 -0.0078 0.0066 0.0064 -0.0066 0.0068 -0.0055 1.01E-05 0.9966 
92 0.0035 -0.0014 -0.0018 -0.0051 0.0028 0.0021 
-6.78E-
06 0.9998 
93 0.0128 -0.0016 -0.0088 -0.0125 -0.0095 0.0196 
-3.18E-
05 0.9991 
94 0.0061 -0.0038 0.0018 -0.0107 -0.0002 0.0069 
-1.28E-
05 0.9993 
95 0.0092 -0.0014 -0.0083 -0.0087 -0.0004 0.0096 
-2.04E-
05 0.9999 
96 0.0038 -0.0010 -0.0036 -0.0026 -0.0002 0.0035 
-7.80E-
06 1.0000 
97 0.0096 -0.0039 -0.0067 -0.0089 0.0034 0.0064 
-1.78E-
05 0.9995 
98 
        
99 0.0070 -0.0032 -0.0027 -0.0087 0.0017 0.0059 
-1.38E-
05 0.9996 
100 -0.0032 -0.0036 0.0062 0.0056 0.0025 -0.0074 1.21E-05 0.9974 
101 0.0099 -0.0026 -0.0077 -0.0117 0.0053 0.0069 
-1.98E-
05 0.9988 
102 
        
103 0.0089 -0.0047 -0.0041 -0.0089 0.0029 0.0060 
-1.60E-
05 0.9997 
104 0.0045 -0.0012 -0.0009 -0.0065 -0.0031 0.0072 
-1.13E-
05 0.9997 
105 
        
106 0.0082 -0.0061 -0.0009 -0.0117 0.0085 0.0022 
-1.25E-
05 0.9984 
107 
        
108 
        
109 
        
110 
        
111 0.0034 -0.0022 -0.0013 -0.0034 0.0015 0.0019 
-5.76E-
06 0.9999 
112 0.0084 -0.0053 -0.0034 -0.0058 -0.0005 0.0065 
-1.46E-
05 0.9997 
113 0.0163 -0.0014 -0.0093 -0.0158 -0.0208 0.0309 
-4.40E-
05 0.9937 
114 0.0039 -0.0024 -0.0005 -0.0011 -0.0071 0.0071 
-8.71E-
06 0.9987 
115 0.0068 -0.0033 -0.0031 -0.0035 -0.0056 0.0087 
-1.39E-
05 0.9997 
116 -0.0001 -0.0023 0.0021 0.0025 -0.0011 -0.0011 2.61E-06 0.9999 
117 -0.0006 -0.0010 0.0029 0.0012 -0.0032 0.0008 1.43E-06 0.9998 
118 
        
 148 
 
119 0.0036 -0.0017 -0.0024 -0.0034 0.0023 0.0016 
-6.11E-
06 0.9999 
120 0.0041 -0.0038 -0.0010 -0.0014 0.0000 0.0021 
-5.58E-
06 0.9999 
121 0.0046 -0.0011 -0.0013 -0.0065 -0.0025 0.0069 
-1.13E-
05 0.9997 
122 0.0034 -0.0023 -0.0023 0.0004 -0.0022 0.0029 
-5.41E-
06 0.9998 
123 0.0058 -0.0059 -0.0052 0.0018 0.0060 -0.0025 
-4.20E-
06 0.9934 
124 0.0033 -0.0005 -0.0016 -0.0052 -0.0003 0.0043 
-8.12E-
06 0.9997 
125 0.0065 -0.0016 -0.0043 -0.0080 0.0013 0.0061 
-1.40E-
05 0.9997 
126 0.0027 0.0013 -0.0042 -0.0056 0.0041 0.0017 
-7.04E-
06 0.9995 
127 0.0009 -0.0048 0.0060 -0.0032 0.0035 -0.0023 2.11E-06 0.9996 
128 0.0052 -0.0065 0.0020 -0.0049 0.0030 0.0011 
-5.84E-
06 0.9995 
129 -0.0003 -0.0087 -0.0005 0.0095 0.0203 -0.0203 1.79E-05 0.9730 
130 
        
131 
        
132 
        
133 
        
134 -0.0060 -0.0002 0.0073 0.0063 -0.0023 -0.0051 1.34E-05 0.9993 
135 
        
136 
        
137 0.0029 -0.0011 0.0003 -0.0041 -0.0031 0.0052 
-7.25E-
06 0.9998 
138 
        
139 0.0010 0.0001 -0.0001 -0.0027 0.0001 0.0016 
-2.93E-
06 1.0000 
140 0.0037 -0.0034 0.0005 -0.0026 -0.0016 0.0034 
-6.08E-
06 0.9999 
141 
        
142 
        
143 
        
144 0.0035 -0.0011 -0.0005 -0.0062 0.0000 0.0043 
-8.14E-
06 0.9998 
145 0.0037 -0.0027 -0.0005 -0.0034 -0.0004 0.0032 
-6.54E-
06 0.9999 
146 
        
147 0.0013 0.0015 -0.0025 -0.0021 -0.0014 0.0032 
-5.03E-
06 0.9999 
148 0.0183 -0.0135 -0.0119 -0.0039 0.0036 0.0074 
-2.56E-
05 0.9955 
149 0.0111 -0.0038 -0.0087 -0.0086 0.0004 0.0095 
-2.19E-
05 0.9999 
150 -0.0038 -0.0020 0.0076 0.0125 -0.0192 0.0049 6.90E-06 0.9928 
151 0.0046 -0.0006 -0.0037 -0.0049 -0.0011 0.0056 
-1.08E-
05 0.9999 
152 0.0042 -0.0015 -0.0033 -0.0018 -0.0021 0.0045 
-8.44E-
06 1.0000 
153 
         
 149 
 
Table A1.4 - G93A residual curvature. The quadratic coefficient (a) obtained by fitting residual data to the quadratic 
equation and associated R
2
 value is given. Only residues for which crosspeaks were observed at all temperature are 
included. 
 
24°C 36.5°C 49.5°C 61.5°C 72.5°C 84°C 
  
Res R1 R2 R3 R4 R5 R6 a R2 
1 
        
2 
        
3 0.0054 -0.0076 0.0015 -0.0025 0.0036 -0.0004 -4.26E-06 0.9977 
4 0.0067 -0.0010 -0.0048 -0.0084 0.0001 0.0075 -1.54E-05 0.9999 
5 0.0063 -0.0042 -0.0021 -0.0041 -0.0012 0.0053 -1.09E-05 0.9998 
6 0.0158 -0.0082 -0.0090 -0.0112 0.0000 0.0125 -2.88E-05 0.9996 
7 0.0010 -0.0003 0.0014 -0.0048 0.0009 0.0017 -3.14E-06 0.9994 
8 0.0075 -0.0033 -0.0054 -0.0049 0.0001 0.0059 -1.39E-05 0.9999 
9 
        
10 
        
11 
        
12 
        
13 
        
14 -0.0083 0.0033 0.0071 0.0035 0.0016 -0.0072 1.56E-05 0.9998 
15 0.0069 -0.0029 -0.0042 -0.0057 -0.0005 0.0063 -1.36E-05 1.0000 
16 0.0023 -0.0017 -0.0008 -0.0017 0.0008 0.0011 -3.53E-06 1.0000 
17 0.0028 -0.0005 0.0038 -0.0081 -0.0082 0.0103 -1.09E-05 0.9987 
18 0.0039 -0.0035 -0.0009 -0.0024 0.0011 0.0017 -5.46E-06 0.9998 
19 
        
20 0.0097 -0.0089 -0.0033 -0.0030 0.0022 0.0034 -1.24E-05 0.9995 
21 0.0025 -0.0037 0.0021 -0.0002 -0.0037 0.0030 -3.33E-06 0.9996 
22 0.0115 -0.0059 -0.0053 -0.0107 0.0009 0.0094 -2.15E-05 0.9990 
23 
        
24 
        
25 
        
26 
        
27 0.0045 -0.0029 -0.0001 -0.0048 -0.0019 0.0052 -9.01E-06 0.9996 
28 
        
29 0.0043 -0.0002 -0.0039 -0.0043 -0.0013 0.0054 -1.02E-05 0.9999 
30 0.0061 -0.0022 -0.0036 -0.0067 0.0013 0.0052 -1.22E-05 0.9998 
31 0.0085 -0.0023 -0.0047 -0.0099 -0.0009 0.0095 -1.87E-05 0.9998 
32 
        
33 -0.0008 0.0000 0.0012 -0.0022 0.0047 -0.0030 2.48E-06 0.9997 
34 0.0019 -0.0007 0.0004 -0.0050 0.0012 0.0021 -4.62E-06 0.9999 
35 0.0049 -0.0020 -0.0025 -0.0059 0.0017 0.0038 -9.62E-06 0.9999 
36 
        
37 
        
 150 
 
38 -0.0018 0.0061 -0.0021 -0.0070 0.0043 0.0005 -2.21E-06 0.9969 
39 0.0047 -0.0029 -0.0014 -0.0050 0.0016 0.0031 -8.16E-06 0.9984 
40 
        
41 0.0050 -0.0014 -0.0045 -0.0042 0.0015 0.0036 -9.64E-06 0.9999 
42 
        
43 0.0059 -0.0059 0.0020 -0.0066 0.0004 0.0041 -9.15E-06 0.9991 
44 0.0017 -0.0006 0.0007 -0.0040 -0.0008 0.0030 -4.57E-06 0.9999 
45 0.0044 -0.0044 0.0002 -0.0021 -0.0012 0.0031 -6.28E-06 0.9998 
46 -0.0088 -0.0109 -0.0114 0.0739 -0.0198 -0.0231 4.51E-05 0.9617 
47 0.0044 -0.0040 0.0010 -0.0048 -0.0003 0.0036 -7.41E-06 0.9997 
48 
        
49 0.0052 -0.0028 -0.0014 -0.0056 -0.0004 0.0051 -1.02E-05 0.9999 
50 0.0030 -0.0008 -0.0028 -0.0023 0.0006 0.0023 -5.87E-06 1.0000 
51 0.0043 -0.0008 -0.0032 -0.0041 -0.0013 0.0051 -9.70E-06 1.0000 
52 -0.0022 0.0006 0.0024 0.0011 -0.0003 -0.0016 4.25E-06 1.0000 
53 -0.0020 0.0008 0.0003 0.0013 0.0037 -0.0041 5.07E-06 0.9642 
54 0.0040 -0.0025 0.0007 -0.0065 0.0001 0.0042 -8.19E-06 0.9998 
55 
        
56 0.0015 0.0042 0.0034 -0.0135 -0.0085 0.0131 -1.39E-05 0.9976 
57 
        
58 
        
59 
        
60 0.0013 -0.0008 0.0013 -0.0042 0.0006 0.0017 -3.23E-06 0.9999 
61 0.0047 -0.0043 -0.0009 -0.0021 0.0001 0.0026 -6.61E-06 0.9998 
62 
        
63 
        
64 
        
65 
        
66 
        
67 0.0085 -0.0029 -0.0062 -0.0056 -0.0032 0.0093 -1.77E-05 0.9999 
68 0.0133 -0.0264 0.0126 0.0013 -0.0004 -0.0003 -4.85E-06 0.9925 
69 0.0046 -0.0033 -0.0005 -0.0050 0.0012 0.0031 -7.72E-06 0.9997 
70 0.0119 -0.0049 -0.0080 -0.0097 0.0011 0.0096 -2.27E-05 0.9994 
71 0.0034 -0.0025 0.0014 -0.0065 0.0009 0.0032 -6.73E-06 0.9995 
72 0.0008 -0.0044 0.0015 0.0062 -0.0023 -0.0017 3.42E-06 0.9994 
73 0.0035 -0.0020 -0.0002 -0.0040 -0.0016 0.0043 -7.27E-06 0.9998 
74 
        
75 
        
76 0.0051 -0.0060 0.0010 -0.0022 -0.0004 0.0025 -6.15E-06 0.9995 
77 -0.0053 0.0059 0.0151 -0.0186 -0.0052 0.0082 -2.41E-06 0.9917 
78 
        
79 0.0052 -0.0031 -0.0020 -0.0037 -0.0012 0.0048 -9.55E-06 0.9999 
80 
        
 151 
 
81 0.0053 -0.0025 -0.0038 -0.0031 0.0005 0.0037 -9.30E-06 1.0000 
82 0.0049 -0.0001 -0.0044 -0.0060 0.0000 0.0057 -1.17E-05 0.9999 
83 0.0000 -0.0004 0.0000 0.0008 0.0002 -0.0006 7.55E-07 1.0000 
84 0.0011 -0.0025 0.0009 0.0013 -0.0012 0.0003 -2.47E-07 0.9999 
85 0.0107 -0.0121 -0.0016 0.0004 -0.0021 0.0046 -1.22E-05 0.9984 
86 
        
87 0.0008 -0.0021 0.0032 -0.0019 -0.0014 0.0013 -9.81E-07 0.9998 
88 0.0051 -0.0010 -0.0031 -0.0061 -0.0010 0.0061 -1.17E-05 0.9998 
89 0.0087 0.0003 -0.0069 -0.0133 0.0003 0.0109 -2.20E-05 0.9989 
90 0.0024 -0.0016 -0.0013 -0.0006 -0.0013 0.0023 -4.22E-06 0.9999 
91 
        
92 0.0058 -0.0018 -0.0051 -0.0030 -0.0014 0.0055 -1.15E-05 0.9999 
93 0.0037 -0.0032 -0.0043 0.0021 0.0030 -0.0013 -2.92E-06 0.9996 
94 0.0085 -0.0035 -0.0058 -0.0056 -0.0016 0.0080 -1.66E-05 0.9999 
95 0.0069 -0.0039 -0.0046 -0.0045 0.0025 0.0035 -1.13E-05 0.9995 
96 0.0055 -0.0018 -0.0028 -0.0055 -0.0017 0.0064 -1.19E-05 0.9999 
97 0.0079 -0.0026 -0.0044 -0.0095 0.0011 0.0074 -1.66E-05 0.9997 
98 0.0032 -0.0026 -0.0019 -0.0012 0.0022 0.0003 -3.88E-06 0.9999 
99 0.0055 -0.0017 -0.0032 -0.0052 -0.0018 0.0064 -1.19E-05 0.9999 
100 
        
101 0.0110 -0.0073 -0.0061 -0.0059 0.0023 0.0059 -1.73E-05 0.9991 
102 
        
103 0.0074 -0.0053 -0.0016 -0.0055 -0.0009 0.0060 -1.26E-05 0.9998 
104 0.0060 -0.0009 -0.0049 -0.0058 -0.0018 0.0073 -1.38E-05 1.0000 
105 
        
106 0.0071 -0.0040 -0.0035 -0.0072 0.0039 0.0036 -1.21E-05 0.9996 
107 
        
108 
        
109 
        
110 
        
111 -0.0001 0.0019 -0.0007 -0.0023 -0.0009 0.0020 -2.45E-06 0.9999 
112 0.0061 -0.0013 -0.0042 -0.0073 0.0002 0.0064 -1.36E-05 0.9999 
113 0.0065 -0.0017 -0.0028 -0.0070 -0.0043 0.0095 -1.54E-05 0.9997 
114 0.0030 -0.0019 -0.0007 -0.0028 -0.0002 0.0026 -5.42E-06 0.9999 
115 0.0067 -0.0040 -0.0034 -0.0043 0.0001 0.0049 -1.15E-05 0.9999 
116 0.0012 -0.0019 0.0006 0.0001 -0.0005 0.0005 -9.54E-07 1.0000 
117 0.0020 -0.0014 -0.0006 -0.0012 -0.0004 0.0016 -3.38E-06 1.0000 
118 
        
119 0.0041 -0.0011 -0.0038 -0.0036 0.0014 0.0030 -8.08E-06 1.0000 
120 
        
121 0.0070 -0.0023 -0.0042 -0.0070 -0.0006 0.0072 -1.47E-05 0.9999 
122 0.0040 -0.0041 0.0005 -0.0024 -0.0007 0.0027 -5.78E-06 0.9997 
123 0.0043 -0.0042 -0.0034 -0.0003 0.0060 -0.0023 -3.18E-06 0.9958 
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124 0.0062 -0.0035 -0.0025 -0.0061 0.0017 0.0043 -1.11E-05 0.9993 
125 0.0070 -0.0057 -0.0029 -0.0022 0.0004 0.0035 -9.86E-06 0.9995 
126 0.0074 -0.0036 -0.0035 -0.0075 0.0016 0.0056 -1.38E-05 0.9998 
127 0.0017 -0.0029 0.0000 0.0008 0.0016 -0.0011 -2.63E-07 0.9999 
128 -0.0003 -0.0022 0.0030 0.0010 -0.0002 -0.0013 2.76E-06 0.9999 
129 -0.0050 -0.0056 0.0045 0.0111 0.0141 -0.0191 2.31E-05 0.9892 
130 
        
131 
        
132 
        
133 
        
134 
        
135 
        
136 0.0095 -0.0052 -0.0013 -0.0096 -0.0052 0.0119 -1.98E-05 0.9994 
137 
        
138 -0.0018 -0.0217 0.0439 -0.0126 -0.0084 0.0005 1.36E-05 0.9813 
139 0.0017 -0.0015 0.0011 -0.0039 0.0017 0.0010 -2.99E-06 0.9999 
140 0.0017 -0.0027 0.0018 -0.0036 0.0041 -0.0013 -9.52E-07 0.9997 
141 
        
142 
        
143 
        
144 0.0033 -0.0022 -0.0005 -0.0061 0.0051 0.0003 -5.16E-06 0.9994 
145 0.0035 -0.0036 0.0008 -0.0029 0.0003 0.0020 -4.92E-06 0.9998 
146 0.0096 -0.0043 -0.0049 -0.0082 -0.0012 0.0091 -1.88E-05 0.9998 
147 0.0042 -0.0020 -0.0014 -0.0044 -0.0008 0.0045 -8.58E-06 1.0000 
148 0.0068 -0.0037 -0.0010 -0.0096 0.0016 0.0059 -1.32E-05 0.9989 
149 0.0089 -0.0017 -0.0083 -0.0090 0.0034 0.0068 -1.82E-05 0.9996 
150 0.0018 -0.0022 0.0022 -0.0043 0.0012 0.0012 -2.98E-06 0.9996 
151 0.0019 -0.0007 -0.0011 -0.0017 -0.0004 0.0020 -3.90E-06 1.0000 
152 0.0022 -0.0001 0.0004 -0.0038 -0.0048 0.0061 -7.30E-06 0.9997 
153 0.0037 -0.0033 0.0000 -0.0023 -0.0012 0.0031 -5.92E-06 0.9992 
 
Table A1.5 - E100G residual curvature. The quadratic coefficient (a) obtained by fitting residual data to the 
quadratic equation and associated R
2
 value is given. Only residues for which crosspeaks were observed at all 
temperature are included. 
 
24°C 36.5°C 49.5°C 61.5°C 72.5°C 84°C 
  
Res R1 R2 R3 R4 R5 R6 a R2 
1 
        
2 -0.0018 0.0042 0.0011 -0.0038 -0.0034 0.0038 -2.20E-06 0.9925 
3 
        
4 
        
5 0.0071 -0.0039 -0.0033 -0.0038 -0.0035 0.0074 -1.35E-05 0.9997 
6 0.0098 -0.0037 -0.0039 -0.0119 -0.0009 0.0106 -2.10E-05 0.9997 
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7 
        
8 0.0065 -0.0020 -0.0076 0.0010 -0.0049 0.0070 -1.26E-05 0.9993 
9 
        
10 
        
11 
        
12 
        
13 
        
14 -0.0073 -0.0018 0.0087 0.0093 0.0012 -0.0101 1.96E-05 0.9993 
15 
        
16 
        
17 -0.0029 -0.0025 0.0037 0.0064 0.0016 -0.0064 1.05E-05 0.9998 
18 -0.0048 0.0058 0.0010 0.0000 -0.0022 0.0001 4.09E-06 0.9993 
19 
        
20 -0.0022 -0.0017 0.0019 0.0065 0.0000 -0.0045 7.99E-06 0.9999 
21 0.0067 -0.0053 -0.0053 0.0007 0.0016 0.0016 -8.25E-06 0.9994 
22 0.0125 -0.0038 -0.0122 -0.0076 0.0018 0.0093 -2.39E-05 0.9993 
23 
        
24 
        
25 
        
26 
        
27 -0.0209 0.0414 -0.0158 -0.0049 -0.0051 0.0053 4.84E-06 0.9622 
28 
        
29 0.0042 -0.0015 -0.0045 0.0000 -0.0020 0.0038 -7.66E-06 0.9996 
30 
        
31 0.0100 -0.0046 -0.0083 -0.0047 0.0010 0.0066 -1.74E-05 0.9997 
32 
        
33 0.0050 -0.0037 -0.0061 0.0018 0.0038 -0.0008 -5.11E-06 0.9994 
34 0.0014 -0.0006 -0.0028 0.0035 -0.0029 0.0015 -1.98E-06 0.9998 
35 0.0041 -0.0029 -0.0030 0.0002 -0.0010 0.0025 -6.10E-06 0.9999 
36 
        
37 -0.0237 0.0518 -0.0217 -0.0102 -0.0048 0.0087 4.48E-07 0.9592 
38 0.0069 -0.0015 -0.0062 -0.0052 -0.0013 0.0072 -1.48E-05 1.0000 
39 
        
40 -0.0265 0.0206 0.0164 0.0040 -0.0037 -0.0107 3.62E-05 0.9924 
41 0.0047 -0.0026 -0.0035 -0.0010 -0.0013 0.0037 -8.02E-06 0.9999 
42 
        
43 0.0047 -0.0019 -0.0057 0.0009 -0.0013 0.0033 -7.96E-06 0.9997 
44 0.0028 -0.0033 -0.0029 0.0065 -0.0050 0.0019 -2.38E-06 0.9992 
45 0.0060 -0.0036 -0.0067 0.0032 -0.0027 0.0038 -8.84E-06 0.9995 
46 0.0059 -0.0046 -0.0063 0.0044 -0.0016 0.0022 -7.11E-06 0.9994 
47 0.0087 -0.0032 -0.0097 0.0010 -0.0051 0.0082 -1.60E-05 0.9994 
48 
        
49 0.0048 -0.0004 -0.0064 -0.0010 -0.0021 0.0051 -1.03E-05 0.9999 
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50 
        
51 0.0052 -0.0028 -0.0021 -0.0028 -0.0040 0.0065 -1.05E-05 0.9997 
52 -0.0031 -0.0024 0.0035 0.0092 -0.0024 -0.0048 1.05E-05 0.9997 
53 
        
54 0.0064 -0.0034 -0.0077 0.0018 0.0000 0.0028 -9.39E-06 0.9996 
55 
        
56 
        
57 
        
58 
        
59 
        
60 0.0022 -0.0021 -0.0021 0.0031 -0.0024 0.0014 -2.48E-06 0.9998 
61 0.0035 -0.0036 -0.0044 0.0043 0.0014 -0.0012 -2.03E-06 0.9994 
62 
        
63 
        
64 
        
65 
        
66 
        
67 0.0106 -0.0031 -0.0089 -0.0057 -0.0045 0.0117 -2.21E-05 0.9996 
68 
        
69 0.0056 -0.0028 -0.0054 -0.0004 -0.0007 0.0037 -9.18E-06 0.9998 
70 0.0131 -0.0070 -0.0074 -0.0093 0.0012 0.0095 -2.31E-05 0.9988 
71 0.0010 -0.0011 -0.0002 0.0009 -0.0019 0.0013 -1.39E-06 0.9999 
72 -0.0003 -0.0016 -0.0038 0.0117 -0.0031 -0.0028 4.98E-06 0.9985 
73 0.0052 -0.0019 -0.0047 -0.0002 -0.0047 0.0063 -1.04E-05 0.9995 
74 
        
75 
        
76 0.0050 -0.0036 -0.0021 -0.0017 -0.0014 0.0039 -8.07E-06 0.9999 
77 
        
78 -0.0306 0.0074 0.0350 0.0165 -0.0081 -0.0202 5.78E-05 0.9944 
79 0.0082 -0.0042 -0.0092 0.0019 -0.0017 0.0050 -1.29E-05 0.9994 
80 0.0061 -0.0037 -0.0043 -0.0003 -0.0027 0.0050 -1.01E-05 0.9998 
81 0.0057 -0.0034 -0.0050 0.0014 -0.0033 0.0046 -9.17E-06 0.9997 
82 -0.0011 0.0010 -0.0002 0.0013 -0.0005 -0.0006 1.71E-06 1.0000 
83 0.0030 -0.0042 -0.0015 0.0036 -0.0011 0.0001 -1.72E-06 0.9997 
84 0.0048 -0.0045 -0.0017 0.0009 -0.0036 0.0040 -6.95E-06 0.9998 
85 -0.0313 0.0516 -0.0131 -0.0025 -0.0055 0.0008 1.81E-05 0.9686 
86 0.0016 -0.0020 -0.0003 0.0010 -0.0012 0.0009 -1.58E-06 0.9998 
87 0.0024 -0.0018 -0.0027 0.0019 -0.0011 0.0012 -3.09E-06 0.9999 
88 0.0043 -0.0038 -0.0011 -0.0022 0.0009 0.0019 -5.95E-06 0.9996 
89 0.0138 -0.0047 -0.0122 -0.0078 -0.0007 0.0116 -2.66E-05 0.9997 
90 0.0034 -0.0039 -0.0028 0.0055 -0.0040 0.0018 -3.04E-06 0.9987 
91 
        
92 0.0036 -0.0048 -0.0008 0.0042 -0.0048 0.0026 -3.47E-06 0.9994 
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93 0.0040 -0.0020 -0.0034 0.0031 -0.0084 0.0067 -8.01E-06 0.9992 
94 0.0415 -0.0114 -0.0445 -0.0222 0.0075 0.0290 -7.83E-05 0.9871 
95 0.0051 -0.0027 -0.0028 -0.0024 -0.0024 0.0053 -9.72E-06 0.9997 
96 
        
97 0.0083 -0.0049 -0.0083 0.0007 0.0000 0.0041 -1.24E-05 0.9993 
98 
        
99 0.0071 -0.0020 -0.0074 -0.0023 -0.0018 0.0065 -1.38E-05 0.9998 
100 
        
101 
        
102 
        
103 0.0127 -0.0262 0.0560 -0.0661 0.0035 0.0202 -2.61E-05 0.9248 
104 0.0066 -0.0040 -0.0049 -0.0004 -0.0025 0.0052 -1.09E-05 0.9997 
105 
        
106 0.0081 -0.0041 -0.0067 -0.0026 0.0000 0.0053 -1.37E-05 0.9999 
107 
        
108 
        
109 
        
110 
        
111 0.0006 -0.0016 0.0008 0.0021 -0.0028 0.0010 -8.61E-08 0.9999 
112 0.0061 -0.0028 -0.0042 -0.0016 -0.0042 0.0068 -1.17E-05 0.9997 
113 0.0089 -0.0035 -0.0080 -0.0005 -0.0072 0.0102 -1.75E-05 0.9992 
114 0.0059 -0.0039 -0.0054 0.0017 -0.0016 0.0033 -8.49E-06 0.9992 
115 0.0067 -0.0026 -0.0075 -0.0011 0.0007 0.0038 -1.13E-05 0.9998 
116 -0.0008 -0.0014 0.0006 0.0065 -0.0047 -0.0003 3.40E-06 0.9995 
117 0.0043 -0.0048 -0.0035 0.0040 -0.0001 0.0001 -3.36E-06 0.9995 
118 
        
119 0.0035 -0.0028 -0.0053 0.0057 -0.0017 0.0006 -3.21E-06 0.9995 
120 0.0013 -0.0029 -0.0004 0.0047 -0.0025 -0.0001 5.41E-07 0.9997 
121 0.0080 -0.0024 -0.0083 -0.0032 -0.0009 0.0067 -1.54E-05 0.9998 
122 0.0038 -0.0038 -0.0008 0.0010 -0.0036 0.0035 -5.39E-06 0.9995 
123 -0.0009 -0.0036 -0.0018 0.0081 0.0089 -0.0108 1.05E-05 0.9916 
124 0.0063 -0.0034 -0.0052 -0.0037 0.0042 0.0019 -9.62E-06 0.9987 
125 0.0083 -0.0046 -0.0089 -0.0023 0.0073 0.0003 -1.10E-05 0.9979 
126 0.0062 -0.0021 -0.0063 -0.0036 0.0020 0.0037 -1.12E-05 0.9998 
127 0.0021 -0.0054 -0.0023 0.0097 -0.0007 -0.0034 3.34E-06 0.9994 
128 0.0025 -0.0020 -0.0024 0.0030 -0.0031 0.0021 -3.25E-06 0.9998 
129 -0.0126 -0.0058 0.0071 0.0320 0.0057 -0.0265 4.28E-05 0.9866 
130 
        
131 
        
132 
        
133 
        
134 
        
135 0.0122 -0.0002 -0.0058 -0.0089 -0.0283 0.0309 -3.69E-05 0.9931 
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136 -0.0018 -0.0054 0.0000 0.0115 0.0091 -0.0134 1.50E-05 0.9984 
137 
        
138 
        
139 0.0050 -0.0054 -0.0049 0.0060 -0.0009 0.0002 -3.78E-06 0.9996 
140 
        
141 -0.0208 0.0386 -0.0126 -0.0035 -0.0062 0.0045 7.07E-06 0.9643 
142 
        
143 
        
144 0.0042 -0.0009 -0.0049 -0.0002 -0.0028 0.0047 -8.63E-06 0.9998 
145 0.0046 -0.0036 -0.0042 0.0030 -0.0021 0.0024 -5.86E-06 0.9997 
146 0.0130 -0.0073 -0.0084 -0.0061 -0.0006 0.0094 -2.23E-05 0.9994 
147 -0.0350 0.0709 -0.0289 -0.0093 -0.0050 0.0074 7.77E-06 0.9617 
148 
        
149 0.0055 0.0002 -0.0082 -0.0025 0.0002 0.0049 -1.18E-05 0.9998 
150 0.0086 -0.0038 -0.0078 -0.0046 0.0028 0.0047 -1.47E-05 0.9994 
151 0.0032 -0.0025 -0.0021 0.0012 -0.0026 0.0027 -4.75E-06 0.9996 
152 0.0041 -0.0051 -0.0014 0.0046 -0.0052 0.0029 -4.16E-06 0.9994 
153 
         
 Table A1.6 - V148I residual curvature. The quadratic coefficient (a) obtained by fitting residual data to the 
quadratic equation and associated R
2
 value is given. Only residues for which crosspeaks were observed at all 
temperature are included. 
 
24.5°C 30°C 37°C 43°C 48°C 55°C 61°C 67°C 72.5°C 77.5°C 82°C 87.5°C 
  
Res R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 R11 R12 a R2 
1 
              
2 
              
3 0.0056 0.0018 
-
0.0011 
-
0.0059 
-
0.0026 
-
0.0026 
-
0.0034 
-
0.0002 0.0011 0.0114 0.0028 
-
0.0069 
-
3.98E-
06 0.9964 
4 
              
5 0.0047 0.0014 0.0016 
-
0.0003 0.0008 
-
0.0070 
-
0.0048 
-
0.0027 
-
0.0060 
-
0.0009 0.0057 0.0074 
-
1.05E-
05 0.9994 
6 
              
7 
              
8 0.0076 
-
0.0003 0.0007 
-
0.0045 
-
0.0011 
-
0.0030 
-
0.0043 
-
0.0025 
-
0.0024 0.0020 0.0038 0.0039 
-
9.25E-
06 0.9998 
9 0.0104 
-
0.0017 0.0026 
-
0.0060 
-
0.0025 
-
0.0062 
-
0.0038 
-
0.0004 
-
0.0025 0.0000 0.0051 0.0050 
-
1.16E-
05 0.9993 
10 
              
11 
              
12 
              
13 
              
14 
-
0.0107 
-
0.0035 
-
0.0027 0.0014 0.0088 0.0095 0.0066 0.0066 0.0009 
-
0.0007 
-
0.0042 
-
0.0120 
1.90E-
05 0.9994 
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15 0.0090 0.0004 0.0002 
-
0.0046 
-
0.0039 
-
0.0052 
-
0.0030 0.0012 
-
0.0023 0.0003 0.0033 0.0047 
-
1.03E-
05 0.9998 
16 
              
17 0.0053 0.0029 0.0000 
-
0.0019 0.0012 
-
0.0057 
-
0.0046 
-
0.0045 
-
0.0079 
-
0.0098 0.0288 
-
0.0036 
-
1.08E-
05 0.9960 
18 
              
19 0.0030 0.0019 0.0002 
-
0.0044 
-
0.0009 
-
0.0036 
-
0.0012 0.0032 0.0001 0.0006 0.0006 0.0006 
-
3.65E-
06 0.9998 
20 0.0006 
-
0.0045 
-
0.0011 
-
0.0010 
-
0.0003 0.0021 0.0042 0.0063 0.0032 
-
0.0001 
-
0.0036 
-
0.0057 
6.64E-
06 0.9998 
21 0.0122 0.0014 
-
0.0005 
-
0.0124 
-
0.0033 
-
0.0021 
-
0.0020 0.0001 
-
0.0028 0.0003 0.0024 0.0065 
-
1.27E-
05 0.9991 
22 0.0080 0.0055 0.0004 
-
0.0079 
-
0.0005 
-
0.0066 
-
0.0069 
-
0.0033 
-
0.0027 0.0006 0.0049 0.0084 
-
1.49E-
05 0.9995 
23 
              
24 
              
25 
              
26 
              
27 0.0055 0.0031 
-
0.0016 
-
0.0037 
-
0.0013 
-
0.0040 
-
0.0031 
-
0.0003 
-
0.0016 
-
0.0003 0.0039 0.0035 
-
8.20E-
06 0.9998 
28 
              
29 0.0100 0.0009 
-
0.0028 
-
0.0061 0.0000 
-
0.0036 
-
0.0029 
-
0.0032 
-
0.0023 0.0008 0.0031 0.0060 
-
1.12E-
05 0.9992 
30 0.0048 0.0014 0.0008 
-
0.0037 
-
0.0021 
-
0.0027 
-
0.0022 
-
0.0008 
-
0.0012 0.0004 0.0010 0.0045 
-
7.09E-
06 0.9999 
31 0.0131 
-
0.0047 0.0036 
-
0.0098 
-
0.0021 
-
0.0037 
-
0.0032 
-
0.0006 
-
0.0015 0.0013 0.0017 0.0059 
-
1.16E-
05 0.9992 
32 
              
33 0.0002 
-
0.0019 0.0008 
-
0.0011 0.0015 0.0002 
-
0.0017 0.0024 0.0013 0.0019 
-
0.0007 
-
0.0029 
1.91E-
06 0.9999 
34 0.0020 
-
0.0006 
-
0.0016 
-
0.0004 0.0011 
-
0.0020 
-
0.0017 0.0035 
-
0.0001 0.0014 
-
0.0019 0.0004 
-
7.95E-
07 0.9999 
35 
-
0.0007 
-
0.0040 
-
0.0041 
-
0.0067 
-
0.0057 0.0421 
-
0.0065 
-
0.0041 
-
0.0044 
-
0.0024 
-
0.0031 
-
0.0004 
8.25E-
06 0.9929 
36 
              
37 0.0077 0.0020 
-
0.0007 
-
0.0058 
-
0.0021 
-
0.0048 
-
0.0039 0.0001 0.0004 0.0000 0.0049 0.0022 
-
9.31E-
06 0.9997 
38 0.0096 0.0045 
-
0.0030 
-
0.0045 
-
0.0022 
-
0.0057 
-
0.0072 
-
0.0038 
-
0.0019 0.0015 0.0063 0.0062 
-
1.45E-
05 0.9998 
39 
              
40 
              
41 0.0066 0.0048 
-
0.0012 
-
0.0047 
-
0.0018 
-
0.0058 
-
0.0043 
-
0.0029 
-
0.0027 0.0022 0.0048 0.0050 
-
1.16E-
05 0.9998 
42 0.0065 0.0017 
-
0.0017 
-
0.0043 0.0028 
-
0.0046 
-
0.0032 
-
0.0048 
-
0.0046 
-
0.0024 0.0146 
-
0.0001 
-
9.27E-
06 0.9898 
43 0.0080 0.0005 
-
0.0023 
-
0.0019 
-
0.0032 
-
0.0040 
-
0.0026 
-
0.0012 
-
0.0006 0.0021 0.0019 0.0034 
-
8.56E-
06 0.9999 
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44 0.0049 0.0003 
-
0.0028 
-
0.0019 
-
0.0010 
-
0.0021 
-
0.0012 
-
0.0004 0.0010 0.0019 0.0014 
-
0.0002 
-
3.91E-
06 0.9999 
45 0.0051 0.0003 
-
0.0002 
-
0.0056 
-
0.0007 
-
0.0013 
-
0.0026 0.0020 
-
0.0007 0.0022 0.0017 
-
0.0001 
-
4.37E-
06 0.9998 
46 
              
47 
-
0.0012 
-
0.0013 0.0021 
-
0.0015 
-
0.0010 0.0014 
-
0.0002 
-
0.0068 0.0122 0.0037 0.0058 
-
0.0132 
4.67E-
06 0.9983 
48 
              
49 0.0036 0.0023 0.0001 
-
0.0027 
-
0.0023 
-
0.0015 
-
0.0034 0.0007 
-
0.0025 
-
0.0001 0.0020 0.0038 
-
6.31E-
06 0.9999 
50 0.0090 
-
0.0009 
-
0.0031 
-
0.0045 0.0000 
-
0.0022 
-
0.0036 0.0001 
-
0.0029 0.0007 0.0077 
-
0.0003 
-
7.63E-
06 0.9991 
51 0.0097 0.0001 
-
0.0018 
-
0.0028 0.0000 
-
0.0048 
-
0.0059 
-
0.0039 
-
0.0025 0.0003 0.0046 0.0070 
-
1.23E-
05 0.9997 
52 
-
0.0063 0.0000 0.0005 0.0003 0.0012 0.0017 0.0034 0.0071 0.0025 0.0004 
-
0.0041 
-
0.0067 
9.55E-
06 0.9999 
53 
              
54 0.0090 0.0014 
-
0.0003 
-
0.0042 
-
0.0036 
-
0.0052 
-
0.0032 
-
0.0012 
-
0.0018 
-
0.0021 0.0039 0.0073 
-
1.20E-
05 0.9999 
55 0.0033 0.0031 
-
0.0028 
-
0.0028 0.0020 
-
0.0029 
-
0.0030 
-
0.0010 
-
0.0012 
-
0.0004 0.0023 0.0032 
-
5.73E-
06 0.9997 
56 
-
0.0125 
-
0.0076 0.0002 0.0061 0.0090 0.0058 0.0077 0.0095 0.0034 
-
0.0027 
-
0.0038 
-
0.0150 
2.27E-
05 0.9998 
57 
              
58 
              
59 
-
0.0091 
-
0.0055 0.0020 0.0003 0.0053 0.0068 0.0071 0.0063 0.0040 0.0001 
-
0.0065 
-
0.0108 
1.74E-
05 0.9999 
60 0.0054 0.0001 
-
0.0024 
-
0.0051 
-
0.0010 
-
0.0015 
-
0.0002 0.0021 0.0018 0.0009 0.0004 
-
0.0009 
-
3.01E-
06 0.9998 
61 0.0043 
-
0.0015 0.0013 
-
0.0033 
-
0.0002 
-
0.0024 
-
0.0020 0.0014 
-
0.0004 0.0007 0.0015 0.0007 
-
3.61E-
06 0.9998 
62 
              
63 
              
64 
              
65 
-
0.0297 
-
0.0051 0.0174 0.0149 0.0135 0.0040 0.0015 0.0001 
-
0.0013 
-
0.0027 
-
0.0061 
-
0.0065 
2.49E-
05 0.9951 
66 
              
67 0.0125 0.0040 
-
0.0026 
-
0.0072 
-
0.0037 
-
0.0063 
-
0.0069 
-
0.0034 
-
0.0009 0.0006 0.0072 0.0067 
-
1.67E-
05 0.9994 
68 
-
0.0010 0.0024 
-
0.0010 
-
0.0029 0.0006 0.0003 
-
0.0006 0.0035 0.0018 
-
0.0006 0.0002 
-
0.0025 
1.36E-
06 0.9999 
69 0.0039 0.0040 
-
0.0019 
-
0.0061 
-
0.0006 
-
0.0035 0.0003 0.0011 
-
0.0017 0.0008 0.0017 0.0018 
-
5.49E-
06 0.9996 
70 0.0132 0.0067 0.0002 
-
0.0086 
-
0.0047 
-
0.0072 
-
0.0100 
-
0.0068 
-
0.0043 0.0005 0.0067 0.0142 
-
2.29E-
05 0.9995 
71 0.0003 
-
0.0026 
-
0.0019 0.0111 
-
0.0036 
-
0.0160 0.0180 
-
0.0010 
-
0.0029 
-
0.0015 
-
0.0011 0.0011 
8.98E-
07 0.9952 
72 0.0014 
-
0.0030 
-
0.0053 
-
0.0077 
-
0.0012 
-
0.0015 0.0351 
-
0.0002 
-
0.0057 
-
0.0042 
-
0.0027 
-
0.0052 
9.49E-
06 0.9928 
73 0.0063 0.0011 
-
0.0004 
-
0.0054 
-
0.0008 
-
0.0023 
-
0.0023 
-
0.0002 
-
0.0025 0.0001 0.0024 0.0041 
-
7.61E-
06 0.9997 
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74 
              
75 
              
76 0.0069 
-
0.0007 
-
0.0005 
-
0.0032 
-
0.0027 
-
0.0025 
-
0.0022 
-
0.0009 0.0005 0.0009 0.0024 0.0018 
-
6.61E-
06 0.9998 
77 
              
78 0.0040 0.0053 
-
0.0025 
-
0.0026 
-
0.0030 
-
0.0048 0.0001 
-
0.0020 
-
0.0028 0.0018 0.0047 0.0019 
-
7.72E-
06 0.9945 
79 0.0089 0.0024 
-
0.0011 
-
0.0053 
-
0.0031 
-
0.0046 
-
0.0067 0.0011 
-
0.0014 0.0008 0.0047 0.0042 
-
1.15E-
05 0.9998 
80 0.0047 0.0035 
-
0.0002 
-
0.0022 
-
0.0016 
-
0.0063 
-
0.0043 
-
0.0003 
-
0.0005 0.0002 0.0016 0.0055 
-
8.97E-
06 0.9999 
81 0.0064 0.0007 
-
0.0005 
-
0.0027 
-
0.0019 
-
0.0052 
-
0.0044 0.0024 
-
0.0003 
-
0.0005 0.0038 0.0021 
-
7.54E-
06 0.9998 
82 0.0009 0.0018 
-
0.0001 
-
0.0005 
-
0.0003 
-
0.0032 
-
0.0016 0.0020 
-
0.0011 
-
0.0009 0.0026 0.0005 
-
2.59E-
06 0.9999 
83 0.0026 
-
0.0027 0.0024 
-
0.0022 
-
0.0013 
-
0.0022 0.0003 0.0027 0.0014 0.0003 
-
0.0006 
-
0.0009 
-
5.75E-
07 0.9999 
84 0.0050 0.0003 0.0006 
-
0.0051 
-
0.0029 
-
0.0025 
-
0.0012 0.0041 0.0003 
-
0.0004 0.0018 0.0001 
-
4.19E-
06 0.9998 
85 
              
86 0.0043 0.0025 0.0001 
-
0.0046 
-
0.0016 
-
0.0040 
-
0.0007 0.0006 
-
0.0022 0.0009 0.0018 0.0030 
-
6.50E-
06 0.9997 
87 0.0046 0.0026 0.0002 
-
0.0055 
-
0.0026 
-
0.0030 
-
0.0028 0.0035 
-
0.0005 0.0004 0.0011 0.0021 
-
6.00E-
06 0.9997 
88 0.0042 0.0008 
-
0.0006 
-
0.0039 0.0018 
-
0.0026 
-
0.0010 
-
0.0013 
-
0.0027 
-
0.0010 0.0018 0.0045 
-
5.80E-
06 0.9996 
89 0.0097 0.0049 
-
0.0006 
-
0.0064 
-
0.0023 
-
0.0069 
-
0.0076 
-
0.0023 
-
0.0032 
-
0.0001 0.0058 0.0090 
-
1.62E-
05 0.9997 
90 0.0038 0.0011 
-
0.0003 
-
0.0046 0.0013 
-
0.0031 
-
0.0004 0.0003 
-
0.0023 
-
0.0004 0.0022 0.0025 
-
4.83E-
06 0.9997 
91 
-
0.0101 
-
0.0017 0.0008 0.0036 0.0056 0.0041 0.0039 0.0036 0.0000 0.0009 
-
0.0015 
-
0.0092 
1.34E-
05 0.9998 
92 0.0026 0.0010 
-
0.0043 
-
0.0054 
-
0.0033 
-
0.0036 
-
0.0047 0.0362 
-
0.0044 
-
0.0043 
-
0.0046 
-
0.0052 
4.64E-
06 0.9935 
93 0.0068 0.0049 0.0009 
-
0.0038 
-
0.0019 
-
0.0060 
-
0.0076 
-
0.0022 
-
0.0052 
-
0.0123 0.0242 0.0023 
-
1.46E-
05 0.9968 
94 0.0111 0.0040 
-
0.0005 
-
0.0051 
-
0.0078 
-
0.0063 
-
0.0039 
-
0.0025 
-
0.0016 
-
0.0003 0.0035 0.0094 
-
1.61E-
05 0.9999 
95 0.0061 0.0021 
-
0.0014 
-
0.0029 0.0005 
-
0.0020 
-
0.0045 
-
0.0051 
-
0.0041 
-
0.0008 0.0061 0.0060 
-
1.02E-
05 0.9990 
96 0.0050 0.0023 
-
0.0020 
-
0.0065 0.0027 
-
0.0017 
-
0.0032 
-
0.0018 
-
0.0015 0.0017 0.0028 0.0021 
-
6.36E-
06 0.9993 
97 0.0074 0.0020 0.0010 
-
0.0046 
-
0.0038 
-
0.0038 
-
0.0045 
-
0.0021 
-
0.0014 0.0014 0.0034 0.0050 
-
1.07E-
05 0.9999 
98 
              
99 0.0078 0.0039 
-
0.0015 
-
0.0045 
-
0.0022 
-
0.0055 
-
0.0046 
-
0.0026 
-
0.0015 
-
0.0002 0.0043 0.0065 
-
1.22E-
05 0.9999 
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100 
-
0.0084 
-
0.0047 
-
0.0076 
-
0.0004 0.0060 0.0130 0.0142 0.0084 0.0002 0.0026 
-
0.0065 
-
0.0168 
2.28E-
05 0.9945 
101 0.0020 0.0067 0.0001 
-
0.0057 
-
0.0004 
-
0.0061 
-
0.0018 0.0015 
-
0.0048 0.0025 0.0032 0.0029 
-
7.43E-
06 0.9992 
102 
              
103 0.0088 
-
0.0031 0.0017 
-
0.0039 
-
0.0029 
-
0.0052 
-
0.0028 0.0016 0.0018 0.0008 0.0005 0.0027 
-
7.33E-
06 0.9997 
104 0.0089 0.0025 
-
0.0002 
-
0.0066 
-
0.0039 
-
0.0036 
-
0.0020 
-
0.0025 
-
0.0039 0.0009 0.0038 0.0065 
-
1.21E-
05 0.9998 
105 
              
106 0.0024 0.0017 
-
0.0003 
-
0.0025 
-
0.0008 
-
0.0028 
-
0.0019 0.0019 0.0012 
-
0.0001 0.0000 0.0013 
-
3.29E-
06 0.9999 
107 0.0100 0.0017 0.0010 
-
0.0054 
-
0.0026 
-
0.0073 
-
0.0058 
-
0.0022 
-
0.0026 0.0022 0.0031 0.0078 
-
1.42E-
05 0.9998 
108 
              
109 
              
110 
              
111 0.0069 0.0017 0.0014 
-
0.0016 
-
0.0012 
-
0.0035 
-
0.0044 
-
0.0014 
-
0.0077 
-
0.0063 
-
0.0083 0.0244 
-
1.52E-
05 0.9975 
112 0.0069 0.0011 0.0020 
-
0.0052 
-
0.0016 
-
0.0067 
-
0.0039 0.0009 
-
0.0019 0.0007 0.0038 0.0040 
-
9.61E-
06 0.9996 
113 
              
114 0.0078 0.0030 
-
0.0026 
-
0.0063 
-
0.0001 
-
0.0048 
-
0.0025 
-
0.0012 
-
0.0009 
-
0.0007 0.0035 0.0048 
-
9.93E-
06 0.9994 
115 0.0059 
-
0.0002 
-
0.0008 
-
0.0027 
-
0.0010 
-
0.0036 
-
0.0015 
-
0.0014 
-
0.0005 0.0022 0.0008 0.0027 
-
6.20E-
06 0.9999 
116 0.0002 
-
0.0048 
-
0.0071 
-
0.0075 
-
0.0050 0.0407 
-
0.0027 
-
0.0001 
-
0.0021 
-
0.0056 
-
0.0026 
-
0.0036 
1.10E-
05 0.9930 
117 0.0054 
-
0.0037 0.0006 
-
0.0033 
-
0.0017 0.0007 
-
0.0013 0.0028 
-
0.0014 0.0033 
-
0.0002 
-
0.0013 
-
1.73E-
06 0.9996 
118 0.0108 
-
0.0067 0.0005 
-
0.0065 0.0004 
-
0.0024 
-
0.0023 0.0017 0.0022 0.0031 
-
0.0017 0.0008 
-
5.03E-
06 0.9992 
119 0.0017 0.0018 0.0010 
-
0.0052 
-
0.0019 0.0003 0.0001 0.0018 0.0009 
-
0.0008 
-
0.0003 0.0008 
-
2.05E-
06 0.9999 
120 
              
121 0.0096 0.0011 
-
0.0031 
-
0.0052 
-
0.0011 
-
0.0054 
-
0.0025 
-
0.0005 
-
0.0010 0.0001 0.0047 0.0033 
-
1.01E-
05 0.9995 
122 0.0074 0.0003 
-
0.0011 
-
0.0046 
-
0.0012 
-
0.0046 
-
0.0011 
-
0.0006 
-
0.0006 0.0008 0.0027 0.0026 
-
7.59E-
06 0.9997 
123 0.0055 0.0028 
-
0.0022 
-
0.0056 0.0005 
-
0.0045 
-
0.0049 
-
0.0023 
-
0.0010 0.0142 0.0051 
-
0.0076 
-
5.24E-
06 0.9871 
124 0.0036 0.0041 0.0009 
-
0.0058 
-
0.0001 
-
0.0023 
-
0.0040 
-
0.0028 
-
0.0023 0.0004 0.0034 0.0049 
-
8.43E-
06 0.9994 
125 0.0032 0.0017 
-
0.0021 
-
0.0031 0.0018 
-
0.0019 
-
0.0019 0.0012 
-
0.0024 
-
0.0005 0.0008 0.0033 
-
4.31E-
06 0.9998 
126 0.0010 0.0022 
-
0.0017 
-
0.0026 0.0027 
-
0.0023 
-
0.0021 0.0010 
-
0.0008 0.0015 0.0019 
-
0.0009 
-
1.84E-
06 0.9998 
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127 
-
0.0011 
-
0.0038 0.0022 0.0000 
-
0.0002 0.0008 0.0007 0.0045 0.0038 0.0015 
-
0.0033 
-
0.0050 
5.52E-
06 0.9999 
128 0.0017 0.0003 0.0002 
-
0.0001 
-
0.0037 
-
0.0007 
-
0.0010 0.0027 0.0003 0.0007 
-
0.0010 0.0005 
-
1.56E-
06 0.9999 
129 0.0115 0.0067 
-
0.0009 
-
0.0066 
-
0.0015 
-
0.0080 
-
0.0068 
-
0.0125 
-
0.0063 0.0048 0.0057 0.0139 
-
2.17E-
05 0.9956 
130 
              
131 
              
132 
              
133 
              
134 
              
135 0.0031 0.0024 
-
0.0005 
-
0.0043 
-
0.0019 
-
0.0028 
-
0.0016 0.0016 0.0019 0.0013 0.0027 
-
0.0020 
-
3.39E-
06 0.9998 
136 0.0054 
-
0.0010 
-
0.0013 
-
0.0030 
-
0.0001 
-
0.0015 
-
0.0022 0.0021 
-
0.0003 
-
0.0004 
-
0.0022 0.0044 
-
4.63E-
06 0.9998 
137 0.0017 0.0010 0.0005 
-
0.0018 
-
0.0029 
-
0.0024 0.0003 0.0040 
-
0.0027 0.0033 
-
0.0002 
-
0.0009 
-
1.62E-
06 0.9998 
138 0.0061 0.0057 
-
0.0025 
-
0.0086 
-
0.0014 
-
0.0026 
-
0.0027 0.0013 
-
0.0021 0.0000 0.0037 0.0033 
-
8.93E-
06 0.9996 
139 0.0011 
-
0.0009 
-
0.0005 
-
0.0027 0.0005 
-
0.0001 0.0007 0.0025 0.0025 0.0017 
-
0.0030 
-
0.0020 
1.61E-
06 0.9999 
140 0.0032 
-
0.0026 
-
0.0006 
-
0.0015 
-
0.0013 
-
0.0014 0.0007 0.0038 0.0040 0.0003 
-
0.0034 
-
0.0012 
6.80E-
07 0.9998 
141 0.0011 0.0001 0.0009 
-
0.0032 0.0017 
-
0.0014 0.0005 
-
0.0006 
-
0.0017 0.0012 0.0012 0.0001 
-
1.39E-
06 0.9997 
142 
              
143 
              
144 0.0030 
-
0.0003 0.0008 
-
0.0043 0.0002 
-
0.0027 
-
0.0009 0.0019 0.0036 
-
0.0009 
-
0.0005 0.0001 
-
2.07E-
06 0.9997 
145 0.0022 0.0009 
-
0.0019 
-
0.0027 
-
0.0006 
-
0.0014 0.0008 0.0030 0.0006 
-
0.0002 0.0014 
-
0.0020 
-
7.33E-
07 0.9999 
146 0.0135 0.0057 
-
0.0012 
-
0.0077 
-
0.0047 
-
0.0086 
-
0.0071 
-
0.0056 
-
0.0024 
-
0.0005 0.0062 0.0124 
-
2.11E-
05 0.9998 
147 0.0018 
-
0.0107 0.0011 0.0031 0.0052 0.0020 0.0000 0.0030 
-
0.0005 
-
0.0013 
-
0.0006 
-
0.0031 
5.67E-
06 0.9994 
148 
              
149 0.0050 0.0025 
-
0.0028 
-
0.0042 0.0003 
-
0.0040 
-
0.0004 0.0002 
-
0.0022 0.0013 0.0007 0.0033 
-
6.18E-
06 0.9998 
150 
-
0.0012 
-
0.0025 0.0023 
-
0.0014 0.0016 0.0014 0.0018 0.0022 
-
0.0021 
-
0.0011 0.0012 
-
0.0022 
3.06E-
06 0.9998 
151 
              
152 0.0086 0.0024 
-
0.0037 
-
0.0038 
-
0.0030 
-
0.0041 
-
0.0043 0.0016 
-
0.0005 0.0004 0.0023 0.0041 
-
9.68E-
06 0.9999 
153 0.0029 0.0035 
-
0.0005 
-
0.0035 0.0007 
-
0.0043 
-
0.0023 
-
0.0002 
-
0.0036 0.0007 0.0035 0.0031 
-
6.48E-
06 0.9992 
 
  
 162 
 
Appendix 2 – Pulse programs for NMR 
 
A2.1 Edited 
1
H-
15
N HSQC Pulse Program (gradients; 600 MHz spectrometer) 
 
 
;invifpf3gpsi 
;avance-version 
;2D H-1/X correlation via double inept transfer 
;   using sensitivity improvement 
;phase sensitive using Echo/Antiecho-TPPI 
gradient selection 
;with decoupling during acquisition 
;using f3 - channel 
;using flip-back pulse 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. 
Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. 
Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher, M. Schwendinger, M. Sattler, P. 
Schmidt, O. Schedletzky, 
;   S.J. Glaser, O.W. Sorensen & C. Griesinger, 
J. Biomol. NMR 4, 
;   301-306 (1994) 
;S. Grzesiek & A. Bax, J. Am. Chem. Soc. 115, 
12593-12594 (1993) 
;modified by jgaspar to include delay prior to 
aquisition 
 
define list<gradient> EA=<EA> 
 
;$Id: Grad1.incl,v 1.7 2002/06/12 09:04:22 ber 
Exp $ 
# 22 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invifpf3gpsid31" 2 
 
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/Delay.incl" 1 
;Delay.incl  -  include file for commonly used 
delays 
;version 00/02/07 
 
 
;general delays 
 
define delay DELTA 
define delay DELTA1 
define delay DELTA2 
define delay DELTA3 
define delay DELTA4 
define delay DELTA5 
define delay DELTA6 
define delay DELTA7 
define delay DELTA8 
 
define delay TAU 
define delay TAU1 
define delay TAU2 
define delay TAU3 
define delay TAU4 
define delay TAU5 
 
 
;delays for centering pulses 
 
define delay CEN_HN1 
define delay CEN_HN2 
define delay CEN_HN3 
define delay CEN_HC1 
define delay CEN_HC2 
define delay CEN_HC3 
define delay CEN_HC4 
define delay CEN_HP1 
define delay CEN_HP2 
define delay CEN_CN1 
define delay CEN_CN2 
define delay CEN_CN3 
define delay CEN_CN4 
define delay CEN_CP1 
define delay CEN_CP2 
 
;loop counters 
 
define loopcounter COUNTER 
define loopcounter SCALEF 
define loopcounter FACTOR1 
define loopcounter FACTOR2 
define loopcounter FACTOR3 
 
;$Id: Delay.incl,v 1.11 2002/06/12 09:04:22 ber 
Exp $ 
# 23 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invifpf3gpsid31" 2 
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"p2=p1*2" 
 
"p22=p21*2" 
 
"d0=3u" 
 
"d11=30m" 
 
"d26=1s/(cnst4*4)" 
 
"DELTA=p16+d16+p2+d0*2" 
"DELTA1=p16+d16+8u" 
 
"CEN_HN1=(p21-p1)/2" 
"CEN_HN2=(p22-p2)/2" 
 
"l3=(td1/2)" 
 
1 ze 
  d31 
  d11 pl16:f3 
2 d1 do:f3 
  6m 
3 d11 
  18m 
4 (p1 ph1) 
  d26 pl3:f3 
  (CEN_HN2 p2 ph2) (p22 ph6):f3 
  d26 setnmr2|0 setnmr0|34|32|33 
  (p1 ph2)  
  4u pl0:f1 
  (p11:sp1 ph1:r):f1 
  4u 
  p16:gp1 
  d16 pl1:f1 
  (p21 ph3):f3 
  d0  
  p2 ph7 
  d0 
  p16:gp2*EA 
  d16 
  (p22 ph4):f3 
  DELTA 
  (CEN_HN1 p1 ph1) (p21 ph4):f3 
  d24 
  (CEN_HN2 p2 ph1) (p22 ph1):f3 
  d24 
  (CEN_HN1 p1 ph2) (p21 ph5):f3 
  d26 
  (CEN_HN2 p2 ph1) (p22 ph1):f3 
  d26 
  (p1 ph1) 
  DELTA1 
  (p2 ph1) 
  4u 
  p16:gp3 
  d16 pl16:f3 
  4u setnmr2^0 setnmr0^34^32^33 
  go=2 ph31 cpd3:f3 
  d1 do:f3 wr #0 if #0 zd 
  3m ip5 igrad EA 
  3m ip5 
  lo to 3 times 2 
  d11 id0 
  3m ip3 
  3m ip3 
  3m ip6 
  3m ip6 
  3m ip31 
  3m ip31 
  lo to 4 times l3 
exit 
    
ph1=0  
ph2=1 
ph3=0 2 
ph4=0 0 2 2 
ph5=1 1 3 3 
ph6=0 
ph7=0 0 2 2 
ph31=2 0 0 2 
   
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl16: f3 channel - power level for CPD/BB 
decoupling 
;sp1: f1 channel - shaped pulse  90 degree 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p11: f1 channel -  90 degree shaped pulse 
;p16: homospoil/gradient pulse                         [1 
msec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;d0 : incremented delay (2D)                           [3 
usec] 
;d1 : relaxation delay; 1-5 * T1 
;d11: delay for disk I/O                               [30 
msec] 
;d16: delay for homospoil/gradient recovery 
;d24: 1/(4J)YH for YH 
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;     1/(8J)YH for all multiplicities 
;d26: 1/(4J(YH)) 
;d31: delay between experiments in multizg 
;cnst4: = J(YH) 
;l3: loop for phase sensitive 2D using  E/A 
method : l3 = td1/2 
;in0: 1/(2 * SW(X)) = DW(X) 
;nd0: 2 
;NS: 1 * n 
;DS: >= 16 
;td1: number of experiments 
;MC2: echo-antiecho 
;cpd3: decoupling according to sequence defined 
by cpdprg3 
;pcpd3: f3 channel - 90 degree pulse for 
decoupling sequence 
 
;use gradient ratio: gp 1 : gp 2 : gp 3 
;     50 :   80 : 20.1       for 
C-13 
;     50 :   80 :  8.1       for 
N-15 
 
;for z-only gradients: 
;gpz1: 50% 
;gpz2: 80% 
;gpz3: 20.1% for C-13, 8.1% for N-15 
 
;use gradient files:    
;gpnam1: SINE.100 
;gpnam2: SINE.100 
;gpnam3: SINE.100 
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A2.2 
1
H-
15
N HSQC Pulse Program (presat; 600 MHz spectrometer) 
 
;hsqcf3phpr 
;avance-version (02/05/31) 
;HSQC 
;2D H-1/X correlation via double inept transfer 
;phase sensitive 
;with decoupling during acquisition 
;using f3 - channel 
;G. Bodenhausen & D.J. Ruben, Chem. Phys. 
Lett. 69, 185 (1980) 
 
;$Id: Avance1.incl,v 1.7.2.3 2003/02/25 
14:48:47 ber Exp $ 
# 12 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hsqcf3phpr" 2 
 
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/Delay.incl" 1 
;Delay.incl  -  include file for commonly used 
delays 
;version 00/02/07 
 
;general delays 
 
define delay DELTA 
define delay DELTA1 
define delay DELTA2 
define delay DELTA3 
define delay DELTA4 
define delay DELTA5 
define delay DELTA6 
define delay DELTA7 
define delay DELTA8 
 
define delay TAU 
define delay TAU1 
define delay TAU2 
define delay TAU3 
define delay TAU4 
define delay TAU5 
 
;delays for centering pulses 
 
define delay CEN_HN1 
define delay CEN_HN2 
define delay CEN_HN3 
define delay CEN_HC1 
define delay CEN_HC2 
define delay CEN_HC3 
define delay CEN_HC4 
define delay CEN_HP1 
define delay CEN_HP2 
define delay CEN_CN1 
define delay CEN_CN2 
define delay CEN_CN3 
define delay CEN_CN4 
define delay CEN_CP1 
define delay CEN_CP2 
 
;loop counters 
 
define loopcounter COUNTER 
define loopcounter SCALEF 
define loopcounter FACTOR1 
define loopcounter FACTOR2 
define loopcounter FACTOR3 
 
;$Id: Delay.incl,v 1.11 2002/06/12 09:04:22 ber 
Exp $ 
# 13 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hsqcf3phpr" 2 
 
"p2=p1*2" 
 
"p22=p21*2" 
 
"d0=3u" 
 
"d11=30m" 
 
"d12=20u" 
 
"d13=4u" 
 
"d26=1s/(cnst4*4)" 
 
"DELTA=d0*2+p2" 
 
# 1 "mc_line 35 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hsqcf3phpr 
expanding definition part of mc command before 
ze" 
define delay MCWRK 
define delay MCREST 
define loopcounter ST1CNT 
"ST1CNT = td1 / (2)" 
"MCWRK = 0.250000*d11" 
"MCREST = d11 - d11" 
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# 35 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hsqcf3phpr" 
1 ze  
# 1 "mc_line 35 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hsqcf3phpr 
expanding definition of mc command after ze" 
# 36 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hsqcf3phpr" 
  d11 pl16:f3 
# 1 "mc_line 37 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hsqcf3phpr 
expanding start label for mc command" 
2 MCWRK  * 3 do:f3 
LBLSTS1, MCWRK  
LBLF1, MCREST 
# 38 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hsqcf3phpr" 
3 d12 pl9:f1 
  d1 cw:f1 ph29 
  d13 do:f1 
  d12 pl1:f1 
  p1 ph1 
  d26 pl3:f3 
  (center (p2 ph2) (p22 ph9):f3 ) 
  d26 
  (p1 ph3)  
  (p21 ph6):f3 
  d0 
  (p2 ph8) 
  d0 
  (p22 ph7):f3 
  DELTA 
  (p21 ph7):f3 
  (p1 ph4)  
  d26 
  (center (p2 ph2) (p22 ph5):f3 ) 
  d26 pl16:f3 
  go=2 ph31 cpd3:f3 
# 1 "mc_line 59 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hsqcf3phpr 
expanding mc command in line" 
  MCWRK  do:f3 wr #0 if #0 zd ip6  MCWRK  
ip9  MCWRK  ip29 
  lo to LBLSTS1 times 2 
  MCWRK id0 
  lo to LBLF1 times ST1CNT 
# 60 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hsqcf3phpr" 
exit  
   
ph1=0 
ph2=0 
ph3=1 
ph4=1 
ph5=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph6=0 2 
ph7=0 0 0 0 2 2 2 2 
ph8=0 0 2 2 
ph9=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph29=0 
ph31=0 2 0 2 2 0 2 0 
 
;pl1 : f1 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl9 : f1 channel - power level for presaturation 
;pl16: f3 channel - power level for CPD/BB 
decoupling 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;d0 : incremented delay (2D)                 [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d11: delay for disk I/O                          [30 
msec] 
;d12: delay for power switching           [20 usec] 
;d13: short delay                                      [4 usec] 
;d26 : 1/(4J)YH 
;cnst4: = J(YH) 
;in0: 1/(2 * SW(X)) = DW(X) 
;nd0: 2 
;NS: 4 * n 
;DS: 16 
;td1: number of experiments 
;FnMODE: States-TPPI, TPPI, States or QSEC 
;cpd3: decoupling according to sequence defined 
by cpdprg3 
;pcpd3: f3 channel - 90 degree pulse for 
decoupling sequence 
 
;$Id: hsqcf3phpr,v 1.1 2002/06/12 09:04:54 ber 
Exp $ 
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A2.3 
1
H-
15
N HSQC Pulse Program (500 MHz spectrometer) 
 
 
;invietgpsi 
;avance-version (00/04/28) 
;HSQC 
;2D H-1/X correlation via double inept transfer 
;   using sensitivity improvement 
;phase sensitive using Echo/Antiecho-TPPI 
gradient selection 
;with decoupling during acquisition 
;using trim pulses in inept transfer 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. 
Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. 
Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher, M. Schwendinger, M. Sattler, P. 
Schmidt, O. Schedletzky, 
;   S.J. Glaser, O.W. Sorensen & C. Griesinger, 
J. Biomol. NMR 4, 
;   301-306 (1994) 
 
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/Avance.incl" 1 
;Avance.incl 
;version  00/07/27 
 
;switch between high and low stage oh H 
amplifier 
;use 2H channel for lock or pulse (lockswitch) 
;allow for 2H decoupling (lockswitch) 
;turn lock-hold on/off (BSMS) 
;switch between 1H or 19F output (H amplifier) 
;select output for 19F (amplifier) 
;homospoil on/off (BSMS) 
;for Q-switch probes 
;for mixing probe 
;gating pulse for RX22, ADC and HPPR 
;not active 
;$Id: Avance1.incl,v 1.5 2000/08/16 13:26:55 
ber Exp $ 
# 19 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invietgpsi" 2 
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/Grad.incl" 1 
;Grad.incl  -  include file for Gradient 
Spectroscopy 
;avance-version (00/07/27) 
;gradient pulse for gs-syntax 
;blank/unblank gradient amplifier and turn lock-
hold on/off 
;blank/unblank gradient amplifier 
;for RCB board (BSMS) 
 
define list<gradient> EA=<EA> 
 
;$Id: Grad1.incl,v 1.6 2000/10/16 11:47:19 ber 
Exp $ 
# 20 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invietgpsi" 2 
 
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/Delay.incl" 1 
;Delay.incl  -  include file for commonly used 
delays 
; 
;version 00/02/07 
 
;general delays 
 
define delay DELTA 
define delay DELTA1 
define delay DELTA2 
define delay DELTA3 
define delay DELTA4 
define delay DELTA5 
define delay DELTA6 
define delay DELTA7 
define delay DELTA8 
 
define delay TAU 
define delay TAU1 
define delay TAU2 
define delay TAU3 
define delay TAU4 
define delay TAU5 
 
;delays for centering pulses 
 
define delay CEN_HN1 
define delay CEN_HN2 
define delay CEN_HN3 
define delay CEN_HC1 
define delay CEN_HC2 
define delay CEN_HC3 
define delay CEN_HC4 
define delay CEN_HP1 
define delay CEN_HP2 
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define delay CEN_CN1 
define delay CEN_CN2 
define delay CEN_CN3 
define delay CEN_CN4 
define delay CEN_CP1 
define delay CEN_CP2 
 
;loop counters 
 
define loopcounter COUNTER 
define loopcounter SCALEF 
define loopcounter FACTOR1 
define loopcounter FACTOR2 
define loopcounter FACTOR3 
 
;$Id: Delay.incl,v 1.10 2000/05/08 11:39:02 eng 
Exp $ 
# 21 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invietgpsi" 2 
 
"p2=p1*2" 
 
"p4=p3*2" 
 
"d0=3u" 
 
"d4=1s/(cnst2*4)" 
 
"d11=30m" 
 
"d13=4u" 
 
"DELTA=p16+d16+50u+p2+d0*2" 
"DELTA1=d13+p16+d16+4u" 
 
# 1 "mc_line 42 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invietgpsi expanding 
definition part of mc command before ze" 
; dimension 2 aq-mode (F2) undefined (F1) 
Echo-Antiecho   
define delay MCWRK 
define delay MCREST 
define loopcounter ST1CNT 
"ST1CNT = td1 / ( 2 ) " 
"MCWRK  = 0.166667 *  d1" 
"MCREST =  d1 -  d1" 
# 42 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invietgpsi" 
1 ze 
  d11 pl12:f2 
# 1 "mc_line 44 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invietgpsi expanding 
start label for mc command" 
2       MCWRK*2  do:f2 
LBLSTS1,       MCWRK*4 
LBLF1,       MCREST 
# 45 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invietgpsi" 
3 (p1 ph1) 
  d4 pl2:f2 
  (p2 ph1) (p4 ph6):f2 
  d4 
  p28 ph1 
  d13 
  (p1 ph2) (p3 ph3):f2 
  d0  
  p2 ph7 
  d0 
  50u setnmr2|0 setnmr0|34|32|33 
  p16:gp1*EA 
  d16 
  (p4 ph4):f2 
  DELTA 
  (p1 ph1) (p3 ph4):f2 
  d24 
  (p2 ph1) (p4 ph1):f2 
  d24 
  (p1 ph2) (p3 ph5):f2 
  d4 
  (p2 ph1) (p4 ph1):f2 
  d4 
  (p1 ph1) 
  DELTA1 
  (p2 ph1) 
  d13 
  p16:gp2 
  d16 pl12:f2 
  4u setnmr2^0 setnmr0^34^32^33 
  go=2 ph31 cpd2:f2 
# 1 "mc_line 76 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invietgpsi expanding 
mc command in line " 
  MCWRK  do:f2 wr #0 if #0 zd   igrad EA  
MCWRK  ip5*2  
  lo to LBLSTS1 times 2 
  MCWRK  id0  MCWRK  ip3*2  MCWRK  
ip6*2  MCWRK  ip31*2  
  lo to LBLF1 times ST1CNT 
# 77 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/invietgpsi" 
exit 
 169 
 
    
ph1=0  
ph2=1 
ph3=0 2 
ph4=0 0 2 2 
ph5=1 1 3 3 
ph6=0 
ph7=0 0 2 2 
ph31=0 2 2 0 
   
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl12: f2 channel - power level for CPD/BB 
decoupling 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p4 : f2 channel - 180 degree high power pulse 
;p16: homospoil/gradient pulse 
;p28: f1 channel - trim pulse 
;d0 : incremented delay (2D)                [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d4 : 1/(4J)XH 
;d11: delay for disk I/O                          [30 
msec] 
;d13: short delay                                    [4 usec] 
;d16: delay for homospoil/gradient recovery 
;d24: 1/(4J)XH for XH 
;     1/(8J)XH for all multiplicities 
;cnst2: = J(XH) 
;in0: 1/(2 * SW(X)) = DW(X) 
;nd0: 2 
;NS: 1 * n 
;DS: >= 16 
;td1: number of experiments 
;FnMODE: echo-antiecho 
;cpd2: decoupling according to sequence defined 
by cpdprg2 
;pcpd2: f2 channel - 90 degree pulse for 
decoupling sequence 
 
;use gradient ratio: gp 1 : gp 2 
;     80 : 20.1    for C-13 
;     80 :  8.1    for N-15 
 
;for z-only gradients: 
;gpz1: 80% 
;gpz2: 20.1% for C-13, 8.1% for N-15 
 
;use gradient files:    
;gpnam1: SINE.100 
;gpnam2: SINE.100 
 
;$Id: invietgpsi,v 1.6 2000/05/08 11:40:23 eng 
Exp $ 
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A2.4 
15
N-3D NOESY Pulse Program 
 
;noesyhsqcfpf3gpsi3d 
;avance-version (03/06/18) 
;NOESY-HSQC 
;3D sequence with 
;   homonuclear correlation via dipolar coupling 
;   dipolar coupling may be due to noe or 
chemical exchange 
;   H-1/X correlation via double inept transfer 
;      using sensitivity improvement 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho-TPPI 
gradient selection (t2) 
;with decoupling during acquisition 
;using flip-back pulse 
;using f3 - channel 
;(use parameterset NOESYHSQCFPF3GPSI3D) 
; 
;O. Zhang, L.E. Kay, J.P. Olivier & J.D. 
Forman-Kay,  
;   J. Biomol. NMR 4, 845 - 858 (1994) 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. 
Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. 
Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher, M. Schwendinger, M. Sattler, P. 
Schmidt, O. Schedletzky, 
;   S.J. Glaser, O.W. Sorensen & C. Griesinger, 
J. Biomol. NMR 4, 
;   301-306 (1994) 
 
prosol relations=<triple> 
 
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/Avance.incl" 1 
;Avance.incl 
; 
;avance-version (03/02/17) 
 
;$Id: Avance1.incl,v 1.7.2.3 2003/02/25 
14:48:47 ber Exp $ 
# 30 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d" 2 
 
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/Grad.incl" 1 
;Grad.incl  -  include file for Gradient 
Spectroscopy 
; 
;avance-version (02/05/31) 
 
 
define list<gradient> EA=<EA> 
 
;$Id: Grad1.incl,v 1.7 2002/06/12 09:04:22 ber 
Exp $ 
# 31 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d" 2 
 
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/Delay.incl" 1 
;Delay.incl  -  include file for commonly used 
delays 
; 
;version 00/02/07 
 
;general delays 
 
define delay DELTA 
define delay DELTA1 
define delay DELTA2 
define delay DELTA3 
define delay DELTA4 
define delay DELTA5 
define delay DELTA6 
define delay DELTA7 
define delay DELTA8 
 
define delay TAU 
define delay TAU1 
define delay TAU2 
define delay TAU3 
define delay TAU4 
define delay TAU5 
 
;delays for centering pulses 
 
define delay CEN_HN1 
define delay CEN_HN2 
define delay CEN_HN3 
define delay CEN_HC1 
define delay CEN_HC2 
define delay CEN_HC3 
define delay CEN_HC4 
 171 
 
define delay CEN_HP1 
define delay CEN_HP2 
define delay CEN_CN1 
define delay CEN_CN2 
define delay CEN_CN3 
define delay CEN_CN4 
define delay CEN_CP1 
define delay CEN_CP2 
 
;loop counters 
 
define loopcounter COUNTER 
define loopcounter SCALEF 
define loopcounter FACTOR1 
define loopcounter FACTOR2 
define loopcounter FACTOR3 
 
;$Id: Delay.incl,v 1.11 2002/06/12 09:04:22 ber 
Exp $ 
# 32 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d" 2 
 
"p2=p1*2" 
 
"p22=p21*2" 
 
"d0=3u" 
 
"d10=3u" 
 
"d11=30m" 
 
"d12=20u" 
 
"d13=4u" 
 
"d26=1s/(cnst4*4)" 
 
"p19=300u" 
 
"DELTA1=d13+p19+d16+4u" 
"DELTA3=d24-p16-d16" 
"DELTA4=d26-p16-d16" 
"DELTA=p16+d16+p2+d10*2" 
"DELTA2=p22+d0*2" 
 
"TAU=d8-p16-d16" 
 
aqseq 321 
 
# 1 "mc_line 74 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d expanding definition part of mc command 
before ze" 
; dimension 3 aq-mode (F2) Echo-Antiecho (F1) 
States-TPPI  F2->F1 
define delay MCWRK 
define delay MCREST 
define loopcounter ST1CNT 
"ST1CNT = td1 / (2)" 
define loopcounter ST2CNT 
"ST2CNT = td2 / (2)" 
"MCWRK = 0.100000*d11" 
"MCREST = d11 - d11" 
# 74 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d" 
1 ze 
# 1 "mc_line 74 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d expanding definition of mc command after ze" 
# 75 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d" 
  d11 pl16:f3 
# 1 "mc_line 76 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d expanding start label for mc command" 
2 MCWRK  * 2 do:f3 
LBLSTS2, MCWRK  * 4 
LBLF2, MCWRK  * 3 
LBLSTS1, MCWRK  
LBLF1, MCREST 
# 77 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d" 
3 d12 
  d1  
  (p1 ph8) 
  DELTA2 pl3:f3 
  (p2 ph9) 
  d0 
  (p22 ph1):f3 
 
  d0 
  (p1 ph10) 
  TAU setnmr2|0 setnmr0|34|32|33 
  p16:gp1 
  d16 
  (p1 ph11) 
  d26 
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  (center (p2 ph1) (p22 ph6):f3 ) 
  d26 
  (p1 ph2)  
 
  4u pl0:f1 
  (p11:sp1 ph12):f1 
  4u 
  p16:gp2 
  d16 pl1:f1 
 
  (p21 ph3):f3 
  d10  
  (p2 ph7) 
 
  d10 
  p16:gp3*EA 
  d16 
  (p22 ph4):f3 
  DELTA 
  (center (p1 ph1) (p21 ph4):f3 ) 
  p16:gp4 
  d16 
  DELTA3 
  (center (p2 ph1) (p22 ph1):f3 ) 
  DELTA3 
  p16:gp4 
  d16 
  (center (p1 ph2) (p21 ph5):f3 ) 
  p16:gp5 
  d16 
  DELTA4 
  (center (p2 ph1) (p22 ph1):f3 ) 
  DELTA4 
  p16:gp5 
  d16 
  (p1 ph1) 
  DELTA1 
  (p2 ph1) 
  d13 
  p19:gp6 
  d16 pl16:f3 
  4u setnmr2^0 setnmr0^34^32^33 
  go=2 ph31 cpd3:f3 
# 1 "mc_line 145 file C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d expanding mc command in line" 
  MCWRK  do:f3 wr #0 if #0 zd igrad EA  
MCWRK  ip5*2 
  lo to LBLSTS2 times 2 
  MCWRK id10  MCWRK  ip3*2  MCWRK  
ip6*2  MCWRK  ip31*2 
  lo to LBLF2 times ST2CNT 
  MCWRK rd10  MCWRK  ip8  MCWRK  ip9 
  lo to LBLSTS1 times 2 
  MCWRK id0 
  lo to LBLF1 times ST1CNT 
# 148 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3
d" 
exit 
 
ph1=0  
ph2=1 
ph3=0 2 
ph4=0 0 2 2 
ph5=1 1 3 3 
ph6=0 
ph7=0 0 2 2 
ph8=0 0 0 0 2 2 2 2 
ph9=1 1 1 1 3 3 3 3 
ph10=0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
     2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
ph11=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph12=2 2 2 2 2 2 2 2 0 0 0 0 0 0 0 0 
ph31=0 2 2 0 2 0 0 2 2 0 0 2 0 2 2 0 
     2 0 0 2 0 2 2 0 0 2 2 0 2 0 0 2 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl16: f3 channel - power level for CPD/BB 
decoupling 
;sp1 : f1 channel - shaped pulse  90 degree 
;sp13: f2 channel - shaped pulse 180 degree 
(adiabatic) 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p8 : f2 channel - 180 degree shaped pulse for 
inversion (adiabatic) 
;p11: f1 channel -  90 degree shaped pulse 
;p16: homospoil/gradient pulse                         [1 
msec] 
;p19: homospoil/gradient pulse                         
[300 usec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;d0 : incremented delay (F1 in 3D)                     
[3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d8 : mixing time 
;d10: incremented delay (F2 in 3D)                     
[3 usec] 
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;d11: delay for disk I/O                               [30 
msec] 
;d12: delay for power switching                        
[20 usec] 
;d13: short delay                                      [4 usec] 
;d16: delay for homospoil/gradient recovery 
;d24: 1/(4J)YH for YH 
;     1/(8J)YH for all multiplicities 
;d26: 1/(4J(YH)) 
;cnst4: = J(YH) 
;in0: 1/(2 * SW(H)) = DW(H) 
;nd0: 2 
;in10: 1/(2 * SW(X)) = DW(X) 
;nd10: 2 
;NS: 8 * n 
;DS: >= 16 
;td1: number of experiments in F1 
;td2: number of experiments in F2 
;FnMODE: States-TPPI (or TPPI) in F1 
;FnMODE: echo-antiecho in F2 
;cpd3: decoupling according to sequence defined 
by cpdprg3 
;pcpd3: f3 channel - 90 degree pulse for 
decoupling sequence 
 
;use gradient ratio: gp 1 : gp 2 : gp 3 :  gp 4 
: gp 5 : gp 6 
;     30 :  -50 :   80 :    11 :    
5 : 8.1*x 
 
;   with x = p16/p19 
 
;for z-only gradients: 
;gpz1: 30% 
;gpz2: -50% 
;gpz3: 80% 
;gpz4: 11% 
;gpz5: 5% 
;gpz6: 27% (8.1% *p16(=1 ms)/p19(=300 us)) 
 
;use gradient files: 
;gpnam1: SINE.100 
;gpnam2: SINE.100 
;gpnam3: SINE.100 
;gpnam4: SINE.100 
;gpnam5: SINE.100 
;gpnam6: SINE.50 
 
                                          ;preprocessor-flags-
start 
;LABEL_CN: for C-13 and N-15 labeled 
samples start experiment with  
;             option -DLABEL_CN (eda: 
ZGOPTNS) 
                                          ;preprocessor-flags-
end 
 
 
;$Id: noesyhsqcfpf3gpsi3d,v 1.1.2.3 2003/06/18 
15:27:56 ber Exp 
  
 
